Processing 00000000.tx.1: Overexpression of Bcl-xL in -cells prevents cell death but impairs mitochondrial signal for insulin secretion Yun-Ping Zhou1, John C. 

Phrase: "Overexpression of Bcl-xL in -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "impairs"

Phrase: "mitochondrial signal for insulin secretion Yun-Ping Zhou1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "John C."
Processing 00000000.tx.2: Pena2, Michael W. 

Phrase: "Pena2,"

Phrase: "Michael W."
Processing 00000000.tx.3: Roe1, Anshu Mittal1, Matteo Levisetti1, Aaron C. 

Phrase: "Roe1,"

Phrase: "Anshu Mittal1,"

Phrase: "Matteo Levisetti1,"

Phrase: "Aaron C."
Processing 00000000.tx.4: Baldwin1, William Pugh1, Diane Ostrega1, Noreen Ahmed1, Vytautas P. 

Phrase: "Baldwin1,"

Phrase: "William Pugh1,"

Phrase: "Diane Ostrega1,"

Phrase: "Noreen Ahmed1,"

Phrase: "Vytautas P."
Processing 00000000.tx.5: Bindokas3, Louis H. 

Phrase: "Bindokas3,"

Phrase: "Louis H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.6: Philipson1, Douglas Hanahan4, Craig B. 

Phrase: "Philipson1,"

Phrase: "Douglas Hanahan4,"

Phrase: "Craig B."
Processing 00000000.tx.7: Thompson2, and Kenneth S. 

Phrase: "Thompson2,"

Phrase: "and"

Phrase: "Kenneth S."
Processing 00000000.tx.8: Polonsky1 1Department of Medicine, Section of Endocrinology; 

Phrase: "Polonsky1 1Department of Medicine,"

Phrase: "Section of Endocrinology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205155:Section [Spatial Concept]
   790   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   790   C1522472:Section [Substance]
   790   C1552923:Section [Quantitative Concept]
   790   C1705191:Section [Physical Object]

Phrase: ";"
Processing 00000000.tx.9: 2Howard Hughes Medical Institute and Departments of Medicine, Molecular Genetics and Cell Biology, 3Pharmacology and Physiology, University of Chicago, Chicago, Illinois 60637; 

Phrase: "2Howard Hughes Medical Institute"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0021622:institute [Organization]
   812   C1272753:Institute [Idea or Concept]

Phrase: "and"

Phrase: "Departments of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1704729:Department [Organization]

Phrase: "Molecular Genetics"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   861   C0017398:Genetics [Biomedical Occupation or Discipline]
   861   C0017399:genetics [Biologic Function]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "and"

Phrase: "Cell Biology,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "3Pharmacology"

Phrase: "and"

Phrase: "Physiology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031842:Physiology [Biomedical Occupation or Discipline]
  1000   C0031843:physiology [Physiologic Function]
   928 E C0205463:Physiologic [Functional Concept]

Phrase: "University of Chicago,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0008044:Chicago [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "Illinois 60637"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020898:Illinois [Geographic Area]

Phrase: ";"
Processing 00000000.tx.10: and 4Department of Biochemistry, University of California at San Francisco, San Francisco, California 94143  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES To study effects of Bcl-xL in the pancreatic -cell, two transgenic lines were produced using different forms of the rat insulin promoter. 

Phrase: "and"

Phrase: "4Department of Biochemistry,"

Phrase: "University of California at San Francisco,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0006754:California [Geographic Area]
   753   C0041740:University [Manufactured Object,Organization]
   753   C3146274:California [Plant]

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "California 94143  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "effects of Bcl-xL"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "in the pancreatic -cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "two transgenic lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0003069:Transgenic [Animal]
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "produced"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "different forms of the rat insulin promoter."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]
Processing 00000000.tx.11: Bcl-xL expression in -cells was increased 2-to 3-fold in founder (Fd) 1and over 10-fold in Fd 2compared with littermate controls. 

Phrase: "Bcl-xL expression in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "in founder (Fd) 1and"

Phrase: "over 10-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "in Fd 2compared"

Phrase: "with littermate controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.12: After exposure to thapsigargin (10M for 48h), losses of cell viability in islets of Fd 1and Fd 2Bcl-xL transgenic mice were significantly lower than in islets of wild-type mice. 

Phrase: "After exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(10M for 48h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "losses of cell viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1517945:Loss [Quantitative Concept]

Phrase: "in islets"

Phrase: "of Fd 1and Fd 2Bcl-xL transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "significantly lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "in islets"

Phrase: "of wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.13: Unexpectedly, severe glucose intolerance was observed in Fd 2but not Fd 1Bcl-xL mice. 

Phrase: "Unexpectedly,"

Phrase: "severe glucose intolerance"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   901   C0271650:Glucose Intolerance [Disease or Syndrome]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0231199:Intolerance [Organism Function]
   827   C1744706:intolerance [Intellectual Product]
   827   C2355652:Intolerance [Organism Attribute]
   755 E C0231200:Intolerant [Functional Concept]

Phrase: "was"

Phrase: "observed in Fd 2but"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0263541:Founder [Disease or Syndrome]
   770   C1441672:Observed [Functional Concept]

Phrase: "not Fd 1Bcl-xL mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.14: Pancreatic insulin content and islet morphology were not different from control in either transgenic line. 

Phrase: "Pancreatic insulin content"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "islet morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "were"

Phrase: "not different from control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "in either transgenic line."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0003069:Transgenic [Animal]
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]
Processing 00000000.tx.15: However, Fd 2Bcl-xL islets had impaired insulin secretory and intracellular free Ca2+ ([Ca2+]i) responses to glucose and KCl. 

Phrase: "However,"

Phrase: "Fd 2Bcl-xL islets"

Phrase: "had"

Phrase: "impaired insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "secretory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secretory [Cell Function]

Phrase: "and"

Phrase: "intracellular free Ca2+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0175996:intracellular [Cell Component]
   827   C0178719:Intracellular [Spatial Concept]
   827   C0332296:free [Functional Concept]
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1880497:Free [Qualitative Concept]
   827   C1996904:Free [Qualitative Concept]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i) responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "KCl."
Processing 00000000.tx.16: Furthermore, insulin and [Ca2+]i responses to pyruvate methyl ester (PME) were similarly reduced as glucose in Fd 2Bcl-xL islets. 

Phrase: "Furthermore,"

Phrase: "insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and ["

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to pyruvate methyl ester (PME)"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "were"

Phrase: "similarly"

Phrase: "reduced as glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "in Fd 2Bcl-xL islets."
Processing 00000000.tx.17: Consistent with a mitochondrial defect, glucose oxidation, but not glycolysis, was significantly lower in Fd 2Bcl-xL islets than in wild-type islets. 

Phrase: "Consistent with a mitochondrial defect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "glucose oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "but"

Phrase: "not glycolysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017952:Glycolysis [Molecular Function]

Phrase: "was"

Phrase: "significantly lower in Fd 2Bcl-xL islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0441994:Lower [Spatial Concept]
   748   C1548802:Lower [Body Location or Region]
   748   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in wild-type islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.18: Glucose-, PME-, and -ketoisocaproate-induced hyperpolarization of mitochondrial membrane potential, NAD(P)H, and ATP production were also significantly reduced in Fd 2Bcl-xL islets. 

Phrase: "Glucose-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "PME-,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: "and -"

Phrase: "ketoisocaproate-induced hyperpolarization of mitochondrial membrane potential,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C2262820:membrane hyperpolarization [Cell Function]

Phrase: "NAD(P)H,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0027289:NAD(H) [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "ATP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "were"

Phrase: "also significantly"

Phrase: "reduced in Fd 2Bcl-xL islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0263541:Founder [Disease or Syndrome]
   753   C0392756:Reduced [Qualitative Concept]
Processing 00000000.tx.19: Thus, although Bcl-xL promotes -cell survival, high levels of expression of Bcl-xL result in reduced glucose-induced insulin secretion and hyperglycemia due to a defect in mitochondrial nutrient metabolism and signaling for insulin secretion. apoptosis; 

Phrase: "Thus,"

Phrase: "although"

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "promotes -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "cell survival,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007620:Cell Survival [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0038952:Survival [Activity]
   861   C0220921:survival [Functional Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "high levels of expression of Bcl-xL result"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   750   C3244092:expression level [Idea or Concept]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "in reduced glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   853   C1719133:Glucose/Insulin [Quantitative Concept]
   840   C1256369:insulin secretion [Cell Function]
   804   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C0036536:secretion [Biologic Function]
   804   C0036537:Secretion [Body Substance]
   804   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   804   C1579433:Insulin [Pharmacologic Substance]
   748 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   721 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "hyperglycemia due to a defect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "in mitochondrial nutrient metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "signaling for insulin secretion. apoptosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1622858:apoptosis signaling [Cell Function]
   760   C0037083:Signaling [Cell Function]
   760   C3537152:signaling [Biologic Function]

Phrase: ";"
Processing 00000000.tx.20: calcium; 

Phrase: "calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0006726:Calcium [Inorganic Chemical]
  1000   C2936886:Calcium [Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.21: islets of Langerhans; 

Phrase: "islets of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets

Phrase: ";"
Processing 00000000.tx.22: mitochondria  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES APOPTOSIS OR PROGRAMMED cell death is an important biological process essential for the development and maintenance of multicellular organisms (36, 42). 

Phrase: "mitochondria  INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "APOPTOSIS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "OR"

Phrase: "PROGRAMMED cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:Programmed Cell Death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "an important biological process"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0031845:Biological Process [Physiologic Function]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "essential for the development"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205224:Essential [Qualitative Concept]

Phrase: "and"

Phrase: "maintenance of multicellular organisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0024501:Maintenance [Activity]

Phrase: "(36,"

Phrase: "42"

Phrase: ")."
Processing 00000000.tx.23: Changes in the rate of apoptosis may underlie a variety of common diseases (38). 

Phrase: "Changes in the rate of apoptosis"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "may"

Phrase: "underlie"

Phrase: "a variety of common diseases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1883525:Variety [Conceptual Entity]
   760   C2346866:Variety [Conceptual Entity]

Phrase: "(38"

Phrase: ")."
Processing 00000000.tx.24: Members of the bcl-2 protooncogene family encode proteins that function either to promote or to inhibit apoptosis (3, 12, 43). 

Phrase: "Members of the bcl-2 protooncogene family"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   774   C0086282:Family Members [Family Group]
   757 E C1611821:Family Member [Intellectual Product]
   748   C0680022:members [Population Group]
   714 E C2698041:Member [Professional or Occupational Group]

Phrase: "encode"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that function either to"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0031843:function [Physiologic Function]
   827   C0542341:Function [Functional Concept]
   827   C0700205:FUNCTION [Classification]
   827   C1705273:Function [Intellectual Product]
   755 E C0205245:Functional [Functional Concept]
   755 E C2700217:Functional [Conceptual Entity]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "or"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "12,"

Phrase: "43"

Phrase: ")."
Processing 00000000.tx.25: Anti-apoptotic products of this gene family, such as Bcl-2 and Bcl-xL, prevent programmed cell death in response to a wide variety of stimuli (3). 

Phrase: "Anti-apoptotic products of this gene family,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C0033684:gene product [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   757   C1704222:Gene Product [Amino Acid, Peptide, or Protein,Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "such as Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "Bcl-xL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "programmed cell death in response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0162638:Programmed Cell Death [Cell Function]
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "to a wide variety"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883525:Variety [Conceptual Entity]
   861   C2346866:Variety [Conceptual Entity]

Phrase: "of stimuli"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234402:Stimuli [Phenomenon or Process]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.26: Bcl-xL is present in mitochondrial, endoplasmic reticulum, and nuclear membranes (38, 29). 

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "is"

Phrase: "present in mitochondrial, endoplasmic reticulum,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "nuclear membranes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028584:Nuclear membranes [Cell Component]
   861   C0025255:Membranes [Tissue]
   861   C0521447:Nuclear [Spatial Concept]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]

Phrase: "(38,"

Phrase: "29"

Phrase: ")."
Processing 00000000.tx.27: Recent studies have demonstrated that Bcl-xL or Bcl-2 inhibits apoptosis via multiple effects in mitochondria, such as inhibiting release of mitochondrial cytochrome c (11), increasing mitochondrial Ca2+ uptake (22), facilitating mitochondrial ATP/ADP exchange (40), and maintaining normal mitochondrial volume (41). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "or"

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis via multiple effects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "in mitochondria,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "such as inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "release of mitochondrial cytochrome c"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   806   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   806   C1153524:cytochrome c [Molecular Function]
   806   C1426584:CYTOCHROME C [Gene or Genome]
   760   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1325304:cytochrome [Molecular Function]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(11"

Phrase: ")"

Phrase: ","

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "mitochondrial Ca2+ uptake"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0243144:Uptake [Physiologic Function]
   827   C0347980:% uptake [Quantitative Concept]
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "(22"

Phrase: ")"

Phrase: ","

Phrase: "facilitating"

Phrase: "mitochondrial ATP/ADP exchange"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1153238:ATP/ADP exchange [Molecular Function]
   812   C0678640:exchange [Social Behavior]

Phrase: "(40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "maintaining normal mitochondrial volume"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   875   C0332506:Normal volume [Quantitative Concept]
   861   C1720929:Mitochondrial Volume [Quantitative Concept]
   812   C0449468:*Volume [Quantitative Concept]
   812   C1690016:% volume [Qualitative Concept]
   812   C1705102:Volume [Intellectual Product]
   812   C2700258:Volume [Laboratory Procedure]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.28: Because mitochondria play an important role in the stimulus-secretion coupling of glucose-induced insulin secretion in pancreatic -cells (19, 24), whether Bcl-xL changes mitochondrial function in -cells, thereby affecting insulin secretion, is an important issue to address. 

Phrase: "Because"

Phrase: "mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in the stimulus-secretion coupling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "of glucose-induced insulin secretion"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in pancreatic -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(19,"

Phrase: "24"

Phrase: ")"

Phrase: ","

Phrase: "whether"

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "mitochondrial function in -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "thereby"

Phrase: "affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affecting [Functional Concept]
  1000   C1314939:Affecting [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "insulin secretion,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "is"

Phrase: "an important issue to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0033213:Issue [Finding]
   827   C1706387:Issue [Intellectual Product]

Phrase: "address."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]
Processing 00000000.tx.29: Apoptosis is known to mediate autoimmune destruction of -cells in type 1diabetes (13) and postpartum involution of -cell mass in the rat (34). 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "mediate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "autoimmune destruction of -cells in type 1diabetes"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   793   C0449475:Type of cell [Intellectual Product]
           cells type
   757 E C0007634:Cell Type [Cell]
           Cells
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "(13"

Phrase: ")"

Phrase: "and"

Phrase: "postpartum involution of -cell mass in the rat"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0577559:Mass [Finding]
   744   C1306372:*Mass [Quantitative Concept]
   744   C3152252:Mass [Quantitative Concept]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.30: We and others have recently suggested that subtle increases in the rate of -cell apoptosis may contribute to loss of -cell mass in some animal models of type 2diabetes, such as the Zucker fatty diabetic rat (26) and Psammomys obesus (1). 

Phrase: "We"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that subtle increases in the rate of -cell apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]

Phrase: "may"

Phrase: "contribute to loss of -cell mass"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0007634:Cell [Cell]
   753   C0577559:Mass [Finding]
   753   C1269647:Cell [Cell]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1517945:Loss [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1880177:Contribute [Activity]
   753   C1948049:Cell [Spatial Concept]
   753   C3152252:Mass [Quantitative Concept]

Phrase: "in some animal models"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0599779:Models, Animal [Animal]
   861   C0003062:Animal [Animal]
   861   C3161035:Models [Intellectual Product]

Phrase: "of type 2diabetes,"

Phrase: "such as the Zucker fatty diabetic rat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0034719:Zucker rat [Mammal]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
   812   C0241863:DIABETIC [Finding]

Phrase: "(26"

Phrase: ")"

Phrase: "and"

Phrase: "Psammomys obesus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1013768:Psammomys obesus [Mammal]
   861   C0033783:Psammomys [Mammal]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.31: In light of these observations, interventions that could reduce the rate of -cell apoptosis may have substantial potential in the prevention and treatment of diabetes. 

Phrase: "In light of these observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "interventions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886296:interventions [Health Care Activity]
  1000   C1273869:Interventions [Health Care Activity]
  1000   C2979881:Interventions [Clinical Attribute]
  1000   C3542921:Interventions [Classification]
   966 E C1948041:Intervention [Therapeutic or Preventive Procedure]
   916 E C3274035:INTERVENTIONAL [Research Activity]

Phrase: "that"

Phrase: "could"

Phrase: "reduce"

Phrase: "the rate of -cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "may"

Phrase: "have"

Phrase: "substantial potential in the prevention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3245505:Potential [Qualitative Concept]

Phrase: "and"

Phrase: "treatment of diabetes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.32: One approach is to overexpress the anti-apoptotic protein Bcl-xL in pancreatic -cells. 

Phrase: "One approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]

Phrase: "is"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "the anti-apoptotic protein Bcl-xL in pancreatic -cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   784   C0288330:BCL-XL Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1332397:bcl-xL [Gene or Genome]
Processing 00000000.tx.33: The present study was undertaken to test the feasibility of such an approach by producing transgenic mice that overexpress Bcl-xL in the pancreatic -cell. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "undertaken"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the feasibility of such"

Phrase: "an approach by producing transgenic mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449445:Approach [Spatial Concept]

Phrase: "that"

Phrase: "overexpress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:overexpress [Genetic Function]

Phrase: "Bcl-xL in the pancreatic -cell."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1332397:bcl-xL [Gene or Genome]
Processing 00000000.tx.34: The results demonstrate that Bcl-xL overexpression does partially protect -cells from death induced by thapsigargin, an agent that induces apoptosis in insulin-secreting -cells by inhibiting the sarcoendoplasmic reticulum Ca2+-ATPase and depleting intracellular Ca2+ stores (46). 

Phrase: "The results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that Bcl-xL overexpression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1514559:Overexpression [Genetic Function]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "does"

Phrase: "partially"

Phrase: "protect -"

Phrase: "cells from death"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   858   C0007587:cells death [Cell Function]
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "induced by thapsigargin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0205263:Induced [Functional Concept]

Phrase: "an agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450442:Agent [Chemical Viewed Functionally]
  1000   C1254351:Agent [Pharmacologic Substance]
  1000   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in insulin-secreting -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "by inhibiting"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C3463820:Inhibiting [Activity]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C0311403:Inhibited [Qualitative Concept]

Phrase: "the sarcoendoplasmic reticulum Ca2+-ATPase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0916181:Sarco-Endoplasmic Reticulum Ca2+-ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0001476:Ca2+ ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0001473:ATPase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1706373:ATPase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "depleting intracellular Ca2+ stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1698986:Store [Functional Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.35: However, marked overexpression of Bcl-xL resulted in a severe defect in insulin secretion and hyperglycemia in the Bcl-xL transgenic mice. 

Phrase: "However,"

Phrase: "marked overexpression of Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "resulted in a severe defect"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205082:Severe [Qualitative Concept]
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and"

Phrase: "hyperglycemia in the Bcl-xL transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020456:Hyperglycaemia [Disease or Syndrome]
   738   C0162418:Hyperglycemic Mice [Mammal]
Processing 00000000.tx.36: Further studies revealed that the impairment in pancreatic -cell function can largely be accounted for by alteration in mitochondrial nutrient metabolism and the consequent generation of ATP or other signaling molecules for insulin secretion. 

Phrase: "Further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "that"

Phrase: "the impairment in pancreatic -cell function"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0684336:Impairment [Pathologic Function]

Phrase: "can"

Phrase: "largely"

Phrase: "be"

Phrase: "accounted for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1551359:account [Idea or Concept]
   799   C2741673:Account # [Clinical Attribute]
   799   C2981730:Account [Classification]

Phrase: "by alteration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1515926:Alteration [Idea or Concept]

Phrase: "in mitochondrial nutrient metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "the consequent generation of ATP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "or"

Phrase: "other signaling molecules for insulin secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   773   C1519315:Signaling Molecule [Biologically Active Substance]
   753   C0567416:molecules [Substance]
Processing 00000000.tx.37: These unexpected phenotypic and functional changes associated with the overexpression of Bcl-xL in -cells should be taken into account in efforts that target Bcl-xL or other proteins to the pancreatic -cell for therapeutic purposes.  

Phrase: "These unexpected phenotypic"

Phrase: "and"

Phrase: "functional changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0205245:Functional [Functional Concept]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   861   C0542341:Functional [Functional Concept]
   861   C2700217:Functional [Conceptual Entity]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "associated with the overexpression of Bcl-xL in -cells"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
   764   C0332281:Associated with [Qualitative Concept]
           Associated
   764   C1332397:bcl-xL [Gene or Genome]
   745   C0699040:cell associated [Cell Component]
   742   C0007634:Cells [Cell]
   742   C1514559:Overexpression [Genetic Function]
   742   C3282337:Cells [Cell]
   708 E C0750490:Associate [Idea or Concept]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1706221:Associate [Professional or Occupational Group]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "should"

Phrase: "be"

Phrase: "taken into account"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1551359:account [Idea or Concept]
   790   C1883727:Taken [Conceptual Entity]
   790   C2741673:Account # [Clinical Attribute]
   790   C2981730:Account [Classification]
   756 E C1515187:Take [Health Care Activity]

Phrase: "in efforts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0015264:Effort [Organism Function]

Phrase: "that"

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "or"

Phrase: "other proteins to the pancreatic -cell"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "for therapeutic purposes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1285529:purposes [Functional Concept]
Processing 00000000.tx.38: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Generation of the transgenic mice. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Generation of the transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]
Processing 00000000.tx.39: Two Bcl-xL rat insulin promoter (RIP) constructs were employed to express Bcl-xL in pancreatic -cells (Fig. 1A). 

Phrase: "Two Bcl-xL rat insulin promoter (RIP) constructs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C2827421:Construct [Classification]

Phrase: "were"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "express"

Phrase: "Bcl-xL in pancreatic -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C1332397:bcl-xL [Gene or Genome]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.40: Both vectors contained the same blunt-ended 0.82-kb human bcl-xL cDNA (25). 

Phrase: "Both vectors"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086022:Vectors [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vectors [Spatial Concept]
   966 E C1705099:Vector [Idea or Concept]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "the same blunt-ended 0.82-kb human bcl-xL cDNA (25"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   801   C1332397:bcl-xL [Gene or Genome]
   788   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   788   C0086418:Human [Human]
   788   C0445247:Same [Qualitative Concept]
   788   C1272693:Ended [Qualitative Concept]
   788   C2746065:Ended [Temporal Concept]
   755 E C0444930:End [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.41: To induce specific expression in -cells, the bcl-xL cDNA was ligated to the 3' ends of either RIP1 or RIP7. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "specific expression in -cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "the bcl-xL cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "was"

Phrase: "ligated to the 3' ends of either RIP1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   744   C0444930:ends [Spatial Concept]
   744   C3539807:RIP1 [Gene or Genome]
   711 E C2746065:End [Temporal Concept]

Phrase: "or"

Phrase: "RIP7."
Processing 00000000.tx.42: RIP1, a 0.50-kb Sac I/BstB I fragment of the RIP (9) was used to generate Fd 1Bcl-xL trangenic mice. 

Phrase: "RIP1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539807:RIP1 [Gene or Genome]

Phrase: "a 0.50-kb Sac I/BstB I fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0332255:fragment [Functional Concept]
   793   C1708096:Fragment [Qualitative Concept]

Phrase: "of the RIP"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(9"

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "Fd 1Bcl-xL trangenic mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.43: RIP7, used in the Fd 2transgenic line, was composed of a much longer (12.9-kb) promoter/enhancer intron region from the rat insulin II gene (23). 

Phrase: "RIP7,"

Phrase: "used in the Fd 2transgenic line,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0205132:Line [Spatial Concept]
   753   C0263541:Founder [Disease or Syndrome]
   753   C1273517:used [Finding]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "composed of a much longer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]

Phrase: "(12.9-kb) promoter/enhancer intron region"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   845   C0033413:Region, Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C0017446:Region [Geographic Area]
   795   C0205147:Region [Spatial Concept]
   724 E C0205276:Regional [Spatial Concept]
   724 E C1947913:Regional [Spatial Concept]

Phrase: "from the rat insulin II gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   875   C1337112:Insulin Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "(23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.44: Original founders were screened by PCR analysis using the primers 5'-CCGAATTCTTG GACAATGGAC-TGGTTGA-3' and 3'-CCGAATTCGTAGAG-TGGATGATCAGTG-5' and were confirmed by Southern blot using a 32P-labeled full-length bcl-xL cDNA probe. 

Phrase: "Original founders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:founders [Disease or Syndrome]

Phrase: "were"

Phrase: "screened by PCR analysis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C0200931:PCR analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0677874:pCR [Finding]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737   C0220908:screen [Health Care Activity]
   737   C1305399:screen [Functional Concept]
   737   C1705053:Screen [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the primers 5'-CCGAATTCTTG GACAATGGAC-TGGTTGA-3'"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   766   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "3'-CCGAATTCGTAGAG-TGGATGATCAGTG-5'"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C0442758:3 5 [Quantitative Concept]
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "were"

Phrase: "confirmed by Southern blot"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0005862:Southern Blot [Molecular Biology Research Technique]
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   833   C1148472:Blot, Southern [Laboratory or Test Result]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1710133:Southern [Spatial Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 32P-labeled full-length bcl-xL cDNA probe."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C0182400:Probe [Medical Device]
   793   C1704681:Probe [Gene or Genome]
   793   C2347609:Probe [Chemical Viewed Functionally]
   793   C3536729:Probe [Manufactured Object]
Processing 00000000.tx.45: Once founder lines were established, PCR was used exclusively to identify transgenic progeny. 

Phrase: "Once founder lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: ","

Phrase: "PCR"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
  1000   C0677874:pCR [Finding]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "exclusively to"

Phrase: "identify"

Phrase: "transgenic progeny."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0680063:Progeny [Family Group]
Processing 00000000.tx.46: View larger version (21K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.47: 1.  

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.48: Transgene construct and expression of Bcl-xL gene in pancreatic islets. 

Phrase: "Transgene construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "expression of Bcl-xL gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0017262:Gene Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in pancreatic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
Processing 00000000.tx.49: A: founder (Fd) 1transgenic line [rat insulin promoter (RIP) 1construct] had the bcl-xL cDNA cloned downstream of RIP1 and was immediately followed by an intronic sequence with a polyadenylation sequence. 

Phrase: "A"

Phrase: ":"

Phrase: "founder"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0263541:Founder [Disease or Syndrome]

Phrase: "(Fd"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0263541:Founder [Disease or Syndrome]

Phrase: ")"

Phrase: "1transgenic line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "[rat insulin promoter"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(RIP"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0034693:Rat, NOS [Mammal]
   827   C0034721:Rat [Mammal]
   827   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: ")"

Phrase: "1construct"

Phrase: "]"

Phrase: "had"

Phrase: "the bcl-xL cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "cloned downstream of RIP1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0009013:cloned [Cell]
   770   C0522506:Downstream [Spatial Concept]
   770   C3539807:RIP1 [Gene or Genome]
   737 E C1522642:Clone [Tissue]

Phrase: "and"

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "followed by an intronic sequence"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C1519249:Sequence [Functional Concept]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "with a polyadenylation sequence."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0004793:Sequence [Nucleotide Sequence]
   861   C0162326:Sequence [Nucleotide Sequence]
   861   C0162327:Sequence [Nucleotide Sequence]
   861   C1519249:Sequence [Functional Concept]
   789 E C1548958:Sequential [Idea or Concept]
   789 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.50: Isolation of the construct was completed using the displayed restriction sites. 

Phrase: "Isolation of the construct"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "was"

Phrase: "completed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:COMPLETED [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the displayed restriction sites."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1882940:Restriction Site [Nucleotide Sequence]
   827   C0205145:Sites [Spatial Concept]
   827   C0443288:Restriction [Functional Concept]
   793 E C1515974:Site [Body Location or Region]
   793 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.51: The Fd 2transgenic line (RIP7 construct) used the enhancer region upstream of RIP2. 

Phrase: "The Fd 2transgenic line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205132:Line [Spatial Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: "(RIP7 construct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2827421:Construct [Classification]

Phrase: ")"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the enhancer region upstream of RIP2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C1883644:Upstream Region [Nucleotide Sequence]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]
Processing 00000000.tx.52: The bcl-xL cDNA was cloned directly downstream of the intronic sequence followed by a polyadenylation sequence. 

Phrase: "The bcl-xL cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "was"

Phrase: "cloned"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0009013:cloned [Cell]
   966 E C1522642:Clone [Tissue]

Phrase: "directly downstream of the intronic sequence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0522506:Downstream [Spatial Concept]
   753   C1519249:Sequence [Functional Concept]
   753   C1947931:Directly [Qualitative Concept]

Phrase: "followed by a polyadenylation sequence."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0004793:Sequence [Nucleotide Sequence]
   760   C0162326:Sequence [Nucleotide Sequence]
   760   C0162327:Sequence [Nucleotide Sequence]
   760   C0949765:Polyadenylation [Molecular Function]
   760   C1519249:Sequence [Functional Concept]
   726 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.53: I, intron; 

Phrase: "I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "intron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ";"
Processing 00000000.tx.54: P(A), polyadenylation signal. 

Phrase: "P(A),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "polyadenylation signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.55: B: Western blot analysis of wild-type vs. transgenic islets from both Fd 1and 2mice. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "Western blot analysis of wild-type"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   790   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1705493:Western [Spatial Concept]

Phrase: "vs. transgenic islets from both Fd 1and 2mice."
Processing 00000000.tx.56: Immunoblotting. 

Phrase: "Immunoblotting."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.57: Islets from wild-type and Bcl-xL transgenic mice were washed in PBS and lysed by passing them through a 25-gauge needle five times in RIPA buffer (1% Nonidet P-40, 1% deoxycholate, and 0.1% SDS) containing aprotinin, phenylmethylsulfonyl fluoride, and leupeptin. 

Phrase: "Islets from wild-type"

Phrase: "and"

Phrase: "Bcl-xL transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "washed in PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "by passing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006539:BY [Geographic Area]
   827   C2828386:Pass [Finding]

Phrase: "them through a 25-gauge needle five times"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0456638:25 gauge [Quantitative Concept]
   767   C3640175:Needle Gauge [Quantitative Concept]
   744   C0027551:Needle [Medical Device]
   744   C0040223:times [Temporal Concept]
   744   C0205451:Five [Quantitative Concept]
   744   C0456564:Gauge [Spatial Concept]
   744   C1521879:GAGE [Immunologic Factor]
   744   C1632851:Times [Quantitative Concept]
   744   C1704318:Needle [Medical Device]
   744   C1882041:Needle [Spatial Concept]
   711 E C3541383:Time [Temporal Concept]

Phrase: "in RIPA buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(1% Nonidet P-40,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0068941:Nonidet P-40 [Organic Chemical,Pharmacologic Substance]
   812   C0068940:nonidet [Organic Chemical,Pharmacologic Substance]
   812   C0439509:/40 [Temporal Concept]

Phrase: "1% deoxycholate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086123:Deoxycholate [Hormone,Pharmacologic Substance,Steroid]

Phrase: "and"

Phrase: "0.1% SDS) containing aprotinin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0003641:Aprotinin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "phenylmethylsulfonyl fluoride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031493:Phenylmethylsulfonyl Fluoride [Organic Chemical,Pharmacologic Substance]
   861   C0016327:Fluoride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "leupeptin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0064858:leupeptin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
Processing 00000000.tx.58: Protein samples (50g, quantified by bicinchoninic acid; Pierce, Rockford, IL) were separated in a 15% polyacrylamide-SDS gel. 

Phrase: "Protein samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "(50g,"

Phrase: "quantified by bicinchoninic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0053554:bicinchoninic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "; Pierce,"

Phrase: "Rockford,"

Phrase: "IL)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: "were"

Phrase: "separated in a 15% polyacrylamide-SDS gel."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   748   C0086972:Separated [Finding]
   748   C0443299:separated [Spatial Concept]
   748   C0687118:Separated [Functional Concept]
   748   C1382104:Gel [Substance]
Processing 00000000.tx.59: Proteins were transferred to nitrocellulose and blotted with a monoclonal antibody to Bcl-xL (18). 

Phrase: "Proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "transferred"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0348011:transferred [Functional Concept]
   966 E C0040671:Transfer [Mental Process]
   966 E C1705822:Transfer [Activity]

Phrase: "to nitrocellulose"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0600190:Nitrocellulose [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   777 E C0009357:Collodion Cotton [Biomedical or Dental Material,Pharmacologic Substance]

Phrase: "and"

Phrase: "blotted with a monoclonal antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   760   C0746619:monoclonal [Finding]

Phrase: "to Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.60: Reactive proteins were detected using an enhanced chemiluminescence kit (Amersham, Arlington Heights, IL), and the intensities of the bands were quantified with a densitometer (Molecular Dynamics, Sunnyvale, CA). 

Phrase: "Reactive proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0205332:Reactive [Qualitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an enhanced chemiluminescence kit (Amersham,"

Phrase: "Arlington Heights,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0489786:heights [Organism Attribute]
   777 E C0205250:High [Qualitative Concept]
   777 E C1299351:High [Qualitative Concept]
   777 E C1522410:Highest [Qualitative Concept]
   777 E C2700149:HIGH [Intellectual Product]

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the intensities of the bands"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522510:intensities [Qualitative Concept]

Phrase: "were"

Phrase: "quantified with a densitometer"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0180321:Densitometer [Medical Device]
   770   C1706216:Densitometer [Medical Device]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "(Molecular Dynamics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596957:Molecular Dynamics [Molecular Function]

Phrase: "Sunnyvale,"

Phrase: "CA)."
Processing 00000000.tx.61: Immunohistochemistry. 

Phrase: "Immunohistochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.62: Pancreatic tissue was fixed in 10% neutral buffered Formalin and paraffin embedded. 

Phrase: "Pancreatic tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "fixed in 10% neutral buffered Formalin"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0492002:Neutral buffered formalin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   814   C1550052:Buffered 10% formalin [Biomedical or Dental Material,Organic Chemical]
   814   C1561456:Buffered 10% formalin [Intellectual Product]
   783   C1550067:10% Formalin [Biomedical or Dental Material,Organic Chemical]
   783   C1561470:10% Formalin [Intellectual Product]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0231441:Fixed [Finding]
   753   C0443218:Fixed [Qualitative Concept]
   753   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   753   C1882074:Neutral [Qualitative Concept]
   753   C2825492:Neutral [Phenomenon or Process]
   753   C2827483:Fixed [Body Substance]

Phrase: "and"

Phrase: "paraffin embedded."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   861   C1707903:Embedded [Laboratory Procedure]
Processing 00000000.tx.63: Sections were deparaffinized and rehydrated by standard methods before immunohistochemistry. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "deparaffinized"

Phrase: "and"

Phrase: "rehydrated by standard methods"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0025663:Methods [Intellectual Product]
   770   C0025664:methods [Intellectual Product]
   770   C0449851:Methods [Functional Concept]
   770   C1442989:Standard [Qualitative Concept]
   770   C2828392:Standard [Intellectual Product]
   737 E C0871511:METHOD [Intellectual Product]

Phrase: "before immunohistochemistry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021044:Immunohistochemistry [Laboratory Procedure]
Processing 00000000.tx.64: An antigen retrieval protocol (boiling the slides in citrate buffer for 10min) was employed for Bcl-xL staining in sections of Fd 1Bcl-xL mice. 

Phrase: "An antigen retrieval protocol"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0442711:Protocol [Intellectual Product]
   827   C1507394:Protocol [Intellectual Product]
   827   C1522729:Protocol [Intellectual Product]
   827   C2348563:Protocol [Intellectual Product]

Phrase: "(boiling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242301:Boil [Disease or Syndrome]
   966   C1546559:Boil [Intellectual Product]

Phrase: "the slides in citrate buffer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0444330:slides [Research Device]
   726 E C1705201:Slide [Manufactured Object]

Phrase: "for 10min"

Phrase: ")"

Phrase: "was"

Phrase: "employed for Bcl-xL staining"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1332397:bcl-xL [Gene or Genome]
   760   C0487602:Staining [Laboratory Procedure]
   760   C0557351:Employed [Finding]
   760   C1704680:Staining [Finding]
   726 E C0457083:Employ [Functional Concept]

Phrase: "in sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "of Fd 1Bcl-xL mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.65: The primary antibodies used were a polyclonal guinea pig anti-bovine insulin antibody (1:1,000); 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "a polyclonal guinea pig anti-bovine insulin antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   893   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   877   C0487014:Anti-bovine insulin antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
           Bovine insulin antibody
   852   C0021644:Anti-insulin antibody [Immunologic Factor]
           Insulin antibody
   845   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   795   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   795   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.66: a cocktail of polyclonal antibodies for glucagon, somatostatin, and pancreatic polypeptide (1:1,000; 

Phrase: "a cocktail of polyclonal antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0678420:Cocktail [Food]

Phrase: "for glucagon,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017687:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
  1000   C0876232:Glucagon [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "somatostatin,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0037659:Somatostatin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1881011:Somatostatin [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   916 E C0373723:somatostatins [Laboratory Procedure]

Phrase: "and"

Phrase: "pancreatic polypeptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
  1000   C1418856:pancreatic polypeptide [Gene or Genome]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   861   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.67: Linco Research, St. 

Phrase: "Linco Research,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035168:research [Research Activity]
   861   C0242481:Research [Research Activity]

Phrase: "St."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3272372:ST [Intellectual Product]
Processing 00000000.tx.68: Charles, MO); 

Phrase: "Charles,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.69: and a monoclonal anti-Bcl-xL antibody (1:200). 

Phrase: "and"

Phrase: "a monoclonal anti-Bcl-xL antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ")."
Processing 00000000.tx.70: All blocking and developing reagents were from a Histomouse-SP Bulk Kit (Zymed Laboratories, San Francisco, CA) and were used according to the manufacturer's instructions. 

Phrase: "All"

Phrase: "blocking"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0233660:Blocking [Mental or Behavioral Dysfunction]
  1000   C0332206:Blocking [Functional Concept]
   966 E C0028778:Block [Pathologic Function]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "and"

Phrase: "developing reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were from a Histomouse-SP Bulk Kit (Zymed Laboratories,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   762   C1420002:SP-A [Gene or Genome]
   742   C0012173:Bulk [Food]
   742   C0022877:Laboratories [Manufactured Object,Organization]
   742   C0812225:KIT [Medical Device]
   742   C1150635:KIT [Molecular Function]
   742   C1337615:Bulk [Biomedical or Dental Material]
   742   C1619828:Laboratories [Intellectual Product]
   742   C1705212:Kit [Medical Device]
   742   C1705213:KIT [Medical Device]
   742   C3273202:Kit [Manufactured Object]
   708 E C3244292:laboratory [Functional Concept]

Phrase: "San Francisco,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036152:San Francisco [Geographic Area]
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "and"

Phrase: "were"

Phrase: "used according to the manufacturer's instructions."
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   753   C0302828:instructions [Intellectual Product]
   753   C0680240:according [Social Behavior]
   753   C0947322:Manufacturer [Intellectual Product]
   753   C1273517:used [Finding]
   753   C1442085:Instructions [Idea or Concept]
   753   C1705426:Manufacturer [Population Group]
   753   C3263700:Instructions [Clinical Attribute]
   719 E C0039401:Instruction [Educational Activity]
   719 E C0042153:use [Functional Concept]
   719 E C0457083:Use [Functional Concept]
   719 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.71: Sections treated with the same protocol in the absence of the primary antibodies served as negative controls. 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "treated with the same protocol"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0442711:Protocol [Intellectual Product]
   760   C0445247:Same [Qualitative Concept]
   760   C1507394:Protocol [Intellectual Product]
   760   C1522326:Treated [Functional Concept]
   760   C1522729:Protocol [Intellectual Product]
   760   C2348563:Protocol [Intellectual Product]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of the primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "served as negative controls."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   799   C1639518:% negative control [Quantitative Concept]
   799   C1947986:Negative Control [Conceptual Entity]
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
   737   C0243148:control [Qualitative Concept]
   737   C1550141:Control [Substance]
   737   C1882979:Control [Conceptual Entity]
   737   C2587213:Control [Functional Concept]
   737   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.72: Isolation of pancreatic islets and tests of in vitro cell viability. 

Phrase: "Isolation of pancreatic islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0204727:Isolation [Therapeutic or Preventive Procedure]
   770   C0205409:Isolation [Functional Concept]
   770   C0220862:isolation [Laboratory Procedure]

Phrase: "and"

Phrase: "tests of in vitro cell viability."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0007620:Cell Viability [Cell Function]
   790   C0021135:In Vitro [Intellectual Product]
   790   C1533691:in vitro [Qualitative Concept]
           vitro
   790   C2827718:In Vitro [Functional Concept]
   753   C0007634:Cell [Cell]
   753   C0022885:Test [Laboratory Procedure]
   753   C0039593:Test [Functional Concept]
   753   C0392366:Tests [Intellectual Product]
   753   C0443348:viability [Qualitative Concept]
   753   C1269647:Cell [Cell]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.73: Islets of Langerhans were isolated from the pancreata of 8-to 12-wk-old Bcl-xL transgenic mice and their wild-type littermates by collagenase digestion and discontinuous Ficoll gradient separation, a modification of the original method of Lacy and Kostianovsky (14). 

Phrase: "Islets of Langerhans"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Islets of Langerhans [Body Part, Organ, or Organ Component]
           Langerhans Islets

Phrase: "were"

Phrase: "isolated from the pancreata of 8-"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0205409:Isolated [Functional Concept]
   753   C1548221:Isolated [Idea or Concept]
   719   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   719 E C0370215:Isolate [Substance]
   719   C1278931:Pancreas [Body Part, Organ, or Organ Component]
   719 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "to 12-wk-old Bcl-xL transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   818   C0025936:Mice, Transgenic [Mammal]
   795   C0003069:Transgenic [Animal]
   795   C0025914:Mice [Mammal]
   795   C0025929:mice [Mammal]
   795   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "their wild-type littermates by collagenase digestion"

Phrase: "and"

Phrase: "discontinuous Ficoll gradient separation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0036679:Separation [Pathologic Function]
   812   C0237868:Separation [Social Behavior]
   812   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "a modification of the original method of Lacy"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392747:Modification [Functional Concept]
   744   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "Kostianovsky"

Phrase: "(14"

Phrase: ")."
Processing 00000000.tx.74: Islets were cultured in RPMI 1640medium supplemented with 11mM glucose, 5% FCS, 100IU/ml penicillin, and 100g/ml streptomycin. 

Phrase: "Islets"

Phrase: "were"

Phrase: "cultured in RPMI 1640medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "supplemented with 11mM glucose,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "5% FCS,"

Phrase: "100IU/ml penicillin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030842:Penicillin [Antibiotic,Organic Chemical]
   827   C0220892:Penicillin [Antibiotic,Organic Chemical]

Phrase: "and"

Phrase: "100g/ml streptomycin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]
Processing 00000000.tx.75: Islet cell viability after 48h exposure to thapsigargin was determined by a colorimetric 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay as previously described (20, 46). 

Phrase: "Islet cell viability after 48h exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0007620:Cell Viability [Cell Function]
   753   C0443348:viability [Qualitative Concept]

Phrase: "to thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "was"

Phrase: "determined by a colorimetric 3-"

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyl tetrazolium bromide assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(20,"

Phrase: "46"

Phrase: ")."
Processing 00000000.tx.76: Assessment of glucose tolerance. 

Phrase: "Assessment of glucose tolerance."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1261322:Assessment [Health Care Activity]
   770   C1516048:Assessment [Activity]
Processing 00000000.tx.77: Intraperitoneal glucose tolerance tests (IPGTTs) were performed after a 4-h fast in Bcl-xL transgenic and wild-type control mice. 

Phrase: "Intraperitoneal glucose tolerance tests (IPGTTs)"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   923   C0017741:Glucose tolerance tests [Diagnostic Procedure]
   875   C0595310:glucose tests [Medical Device]
   861   C0178665:Glucose tolerance [Physiologic Function]
   858 E C0337438:glucose test [Laboratory Procedure]
   827   C0201777:Tolerance test [Laboratory Procedure]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0022885:Tests [Laboratory Procedure]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:Tests [Intellectual Product]
   812   C1704410:Tolerance [Qualitative Concept]
   779 E C0039593:Test [Functional Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "were"

Phrase: "performed after a 4-h fast"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   753   C0015663:Fast [Finding]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0456962:Fast [Qualitative Concept]
   753   C0564385:/h [Quantitative Concept]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "wild-type control mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   906   C1520150:Wild Type Mouse [Mammal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.78: Blood was sampled from the tail vein before and 30,60,and 120min after injection of 2g/kg dextrose intraperitoneally. 

Phrase: "Blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
  1000   C0005767:Blood [Tissue]
  1000   C0005768:blood [Body Substance]
  1000   C0229664:Blood [Body Substance]
   928 E C0333275:Bloody [Qualitative Concept]
   916 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   916 E C0392895:Bloods [Population Group]
   916 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   916 E C1511228:VESSEL, BLOOD [Tissue]
   900 E C1558950:VASCULAR [Finding]
   900 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "sampled from the tail vein"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C2985205:Tail Vein [Body Part, Organ, or Organ Component]
   781   C0586999:Vein sample [Tissue]
   760   C0039259:Tail [Body Part, Organ, or Organ Component]
   760   C0042449:Vein [Body Part, Organ, or Organ Component]
   760   C0441621:sampled [Diagnostic Procedure]
   760   C0870078:sampled [Idea or Concept]
   760   C1278960:Vein [Body Part, Organ, or Organ Component]
   726 E C0370003:Sample [Substance]
   726 E C2347026:Sample [Conceptual Entity]

Phrase: "before"

Phrase: "and"

Phrase: "30,"

Phrase: "60,"

Phrase: "and"

Phrase: "120min after injection of 2g/kg dextrose intraperitoneally."
Processing 00000000.tx.79: Insulin secretion from isolated perifused pancreatic islets. 

Phrase: "Insulin secretion from isolated perifused pancreatic islets."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C1256369:insulin secretion [Cell Function]
   774   C0030296:Pancreatic Secretion [Body Substance]
   774   C0232787:Pancreatic secretion [Organ or Tissue Function]
   748   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C0036536:secretion [Biologic Function]
   748   C0036537:Secretion [Body Substance]
   748   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   748   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.80: Insulin secretion from isolated islets was measured in a temperature-controlled multichamber perifusion system (ACUSYST-S; Cellex Biosciences, Minneapolis, MN), as previously described (37), after an overnight culture in RPMI 1640medium (with 11mM glucose). 

Phrase: "Insulin secretion from isolated islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "was"

Phrase: "measured in a temperature-controlled multichamber perifusion system"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   767   C0449862:Controlled temperature [Phenomenon or Process]
   744   C0005903:temperature [Organism Attribute]
   744   C0039476:*Temperature [Quantitative Concept]
   744   C0444706:Measured [Qualitative Concept]
   744   C0449913:System [Functional Concept]
   744   C1553451:System [Manufactured Object]
   744   C1704459:System [Medical Device]
   744   C2587213:Controlled [Functional Concept]
   744   C3541902:MEASURED [Diagnostic Procedure]
   711 E C0079809:Measure [Quantitative Concept]
   711 E C0242485:Measure [Functional Concept]

Phrase: "(ACUSYST-S"

Phrase: "; Cellex Biosciences,"

Phrase: "Minneapolis,"

Phrase: "MN"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(37"

Phrase: ")"

Phrase: ","

Phrase: "after"

Phrase: "an overnight culture in RPMI 1640medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0010453:Culture [Idea or Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C2242979:Culture [Laboratory Procedure]

Phrase: "("

Phrase: "with 11mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.81: Insulin secretion from the in situ-perfused pancreas. 

Phrase: "Insulin secretion from the in situ-perfused pancreas."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1256369:insulin secretion [Cell Function]
   744   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
   744   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   744   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.82: The pancreas was perfused in situ in a humidified, temperature-controlled chamber using a modification of a protocol previously described in detail (27). 

Phrase: "The pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030274:Pancreas [Body Part, Organ, or Organ Component]
  1000   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "was"

Phrase: "perfused"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1549542:Perfuse [Functional Concept]

Phrase: "in situ in a humidified, temperature-controlled chamber"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0444498:In situ [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modification of a protocol previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392747:Modification [Functional Concept]
   753   C1554963:modification [Qualitative Concept]

Phrase: "described in detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522508:Detail [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "(27"

Phrase: ")."
Processing 00000000.tx.83: Intracellular free Ca2+ measurements. 

Phrase: "Intracellular free Ca2+ measurements."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242485:measurements [Functional Concept]
Processing 00000000.tx.84: Islets attached to glass coverslips were loaded with fura 2-AM (5M; Molecular Probes, Eugene, OR) for 30min at 37C in the Krebs-Ringer bicarbonate (KRB) medium (no BSA). 

Phrase: "Islets"

Phrase: "attached to glass coverslips"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0017596:Glass [Manufactured Object]
   770   C0231441:Attached [Finding]
   770   C1947936:Glass [Medical Device]
   737 E C1314972:ATTACH [Intellectual Product]

Phrase: "were"

Phrase: "loaded with fura 2-AM (5M"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0060845:fura-2-am [Organic Chemical,Pharmacologic Substance]
   790   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "; Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR) for 30min"

Phrase: "at 37C"

Phrase: "in the Krebs-Ringer bicarbonate (KRB) medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0009458:Medium [Intellectual Product]
   812   C0439536:Medium [Quantitative Concept]
   812   C1705217:Medium [Substance]
   812   C3244283:medium [Intellectual Product]

Phrase: "("

Phrase: "no BSA"

Phrase: ")."
Processing 00000000.tx.85: The coverslip was mounted in a microperifusion chamber on the specimen stage of a microscope equipped for epifluorescence and was perifused with KRB at a rate of 2.5ml/min at 37C as described in detail elsewhere (31). 

Phrase: "The coverslip"

Phrase: "was"

Phrase: "mounted in a microperifusion chamber"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0449878:mounted [Finding]
   760   C0935616:Chamber [Body Part, Organ, or Organ Component]
   726 E C0181909:Mount [Medical Device]

Phrase: "on the specimen stage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205390:Stage [Temporal Concept]
   861   C1300072:Stage [Clinical Attribute]
   861   C1306673:Stage [Qualitative Concept]

Phrase: "of a microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181839:Microscope [Medical Device]
  1000   C1706379:Microscope [Medical Device]

Phrase: "equipped for epifluorescence"

Phrase: "and"

Phrase: "was"

Phrase: "perifused with KRB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   760   C0973231:Bicarbonate [Inorganic Chemical]
   760   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   760   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "at a rate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0871208:Rate [Activity]
  1000   C1521828:Rate [Quantitative Concept]

Phrase: "of 2.5ml/min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "at 37C"

Phrase: "as"

Phrase: "described in detail elsewhere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1522508:Detail [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C1561567:detail [Functional Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.86: Intracellular free Ca2+ concentration ([Ca2+]i) was measured using dual-wavelength fluorescence video microscopy and was expressed as the ratio of the fluorescence intensity (detected at 510nm) of fura 2stimulated with light at excitation wavelengths of 340and 380nm (ratio 340/380) as described (31). 

Phrase: "Intracellular free Ca2+ concentration ([Ca2+]i)"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   812   C0086045:Concentration [Mental Process]
   812   C0175996:intracellular [Cell Component]
   812   C0178719:Intracellular [Spatial Concept]
   812   C0332296:free [Functional Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1446561:Concentration [Quantitative Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "dual-wavelength fluorescence video microscopy"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   853   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   840   C0242940:Microscopy, Video [Laboratory Procedure]
   804   C0026018:Microscopy [Laboratory Procedure]
   804   C0042655:Video [Manufactured Object]
   804   C3463807:Video [Intellectual Product]
   733 E C0205288:Microscopic [Qualitative Concept]

Phrase: "and"

Phrase: "was"

Phrase: "expressed as the ratio of the fluorescence intensity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0456603:Ratio [Quantitative Concept]
   744   C0522510:Intensity [Qualitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "("

Phrase: "detected at 510nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "of fura 2stimulated"

Phrase: "with light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "at excitation wavelengths"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:wavelengths [Quantitative Concept]

Phrase: "of 340and 380nm"

Phrase: "(ratio 340/380"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: ")"

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.87: Glucose utilization and mitochondrial glucose oxidation in islets. 

Phrase: "Glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "mitochondrial glucose oxidation in islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.88: These parameters were determined simultaneously by measuring the formation of 3H2O from D-[5-3H]glucose (45) and 14CO2 from [6-14C]glucose (35) in the same test tube. 

Phrase: "These parameters"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0449381:Parameters [Finding]
   966 E C0549193:Parameter [Spatial Concept]
   966 E C1704769:Parameter [Conceptual Entity]
   966 E C2350001:Parameter [Quantitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "simultaneously by measuring"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0444706:measuring [Qualitative Concept]
   790   C0449770:measuring [Quantitative Concept]
   790   C0521115:simultaneously [Temporal Concept]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "the formation of 3H2O"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "from"

Phrase: "D-["

Phrase: "5-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(45"

Phrase: ")"

Phrase: "and"

Phrase: "14CO2 from"

Phrase: "[6-14C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(35"

Phrase: ")"

Phrase: "in the same test tube."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   901   C0183884:Test tube [Medical Device]
   827   C0022885:Test [Laboratory Procedure]
   827   C0039593:Test [Functional Concept]
   827   C0175730:Tube [Medical Device]
   827   C0392366:test [Intellectual Product]
   827   C1547937:Tube NOS [Intellectual Product]
   827   C1561954:tube [Conceptual Entity]
   827   C1704730:TUBE [Medical Device]
Processing 00000000.tx.89: Duplicate batches of 10islets each were incubated in 100l of KRB containing 2or 24mM glucose together with 0.35Ci D-[6-14C]glucose and 1Ci D-[5-3H]glucose. 

Phrase: "Duplicate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205173:Duplicate [Functional Concept]
  1000   C3539942:Duplicate [Intellectual Product]

Phrase: "batches of 10islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1550176:Batch [Idea or Concept]
   790   C1948031:Batch [Quantitative Concept]

Phrase: "each"

Phrase: "were"

Phrase: "incubated in 100l of KRB containing 2or 24mM glucose"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   738   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   738   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   738   C0332256:Containing [Functional Concept]
   738   C0973231:Bicarbonate [Inorganic Chemical]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   738   C2700400:Containing [Activity]
   738   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "together with 0.35Ci"

Phrase: "D-["

Phrase: "6-14C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "1Ci"

Phrase: "D-["

Phrase: "5-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.90: NAD(P)H autofluorescence measurement. 

Phrase: "NAD(P)H autofluorescence measurement."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0242485:Measurement [Functional Concept]
Processing 00000000.tx.91: The reduced forms of NAD and NADP, referred to as NAD(P)H, were measured using the same imaging system described for the measurement of [Ca2+]i. 

Phrase: "The reduced forms of NAD"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "NADP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027303:NADP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "referred"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205543:referred [Functional Concept]
  1000   C1691010:Referred [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "as"

Phrase: "NAD(P)H,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0027289:NAD(H) [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same imaging system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C2697665:Imaging System [Manufactured Object]
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "described for the measurement of [Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0242485:Measurement [Functional Concept]
   753   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C1552738:described [Idea or Concept]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.92: Autofluorescence derived from NAD(P)H was excited at 365nm and was measured at 495nm in dye-free islets (28). 

Phrase: "Autofluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0544711:Autofluorescence [Finding]

Phrase: "derived from NAD(P)H"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   797   C0027289:NAD(H) [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0027270:NAD+ [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "was"

Phrase: "excited at 365nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0549255:Excited [Activity]

Phrase: "and"

Phrase: "was"

Phrase: "measured at 495nm"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "in dye-free islets"

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.93: Mitochondrial membrane potential measurement. 

Phrase: "Mitochondrial membrane potential measurement."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0242485:Measurement [Functional Concept]
   756   C1720920:Membrane Potential, Mitochondrial [Cell Function]
Processing 00000000.tx.94: Rhodamine 123(Rh123) was used as an indicator of mitochondrial membrane potential (m; see Ref. 4). 

Phrase: "Rhodamine 123"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Rh123"

Phrase: ")"

Phrase: "was"

Phrase: "used as an indicator of mitochondrial membrane potential"
Meta Candidates (Total=17; Excluded=3; Pruned=0; Remaining=14)
   800   C1720920:Membrane Potential, Mitochondrial [Cell Function]
   770   C0025251:Membrane Potential [Cell Function]
   770   C0596952:Mitochondrial membrane [Cell Component]
   750   C1524063:Use of [Functional Concept]
   744   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   744   C0025255:Membrane [Tissue]
   744   C0026237:Mitochondrial [Cell Component]
   744   C0521451:Mitochondrial [Functional Concept]
   744   C0596901:Membrane [Cell Component]
   744   C1235732:Indicator [Bird]
   744   C1273517:used [Finding]
   744   C1522602:Indicator [Functional Concept]
   744   C1706182:Membrane [Manufactured Object]
   744   C3245505:Potential [Qualitative Concept]
   711 E C0042153:use [Functional Concept]
   711 E C0457083:Use [Functional Concept]
   711 E C1947944:Use [Intellectual Product]

Phrase: "(m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.95: This fluorescent lipophilic cationic dye is known to be specifically partitioned into negatively charged mitochondrial membranes. 

Phrase: "This fluorescent lipophilic cationic dye"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]
   812   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   741   C0007447:Cation [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "specifically"

Phrase: "partitioned into negatively"

Phrase: "charged"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1706211:Charged [Organism Attribute]
   966 E C0007961:Charge [Quantitative Concept]

Phrase: "mitochondrial membranes."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0596952:Mitochondrial Membranes [Cell Component]
   861   C0025255:Membranes [Tissue]
   827 E C0596901:Membrane [Cell Component]
   827 E C1706182:Membrane [Manufactured Object]
   777 E C0205287:Membranous [Qualitative Concept]
Processing 00000000.tx.96: In cells preloaded with Rh123, when m increases (hyperpolarization) as seen after nutrient stimulation, more Rh123 is concentrated into the mitochondrial membrane, leading to an aggregation of dye molecules and quenching of the fluorescence signal. 

Phrase: "In cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "preloaded with Rh123,"

Phrase: "when"

Phrase: "m increases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:increases [Functional Concept]

Phrase: "(hyperpolarization"

Phrase: ")"

Phrase: "as"

Phrase: "seen after nutrient stimulation,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0205397:Seen [Qualitative Concept]
   770   C0678695:Nutrient [Food]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]
   770   C2347375:Nutrient [Conceptual Entity]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "more Rh123"

Phrase: "is"

Phrase: "concentrated into the mitochondrial membrane,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0596952:Mitochondrial membrane [Cell Component]
   760   C0025255:Membrane [Tissue]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]
   760   C1880165:Concentrated [Biomedical or Dental Material]
   726 E C1880310:Concentrate [Manufactured Object]
   726 E C2003864:Concentrate [Substance]

Phrase: "leading to an aggregation of dye molecules"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   748   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   748   C0332152:Leading [Temporal Concept]
   748   C0332621:Aggregation [Functional Concept]
   748   C0439168:% aggregation [Quantitative Concept]
   748   C0567416:molecules [Substance]
   748   C1522538:Leading [Functional Concept]
   732   C0314678:Molecular aggregation [Molecular Function]
   714 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   714 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   714 E C2348269:Lead [Element, Ion, or Isotope]
   714 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "quenching of the fluorescence signal."
Processing 00000000.tx.97: Depolarization of m, on the other hand, allows dye to redistribute from mitochondria into the cytosol, resulting in an increase of the Rh123 signal. 

Phrase: "Depolarization of m,"

Phrase: "on the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "dye to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "redistribute from mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0026237:Mitochondria [Cell Component]

Phrase: "into the cytosol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "resulting in an increase of the Rh123 signal."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0332294:Resulting in [Functional Concept]
   744   C0442805:Increase [Functional Concept]
   744   C0678226:resulting [Functional Concept]
   744   C1710082:Signal [Phenomenon or Process]
   711 E C1274040:Result [Functional Concept]
   711 E C1546471:Result [Idea or Concept]
   711 E C2825142:Result [Finding]
Processing 00000000.tx.98: In the present study, intact islets were loaded by incubation with 10g/ml Rh123 in KRB (with 2mM glucose) for 20min at 37C. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "intact islets"

Phrase: "were"

Phrase: "loaded by incubation"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1708715:Loaded [Activity]
   756 E C1550025:Load [Idea or Concept]
   756 E C1704782:Load [Manufactured Object]

Phrase: "with 10g/ml Rh123"

Phrase: "in KRB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   827   C0973231:Bicarbonate [Inorganic Chemical]
   827   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "with 2mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "for 20min"

Phrase: "at 37C."
Processing 00000000.tx.99: Rh123 fluorescence was excited at 490nm and was measured at 530nm with a FITC cube. 

Phrase: "Rh123 fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "excited at 490nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0549255:Excited [Activity]

Phrase: "and"

Phrase: "was"

Phrase: "measured at 530nm"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "with a FITC cube."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1880194:Cube [Spatial Concept]
   861   C1880195:Cube [Biomedical or Dental Material]
Processing 00000000.tx.100: ATP response to nutrient stimulation. 

Phrase: "ATP response to nutrient stimulation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   862   C1160632:response to nutrient [Cell Function]
   844   C2246604:response to ATP [Cell Function]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]
Processing 00000000.tx.101: Dynamic changes in the intracellular ATP-to-ADP ratio were measured indirectly by monitoring free Mg2+ levels with the fluorescent dye MgGreen (16), since Mg2+ has much greater affinity for ATP than ADP. 

Phrase: "Dynamic changes in the intracellular ATP-to-ADP ratio"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "indirectly by monitoring free Mg2+ levels"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   753   C0150369:Monitoring [Health Care Activity]
   753   C0332296:free [Functional Concept]
   753   C0441889:Levels [Qualitative Concept]
   753   C1417500:MG2 [Gene or Genome]
   753   C1516647:monitoring [Research Activity]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "with the fluorescent dye MgGreen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C0016320:fluorescent dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(16"

Phrase: ")"

Phrase: ","

Phrase: "since"

Phrase: "Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "has"

Phrase: "much greater affinity for ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "than ADP."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0523452:ADP [Laboratory Procedure]
Processing 00000000.tx.102: Thus a rise in ATP or the ATP-to-ADP ratio decreases free Mg2+ levels, and this reduces the MgGreen signal. 

Phrase: "Thus"

Phrase: "a rise in ATP"

Phrase: "or"

Phrase: "the ATP-to-ADP ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "free Mg2+ levels,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "this"

Phrase: "reduces"

Phrase: "the MgGreen signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.103: Islets were loaded with 5M of the dye in KRB with zero glucose for 30min and rinsed for 15min before data acquisition. 

Phrase: "Islets"

Phrase: "were"

Phrase: "loaded with 5M of the dye"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "in KRB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   827   C0973231:Bicarbonate [Inorganic Chemical]
   827   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "with zero glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "for 30min"

Phrase: "and"

Phrase: "rinsed for 15min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1701810:Rinse [Functional Concept]
   756   C1882955:Rinse [Activity]

Phrase: "before data acquisition."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706701:Acquisition [Activity]
Processing 00000000.tx.104: MgGreen signal was detected at 535nm after excitation at 495nm. 

Phrase: "MgGreen signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "detected at 535nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "after excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "at 495nm."
Processing 00000000.tx.105: To document the ability of this system to detect a change in ATP, at the end of most experimental protocols, islets were exposed to 10M carbonyl cyanide m-chlorophenylhydrazone (CCCP), an uncoupler that leads to ATP consumption and a 214% rise of MgGreen signal over the basal intensity. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "document"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1301746:document [Intellectual Product]
  1000   C1547673:Document [Intellectual Product]

Phrase: "the ability of this system to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0085732:Ability [Organism Attribute]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "a change in ATP,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "at the end"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0444930:End [Spatial Concept]
  1000   C2746065:End [Temporal Concept]
   944 E C0205088:Terminal [Temporal Concept]
   944 E C1705314:Terminal [Manufactured Object]
   944 E C1705315:Terminal [Spatial Concept]

Phrase: "of most experimental protocols,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442711:Protocols [Intellectual Product]
   827 E C1507394:Protocol [Intellectual Product]
   827 E C1522729:Protocol [Intellectual Product]
   827 E C2348563:Protocol [Intellectual Product]

Phrase: "islets"

Phrase: "were"

Phrase: "exposed to 10M carbonyl cyanide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0066028:carbonyl cyanide [Organic Chemical]
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0010505:Cyanide [Inorganic Chemical]
   760   C1442446:10M [Temporal Concept]

Phrase: "m-"

Phrase: "chlorophenylhydrazone"

Phrase: "(CCCP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007043:CCCP [Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "an uncoupler"

Phrase: "that"

Phrase: "leads to ATP consumption"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0009830:Consumption [Activity]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1947907:Consumption [Physiologic Function]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "a 214% rise of MgGreen signal"

Phrase: "over the basal intensity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]
Processing 00000000.tx.106: Assay methods. 

Phrase: "Assay methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.107: Insulin concentrations were measured by a double-antibody RIA using a rat insulin standard. 

Phrase: "Insulin concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "were"

Phrase: "measured by a double-antibody RIA"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0034580:RIA [Laboratory Procedure]
   753   C0205173:Double [Functional Concept]
   753   C0444706:Measured [Qualitative Concept]
   753   C1705764:Double [Activity]
   753   C1705765:Double [Qualitative Concept]
   753   C3541902:MEASURED [Diagnostic Procedure]
   719 E C0079809:Measure [Quantitative Concept]
   719 E C0242485:Measure [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a rat insulin standard."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1442989:Standard [Qualitative Concept]
   827   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.108: Pancreatic insulin content was measured after acid ethanol (0.18M HCl in 75% ethanol) extraction of the whole pancreas (8) and was quantified by RIA after dilution. 

Phrase: "Pancreatic insulin content"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "measured after acid ethanol"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0001128:Acid [Chemical]
   770   C0001962:Ethanol [Organic Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]

Phrase: "(0.18M HCl in 75% ethanol"

Phrase: ")"

Phrase: "extraction of the whole pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0185115:Extraction [Therapeutic or Preventive Procedure]
   760   C0684295:extraction [Laboratory Procedure]

Phrase: "(8"

Phrase: ")"

Phrase: "and"

Phrase: "was"

Phrase: "quantified by RIA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034580:RIA [Laboratory Procedure]
   756   C1709793:Quantify [Quantitative Concept]

Phrase: "after dilution."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079240:Dilution [Laboratory Procedure]
  1000   C1948037:Dilution [Functional Concept]
Processing 00000000.tx.109: To quantify DNA fragmentation, lysates from 200mouse islets were centrifuged at 15,000g for 15min to separate fragmented DNA from intact DNA, and the amount of DNA in the two fractions was determined spectrofluorometrically with Hoechst 33258after phenol-chloroform extraction (46). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "DNA fragmentation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "lysates from 200mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1881488:Lysate [Physical Object]

Phrase: "were"

Phrase: "centrifuged at 15,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0179834:centrifuge [Medical Device]

Phrase: "000g for 15min to"

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "fragmented DNA from intact DNA,"

Phrase: "and"

Phrase: "the amount of DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "in the two fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "spectrofluorometrically with Hoechst 33258after phenol-chloroform extraction"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   748   C0031428:phenol [Organic Chemical,Pharmacologic Substance]
   748   C0070570:phenol [Organic Chemical,Pharmacologic Substance]
   748   C0185115:Extraction [Therapeutic or Preventive Procedure]
   748   C0684295:extraction [Laboratory Procedure]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.110: Data presentation and statistics. 

Phrase: "Data presentation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449450:Presentation [Idea or Concept]

Phrase: "and"

Phrase: "statistics."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0038215:Statistics [Occupation or Discipline]
  1000   C0600673:Statistics [Intellectual Product]
   966 E C2348149:Statistic [Quantitative Concept]
   966 E C2828391:Statistic [Quantitative Concept]
Processing 00000000.tx.111: Intensity data of the NAD(P)H, m, and ATP measurements were normalized using their own basal levels at 2mM glucose [designated as 1for NAD(P)H and m and 100for ATP] to correct the variation that resulted from different islet sizes. 

Phrase: "Intensity data of the NAD(P)H,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "ATP measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "normalized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882115:Normalized [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "their own basal levels at 2mM glucose"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   774   C0428548:glucose levels [Laboratory or Test Result]
   757 E C0337438:glucose level [Laboratory Procedure]
   748   C0441889:Levels [Qualitative Concept]
   714 E C0456079:Level [Classification]
   714 E C1547707:Level [Geographic Area]
   714 E C2946261:Level [Pharmacologic Substance]

Phrase: "["

Phrase: "designated as 1for NAD(P)H"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0027289:NAD(H) [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0027270:NAD+ [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524084:Designated [Functional Concept]

Phrase: "and"

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "100for ATP"

Phrase: "]"

Phrase: "to correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "the variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "that"

Phrase: "resulted from different islet sizes."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0456389:SIZES [Spatial Concept]
   760   C1705242:Different [Qualitative Concept]
   745   C1268722:differences size [Finding]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]
Processing 00000000.tx.112: All data are presented as meansSE, and unpaired Student's t-test or ANOVA was used for comparison between different groups.  

Phrase: "All data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "presented as meansSE,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0449450:Presented [Idea or Concept]
   756 E C0150312:Present [Quantitative Concept]

Phrase: "and"

Phrase: "unpaired Student's t-test"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1710574:Unpaired t-Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0038492:student [Professional or Occupational Group]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]
   812   C1551041:student [Idea or Concept]
   812   C1552573:student [Intellectual Product]

Phrase: "or"

Phrase: "ANOVA"

Phrase: "was"

Phrase: "used for comparison"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C1707455:Comparison [Activity]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "between different groups."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
Processing 00000000.tx.113: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES Islet morphology and Bcl-xL expression in pancreatic islets. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Islet morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Bcl-xL expression in pancreatic islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.114: There were no significant differences in litter size and body weight between the two transgenic founder lines and their wild type littermates throughout their lifetime. 

Phrase: "There"

Phrase: "were"

Phrase: "no significant differences in litter size"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   809   C1268722:Difference in size [Finding]
           differences size
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "and"

Phrase: "body weight between the two transgenic founder lines"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0005910:Body Weight [Organism Attribute]
           weight
   770   C1305866:body weight [Diagnostic Procedure]
           weight
   767   C0682572:body lines [Tissue]
   744   C0043100:Weight [Quantitative Concept]
   744   C0242821:body [Human]
   744   C0460148:Body [Anatomical Structure]
   744   C1268086:Body [Anatomical Structure]
   744   C1705104:Weight [Idea or Concept]

Phrase: "and"

Phrase: "their wild type littermates throughout their lifetime."
Processing 00000000.tx.115: Immunohistochemical staining with anti-insulin antibody (Fig. 2, A-C) or a cocktail of anti-glucagon/somatostatin/pancreatic peptide sera (Fig. 2, D-F) revealed normal islet architecture in both Fd 1and Fd 2Bcl-xL mice. 

Phrase: "Immunohistochemical staining with anti-insulin antibody"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0487602:Staining [Laboratory Procedure]
   753   C1441616:Immunohistochemical [Laboratory Procedure]
   753   C1704680:Staining [Finding]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A-C)"

Phrase: "or"

Phrase: "a cocktail of anti-glucagon/somatostatin/pancreatic peptide sera"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0678420:Cocktail [Food]

Phrase: "(Fig. 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "D-"

Phrase: "F)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "revealed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443289:Revealed [Qualitative Concept]

Phrase: "normal islet architecture in both Fd 1and Fd 2Bcl-xL mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0003737:Architecture [Occupation or Discipline]
Processing 00000000.tx.116: As expected, insulin-positive -cells were located in the center of the islet, and other endocrine cells were present in the surrounding mantle. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "insulin-positive -cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0439178:% positive cells [Quantitative Concept]
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "located in the center of the islet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "other endocrine cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0229525:Endocrine Cells [Cell]
   861   C0007634:Cells [Cell]
   861   C0014136:Endocrine [Body System]
   861   C0521425:Endocrine [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "present in the surrounding mantle."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.117: Pancreatic insulin content was not different in the Fd 1,Fd 2,and wild-type mice (26.52.3,29.84.4,and 342.8mol/mg pancreas, respectively, n=7for each group). 

Phrase: "Pancreatic insulin content"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   827   C0423896:Content [Mental Process]
   827   C0456205:Content [Conceptual Entity]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "was"

Phrase: "not different in the Fd 1,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "Fd 2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:Founder [Disease or Syndrome]

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "(26.52.3,"

Phrase: "29.84.4,"

Phrase: "and"

Phrase: "342.8mol/mg pancreas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   812   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "respectively,"

Phrase: "n=7for"

Phrase: "each group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: ")."
Processing 00000000.tx.118: Therefore, overexpression of Bcl-xL in -cells did not affect either islet morphology or insulin content. 

Phrase: "Therefore,"

Phrase: "overexpression of Bcl-xL in -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "either islet morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "or"

Phrase: "insulin content."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.119: View larger version (158K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(158K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.120: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.121: Islet morphology and Bcl-xL expression in wild-type (A, D, and G), Fd 1(B, E, and H), and Fd 2(C, F, and I) Bcl-xL transgenic mice. 

Phrase: "Islet morphology"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "and"

Phrase: "Bcl-xL expression in wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(A,"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "G"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "Fd 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:Founder [Disease or Syndrome]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "E,"

Phrase: "and"

Phrase: "H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "Fd 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:Founder [Disease or Syndrome]

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "I) Bcl-xL transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]
Processing 00000000.tx.122: Pancreatic sections (5m) were immunochemically stained for insulin (A-C), glucagon/somatostatin/pancreatic polypeptide (D-F), and Bcl-xL (G-I) with hematoxylin as counterstain. 

Phrase: "Pancreatic sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "(5m"

Phrase: ")"

Phrase: "were"

Phrase: "immunochemically"

Phrase: "stained for insulin"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   790   C1579433:Insulin [Pharmacologic Substance]
   790   C2986582:Stained [Qualitative Concept]
   756 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   734 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   706 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(A-C), glucagon/somatostatin/pancreatic polypeptide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0030298:Pancreatic Polypeptide [Amino Acid, Peptide, or Protein,Hormone,Neuroreactive Substance or Biogenic Amine]
   827   C1418856:pancreatic polypeptide [Gene or Genome]
   799   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   799   C1305923:Polypeptide [Amino Acid, Peptide, or Protein]

Phrase: "("

Phrase: "D-"

Phrase: "F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "(G-I) with hematoxylin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0021966:I- [Inorganic Chemical]
   770   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0439267:g% [Quantitative Concept]

Phrase: "as counterstain."
Processing 00000000.tx.123: In islets from all 3groups of animals, insulin-positive -cells were distributed in the center of islets and were surrounded by non--cell hormone-positive cells. 

Phrase: "In islets"

Phrase: "from all 3groups"

Phrase: "of animals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "insulin-positive -cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0439178:% positive cells [Quantitative Concept]
   896   C0030281:Insulin Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "distributed in the center of islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205099:Center [Spatial Concept]
   753   C1704711:Distributed [Functional Concept]

Phrase: "and"

Phrase: "were"

Phrase: "surrounded by non"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1282914:Surrounded [Spatial Concept]
   790   C1518422:Non [Functional Concept]

Phrase: "--"

Phrase: "cell hormone-positive cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439178:% positive cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
Processing 00000000.tx.124: Bcl-xL-positive cells were only found in islets from the 2founder lines of Bcl-xL transgenic mice. 

Phrase: "Bcl-xL-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0439178:% positive cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "found in islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "from the 2founder lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205132:lines [Spatial Concept]
   827 E C1550648:Line [Substance]
   827 E C1552960:Line [Quantitative Concept]

Phrase: "of Bcl-xL transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.125: Aggregates of Bcl-xL staining were found in most of the Fd 2islets (I). 

Phrase: "Aggregates of Bcl-xL staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "found in most of the Fd 2islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0150312:Found [Quantitative Concept]
   748   C0263541:Founder [Disease or Syndrome]
   714 E C0243095:Find [Finding]

Phrase: "(I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.126: The specific expression of Bcl-xL protein in islet cells was documented by immunohistochemistry using anti-Bcl-xL serum. 

Phrase: "The specific expression of Bcl-xL protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1171362:expression protein [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in islet cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "documented by immunohistochemistry"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0021044:Immunohistochemistry [Laboratory Procedure]
   790   C1301725:Documented [Health Care Activity]
   790   C1609436:documented [Idea or Concept]
   756 E C1301746:document [Intellectual Product]
   756 E C1547673:Document [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "anti-Bcl-xL serum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0229671:Serum [Body Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
Processing 00000000.tx.127: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.128: 2, G-I, Bcl-xL-positive cells were seen in the center of the islets from both founders of Bcl-xL transgenic mice but not in the non--cells, exocrine tissue or liver, small intestine, and lymph nodes (data not shown). 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "G-I,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0086706:G I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439267:g% [Quantitative Concept]

Phrase: "Bcl-xL-positive cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0439178:% positive cells [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seen in the center of the islets"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   748   C0205099:Center [Spatial Concept]
   748   C0205397:Seen [Qualitative Concept]
   714 E C0042789:see [Organism Function]
   714 E C1947903:See [Activity]

Phrase: "from both founders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0263541:founders [Disease or Syndrome]

Phrase: "of Bcl-xL transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "but"

Phrase: "not in the non"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1518422:Non [Functional Concept]
           Not

Phrase: "--"

Phrase: "cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "exocrine tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "or"

Phrase: "liver,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0023884:Liver [Body Part, Organ, or Organ Component]
  1000   C0736268:LIVER [Body Part, Organ, or Organ Component]
  1000   C1278929:Liver [Body Part, Organ, or Organ Component]
  1000   C2346688:LIVER [Food]
   944 E C0205054:Hepatic [Body Location or Region]

Phrase: "small intestine,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0021852:Intestine, Small [Body Part, Organ, or Organ Component]
  1000   C1268998:Small intestine [Body Part, Organ, or Organ Component]
  1000   C1519375:SMALL INTESTINE [Tissue]
   944 E C1304890:Enteral [Spatial Concept]
   944 E C1522196:Enteral [Functional Concept]
   861   C0021853:Intestine [Body Part, Organ, or Organ Component]
   861   C0700321:Small [Quantitative Concept]
   861   C1708548:INTESTINE [Tissue]

Phrase: "and"

Phrase: "lymph nodes"
Meta Candidates (Total=11; Excluded=8; Pruned=0; Remaining=3)
  1000   C0024204:lymph nodes [Body Part, Organ, or Organ Component]
   966 E C0440747:LYMPH NODE [Tissue]
   966 E C1269047:Lymph node [Body Part, Organ, or Organ Component]
   861   C0024202:Lymph [Body Substance]
   861   C0746922:nodes [Body Part, Organ, or Organ Component]
   827 E C1706163:Node [Conceptual Entity]
   827 E C2697524:Node [Conceptual Entity]
   827 E C2700445:Node [Plant]
   777 E C0443268:Nodal [Spatial Concept]
   777 E C1417752:NODAL [Gene or Genome]
   755 E C0449725:Nodality [Spatial Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.129: The expression level of Bcl-xL in Fd 2Bcl-xL islets was markedly higher than in Fd 1mice, as evidenced by a significantly stronger signal and greater percentage of Bcl-xL-positive -cells. 

Phrase: "The expression level of Bcl-xL"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C3244092:expression level [Idea or Concept]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "in Fd 2Bcl-xL islets"

Phrase: "was"

Phrase: "markedly higher than"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   756   C0205250:High [Qualitative Concept]
   756   C1299351:High [Qualitative Concept]
   756   C2700149:HIGH [Intellectual Product]
   706 E C0489786:Height [Organism Attribute]

Phrase: "in Fd 1mice,"

Phrase: "as"

Phrase: "evidenced by a significantly stronger signal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1710082:Signal [Phenomenon or Process]
   719   C0332120:Evidence [Functional Concept]
   719   C0442821:Strong [Qualitative Concept]

Phrase: "and"

Phrase: "greater percentage of Bcl-xL-positive -cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439165:Percentage [Quantitative Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]
Processing 00000000.tx.130: The distribution of Bcl-xL staining was also dramatically different between Fd 2and Fd 1mice. 

Phrase: "The distribution of Bcl-xL staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0520511:distribution [Idea or Concept]
   753   C1704711:Distribution [Functional Concept]

Phrase: "was"

Phrase: "also dramatically different between Fd 2and Fd 1mice."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.131: Large Bcl-xL-positive aggregates were found in most of the -cells of the Fd 2mice, whereas in -cells of the Fd 1mice, Bcl-xL staining was evenly distributed in the cytosol. 

Phrase: "Large Bcl-xL-positive aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0205418:aggregates [Qualitative Concept]

Phrase: "were"

Phrase: "found in most of the -cells of the Fd 2mice,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   739   C0007634:Cells [Cell]
   739   C0150312:Found [Quantitative Concept]
   739   C0263541:Founder [Disease or Syndrome]
   739   C3282337:Cells [Cell]
   706 E C0243095:Find [Finding]
   706 E C1269647:Cell [Cell]
   706 E C1704653:Cell [Medical Device]
   706 E C1948049:Cell [Spatial Concept]

Phrase: "whereas"

Phrase: "in -cells of the Fd 1mice,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0007634:Cells [Cell]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "Bcl-xL staining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "was"

Phrase: "evenly"

Phrase: "distributed in the cytosol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1383501:Cytosol [Cell Component]
   770   C1704711:Distributed [Functional Concept]
Processing 00000000.tx.132: The difference in expression levels of Bcl-xL between Fd 1and Fd 2transgenic mice was further evidenced by Western blot analysis (Fig. 1B). 

Phrase: "The difference in expression levels of Bcl-xL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1705241:*Difference [Quantitative Concept]
   744   C1705242:Difference [Qualitative Concept]

Phrase: "between Fd 1and Fd 2transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "was"

Phrase: "further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "evidenced by Western blot analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0949466:Western blot analysis [Laboratory Procedure]
           Western Blot
   806   C0005863:Western Blot [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705493:Western [Spatial Concept]
   726   C0332120:Evidence [Functional Concept]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: On the basis of densitometry, Bcl-xL expression in -cells was increased 2-to 3-fold in Fd 1and at least 10-fold in Fd 2transgenic mice over littermate controls. 

Phrase: "On the basis of densitometry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011321:Densitometry [Laboratory Procedure]

Phrase: "Bcl-xL expression in -cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "2-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "to 3-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "in Fd 1and"

Phrase: "at least 10-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "in Fd 2transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "over littermate controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.134: Effects of Bcl-xL on thapsigargin-induced cell death and DNA fragmentation in islets. 

Phrase: "Effects of Bcl-xL"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on thapsigargin-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "DNA fragmentation in islets."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0376669:DNA Fragmentation [Molecular Function]
   770   C0332472:Fragmentation [Anatomical Abnormality]
   770   C1881708:FRAGMENTATION [Phenomenon or Process]
Processing 00000000.tx.135: In our previous study, we have demonstrated that thapsigargin consistently induces a sizable degree of apoptosis in islet -cells (46). 

Phrase: "In our previous study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that thapsigargin consistently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a sizable degree of apoptosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0441889:Degree [Qualitative Concept]
   760   C0449286:Degree [Quantitative Concept]
   760   C0542560:Degree [Intellectual Product]
   760   C1561545:degree [Quantitative Concept]
   760   C2348088:Degree [Quantitative Concept]

Phrase: "in islet -cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.136: Therefore, we used it as a convenient apoptosis inducer to test whether overexpression of Bcl-xL confers protection against apoptosis in islet -cells. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "it"

Phrase: "as"

Phrase: "a convenient apoptosis inducer to"

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "overexpression of Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514559:Overexpression [Genetic Function]

Phrase: "confers"

Phrase: "protection against apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "in islet -cells."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   966 E C1522529:Islet Cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.137: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.138: 3A, thapsigargin treatment dramatically reduced the viability of wild-type islets, whereas Bcl-xL- overexpressing transgenic islets had significantly higher cell viability. 

Phrase: "3A,"

Phrase: "thapsigargin treatment dramatically"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the viability of wild-type islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0443348:viability [Qualitative Concept]

Phrase: "whereas"

Phrase: "Bcl-xL-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "transgenic islets"

Phrase: "had"

Phrase: "significantly higher cell viability."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0007620:Cell Viability [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0443348:viability [Qualitative Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.139: After exposure to 10M thapsigargin for 48h, 644.6% of wild-type islets remained viable compared with 811.6% in Fd 1and 861.0% in Fd 2Bcl-xL islets (P<0.05vs. wild type for both). 

Phrase: "After exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0274281:Exposure, NOS [Injury or Poisoning]
  1000   C0332157:Exposure [Clinical Attribute]

Phrase: "to 10M thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "for 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "644.6% of wild-type islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1883559:Wild Type [Organism Attribute]
   783   C1960442:Type 6 [Intellectual Product]
   753   C0332307:Type [Qualitative Concept]
   753   C0445392:Wild [Intellectual Product]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "remained"

Phrase: "viable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:Viable [Qualitative Concept]

Phrase: "compared with 811.6%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]

Phrase: "in Fd 1and 861.0%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0263541:Founder [Disease or Syndrome]

Phrase: "in Fd 2Bcl-xL islets"

Phrase: "(P<0.05vs. wild type for both"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1883559:Wild Type [Organism Attribute]
   748   C0332307:Type [Qualitative Concept]
   748   C0445392:Wild [Intellectual Product]
   748   C1547052:*Type [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.140: Protection against apoptosis induced by high concentrations of thapsigargin (20M) was greater in Fd 2than in Fd 1Bcl-xL transgenic islets, as indicated by a greater degree of viability (654vs. 272%, P<0.01,Fig. 3A). 

Phrase: "Protection against apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1545588:Protection [Finding]

Phrase: "induced by high concentrations of thapsigargin"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0086045:Concentrations [Mental Process]
   753   C0205250:High [Qualitative Concept]
   753   C0205263:Induced [Functional Concept]
   753   C1299351:High [Qualitative Concept]
   753   C2700149:HIGH [Intellectual Product]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "(20M"

Phrase: ")"

Phrase: "was"

Phrase: "greater in Fd 2than"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0443228:greater [Quantitative Concept]
   770   C1704243:Greater [Quantitative Concept]
   737 E C0549177:Great [Quantitative Concept]

Phrase: "in Fd 1Bcl-xL transgenic islets,"

Phrase: "as"

Phrase: "indicated by a greater degree of viability"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0441889:Degree [Qualitative Concept]
   748   C0443228:greater [Quantitative Concept]
   748   C0443348:viability [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1444656:Indicated [Finding]
   748   C1561545:degree [Quantitative Concept]
   748   C1704243:Greater [Quantitative Concept]
   748   C2348088:Degree [Quantitative Concept]
   714 E C0549177:Great [Quantitative Concept]

Phrase: "(654vs. 272%,"

Phrase: "P<0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 3A"

Phrase: ")."
Processing 00000000.tx.141: DNA fragmentation measurement was used as an additional indicator of thapsigargin-induced apoptosis in Bcl-xL and wild-type islets. 

Phrase: "DNA fragmentation measurement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0242485:Measurement [Functional Concept]
   734   C0376669:DNA Fragmentation [Molecular Function]

Phrase: "was"

Phrase: "used as an additional indicator of thapsigargin-induced apoptosis"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   745   C1524063:Use of [Functional Concept]
   742   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   742   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   742   C0162638:Apoptosis [Cell Function]
   742   C0205263:Induced [Functional Concept]
   742   C1235732:Indicator [Bird]
   742   C1273517:used [Finding]
   742   C1522602:Indicator [Functional Concept]
   742   C1524062:Additional [Functional Concept]
   708 E C0042153:use [Functional Concept]
   708 E C0457083:Use [Functional Concept]
   708 E C1947944:Use [Intellectual Product]

Phrase: "in Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "and"

Phrase: "wild-type islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.142: Thapsigargin (10M) caused less DNA fragmentation in Bcl-xL islets (Fig. 3B) than in wild-type islets, which is consistent with resistance to apoptosis. 

Phrase: "Thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(10M"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442446:10M [Temporal Concept]

Phrase: ")"

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "less DNA fragmentation in Bcl-xL islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0376669:DNA Fragmentation [Molecular Function]
   748   C0332472:Fragmentation [Anatomical Abnormality]
   748   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "than"

Phrase: "in wild-type islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "which"

Phrase: "is"

Phrase: "consistent with resistance"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "to apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.143: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.144: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.145: Thapsigargin-induced cell death and DNA fragmentation in islets from Bcl-xL transgenic and wild-type mice. 

Phrase: "Thapsigargin-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "DNA fragmentation in islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0376669:DNA Fragmentation [Molecular Function]
   770   C0332472:Fragmentation [Anatomical Abnormality]
   770   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "from Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.146: A: islets from both Fd 1and Fd 2Bcl-xL transgenic and wild-type (WT) mice were cultured in RPMI 1640medium with varying concentrations of thapsigargin for 48h, and cell death was determined as the decrease in cell viability monitored by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay. 

Phrase: "A"

Phrase: ":"

Phrase: "islets from both Fd 1and Fd 2Bcl-xL"

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "wild-type (WT) mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "cultured in RPMI 1640medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "with varying concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "for 48h,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]

Phrase: "and"

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "determined as the decrease in cell viability"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0007620:Cell Viability [Cell Function]
   748   C0007634:Cell [Cell]
   748   C0392756:Decrease [Qualitative Concept]
   748   C0443348:viability [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "monitored by the 3-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   737   C0030695:monitor [Health Care Activity]
   737   C0150369:monitor [Health Care Activity]
   737   C0181904:Monitor [Medical Device]
   737   C0596972:Monitor [Medical Device]
   737   C1521743:Monitor [Professional or Occupational Group]
   737   C1704646:Monitor [Manufactured Object]

Phrase: "(4,"

Phrase: "5-dimethylthiazol-2-yl"

Phrase: ")-"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyl tetrazolium bromide assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.147: B: islets from the Fd 2Bcl-xL mice (Bcl-x) and their wild-type controls were exposed to 10M of thapsigargin for 48h. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "islets from the Fd 2Bcl-xL mice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   757   C1522528:Mouse Islets [Tissue]

Phrase: "(Bcl-x"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0219472:BCL-X [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332397:BCLX [Gene or Genome]
  1000   C1704960:BCLX [Gene or Genome]

Phrase: ")"

Phrase: "and"

Phrase: "their wild-type controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "were"

Phrase: "exposed to 10M of thapsigargin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   760   C1442446:10M [Temporal Concept]

Phrase: "for 48h."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1442464:48H [Temporal Concept]
Processing 00000000.tx.148: Fragmented DNA and intact DNA in islet lysates were then quantified spectrofluorometrically with the specific dye Hoechst 33258.

Phrase: "Fragmented DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "intact DNA in islet lysates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "quantified"

Phrase: "spectrofluorometrically with the specific dye Hoechst 33258."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   800   C0878435:Hoechst dye 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
           Hoechst 33258
   748   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]
   748   C0205369:Specific [Qualitative Concept]
   748   C1552740:specific [Intellectual Product]
Processing 00000000.tx.149: Data represent meansSE of 3(Fd 2) or 5(Fd 1) separate experiments. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "meansSE of 3"

Phrase: "(Fd 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:Founder [Disease or Syndrome]

Phrase: ")"

Phrase: "or"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "(Fd 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:Founder [Disease or Syndrome]

Phrase: ")"

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0681814:Experiments [Research Activity]
   966 E C1706386:Experiment [Conceptual Entity]
   916 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.150: * P<0.05and ** P<0.01compared with wild type. 

Phrase: "* P<0.05and"

Phrase: "*"

Phrase: "* P<0.01compared with wild type."
Processing 00000000.tx.151: Plasma glucose and insulin levels during IPGTT. 

Phrase: "Plasma glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0202042:Plasma glucose [Laboratory Procedure]
  1000   C0455280:plasma glucose [Laboratory or Test Result]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0032105:Plasma [Body Substance]
   861   C1550098:Plasma, NOS (not otherwise specified) [Body Substance]

Phrase: "and"

Phrase: "insulin levels during IPGTT."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   833   C0202098:insulin levels [Laboratory Procedure]
   833   C0428405:insulin levels [Laboratory or Test Result]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0441889:Levels [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.152: In the course of studies on the in vivo effects of overexpression of Bcl-xL in pancreatic islets, unanticipated hyperglycemia was found in random specimens from 85% of male and 60% of the female Fd 2Bcl-xL mice. 

Phrase: "In the course"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750729:Course [Temporal Concept]

Phrase: "of studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "on the in vivo effects"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "of overexpression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514559:Overexpression [Genetic Function]

Phrase: "of Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "in pancreatic islets,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "unanticipated hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "was"

Phrase: "found in random specimens"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0034656:RANDOM [Research Activity]
   770   C0150312:Found [Quantitative Concept]
   770   C0370003:specimens [Substance]
   770   C0439605:Random [Qualitative Concept]
   737 E C0243095:Find [Finding]
   737 E C2347026:Specimen [Conceptual Entity]

Phrase: "from 85%"

Phrase: "of male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "60% of the female Fd 2Bcl-xL mice."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0015780:Female [Finding]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0043210:female [Population Group]
   744   C0086287:female [Population Group]
   744   C0263541:Founder [Disease or Syndrome]
   744   C1705497:Female [Qualitative Concept]
   744   C1705498:Female [Qualitative Concept]
Processing 00000000.tx.153: To determine whether the overexpression of Bcl-xL is associated with a systematic reduction in glucose tolerance, IPGTTs were performed on the transgenic and wild-type animals. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "whether"

Phrase: "the overexpression of Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514559:Overexpression [Genetic Function]

Phrase: "is"

Phrase: "associated with a systematic reduction"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0220922:systematic [Functional Concept]
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in glucose tolerance,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0178665:Glucose tolerance [Physiologic Function]
   861   C0013220:Tolerance [Finding]
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   861   C0020963:Tolerance [Pathologic Function]
   861   C0220929:tolerance [Mental Process]
   861   C0231197:Tolerance [Physiologic Function]
   861   C1704410:Tolerance [Qualitative Concept]
   805 E C0680282:toleration [Social Behavior]
   789 E C0231198:Tolerant [Functional Concept]

Phrase: "IPGTTs"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   923   C0017741:Glucose tolerance tests [Diagnostic Procedure]
   875   C0595310:glucose tests [Medical Device]
   861   C0178665:Glucose tolerance [Physiologic Function]
   858 E C0337438:glucose test [Laboratory Procedure]
   827   C0201777:Tolerance test [Laboratory Procedure]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0022885:Tests [Laboratory Procedure]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:Tests [Intellectual Product]
   812   C1704410:Tolerance [Qualitative Concept]
   779 E C0039593:Test [Functional Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "were"

Phrase: "performed on the transgenic"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0003069:Transgenic [Animal]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "wild-type animals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003070:Animals, Wild [Animal]
   827   C0003062:Animals [Animal]
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.154: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.155: 4, the Fd 1Bcl-xL mice and wild-type controls had comparable blood glucose profiles after intraperitoneal glucose administration. 

Phrase: "4,"

Phrase: "the Fd 1Bcl-xL mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "wild-type controls"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   793   C0243148:control [Qualitative Concept]
   793   C1550141:Control [Substance]
   793   C1882979:Control [Conceptual Entity]
   793   C2587213:Control [Functional Concept]
   793   C3274648:Control [Qualitative Concept]
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "had"

Phrase: "comparable blood glucose profiles after intraperitoneal glucose administration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1979963:Profile [Laboratory Procedure]
   711   C2003903:Profile [Functional Concept]
Processing 00000000.tx.156: In contrast, Fd 2Bcl-xL mice had fasting hyperglycemia (122vs. 91mmol/l in control, P<0.01) and significantly higher glucose levels after the glucose load (192vs. 91mmol/l at 2h, P<0.001). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "Fd 2Bcl-xL mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "had"

Phrase: "fasting hyperglycemia"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "(122vs. 91mmol/l in control,"

Phrase: "P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "significantly higher glucose levels after the glucose load"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   770   C0428548:glucose levels [Laboratory or Test Result]
   754   C0860803:high glucose [Finding]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0441889:Levels [Qualitative Concept]
   737 E C0337438:glucose level [Laboratory Procedure]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]

Phrase: "(192vs. 91mmol/l at 2h,"

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.157: Despite the presence of hyperglycemia, serum insulin levels of Fd 2Bcl-xL mice 30min after glucose administration were >50% lower than the wild type (4.31.0vs. 9.51.7pmol/l, P<0.01). 

Phrase: "Despite the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hyperglycemia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020456:Hyperglycaemia [Disease or Syndrome]

Phrase: "serum insulin levels of Fd 2Bcl-xL mice 30min"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   784   C0428357:insulin levels serum [Laboratory Procedure]
           Serum insulin
   784   C1261415:insulin levels serum [Laboratory or Test Result]
           serum insulin
   764   C0202098:insulin levels [Laboratory Procedure]
   764   C0428405:insulin levels [Laboratory or Test Result]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0229671:Serum [Body Substance]
   742   C0441889:Levels [Qualitative Concept]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1546774:Serum [Intellectual Product]
   742   C1550100:Serum [Body Substance]
   742   C1579433:Insulin [Pharmacologic Substance]
   708 E C0456079:Level [Classification]
   708 E C1547707:Level [Geographic Area]
   708 E C2946261:Level [Pharmacologic Substance]

Phrase: "after glucose administration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001554:Administration [Occupational Activity]
   861   C1533734:Administration [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: ">50% lower than the wild type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "(4.31.0vs. 9.51.7pmol/l,"

Phrase: "P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.158: The basal serum insulin concentrations of the two groups were similar (3.70.5in control and 3.01.0pmol/l in Bcl-xL mice). 

Phrase: "The basal serum insulin concentrations of the two groups"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0683149:concentrations serum [Quantitative Concept]
   742   C0086045:Concentrations [Mental Process]
   708 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "similar"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348205:Similar [Qualitative Concept]

Phrase: "(3.70.5in control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "3.01.0pmol/l in Bcl-xL mice"

Phrase: ")."
Processing 00000000.tx.159: View larger version (12K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.160: 4.  

Phrase: "4."
Processing 00000000.tx.161: Blood glucose levels during ip glucose tolerance tests in Bcl-xL Fd 1(A) and Fd 2(B) transgenic mice and their wild-type littermates. 

Phrase: "Blood glucose levels during ip glucose tolerance tests"
Meta Candidates (Total=22; Excluded=8; Pruned=0; Remaining=14)
   800   C0428554:blood glucose levels [Laboratory or Test Result]
   793   C0017741:Glucose tolerance tests [Diagnostic Procedure]
   793   C0392201:blood glucose tests [Laboratory Procedure]
   770   C0005802:Blood Glucose [Carbohydrate]
   770   C0428548:glucose levels [Laboratory or Test Result]
   767   C0018941:Blood Tests [Laboratory Procedure]
   767   C0178665:Glucose tolerance [Physiologic Function]
   767   C0595310:glucose tests [Medical Device]
   760   C0337438:glucose level test [Laboratory Procedure]
       E   glucose test
       E   glucose level
   750 E C0994779:BLOOD TEST [Medical Device]
   750 E C1706969:Blood Test [Laboratory Procedure]
   744   C0005767:Blood [Tissue]
   744   C0005768:blood [Body Substance]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0229664:Blood [Body Substance]
   744   C0441889:Levels [Qualitative Concept]
   711 E C0456079:Level [Classification]
   711 E C1547707:Level [Geographic Area]
   711 E C2946261:Level [Pharmacologic Substance]
   700 E C0948458:vascular test [Diagnostic Procedure]

Phrase: "in Bcl-xL Fd 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1332397:bcl-xL [Gene or Genome]
   812   C0263541:Founder [Disease or Syndrome]

Phrase: "(A)"

Phrase: "and"

Phrase: "Fd 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0263541:Founder [Disease or Syndrome]

Phrase: "(B) transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0025936:Mice, Transgenic [Mammal]
   827   C0003069:Transgenic [Animal]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "and"

Phrase: "their wild-type littermates."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.162: Glucose (2g/kg body wt) was administrated ip after a 4-h fast. 

Phrase: "Glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "(2g/kg body"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0242821:body [Human]
   827   C0460148:Body [Anatomical Structure]
   827   C1268086:Body [Anatomical Structure]
   743 E C1995017:Bodies [Cell Component]

Phrase: "wt)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700323:WT [Fish]

Phrase: "was"

Phrase: "administrated"

Phrase: "ip after a 4-h fast."
Processing 00000000.tx.163: Data represent meansSE of 10mice in each group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "meansSE of 10mice"

Phrase: "in each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.164: To determine the age of diabetes onset in Fd 2mice, IPGTTs were performed in 4-,8-,and 12-wk-old animals. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the age of diabetes onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   844   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   760   C0001779:Age [Organism Attribute]

Phrase: "in Fd 2mice,"

Phrase: "IPGTTs"
Meta Candidates (Total=16; Excluded=4; Pruned=0; Remaining=12)
   923   C0017741:Glucose tolerance tests [Diagnostic Procedure]
   875   C0595310:glucose tests [Medical Device]
   861   C0178665:Glucose tolerance [Physiologic Function]
   858 E C0337438:glucose test [Laboratory Procedure]
   827   C0201777:Tolerance test [Laboratory Procedure]
   812   C0013220:Tolerance [Finding]
   812   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   812   C0020963:Tolerance [Pathologic Function]
   812   C0022885:Tests [Laboratory Procedure]
   812   C0220929:tolerance [Mental Process]
   812   C0231197:Tolerance [Physiologic Function]
   812   C0392366:Tests [Intellectual Product]
   812   C1704410:Tolerance [Qualitative Concept]
   779 E C0039593:Test [Functional Concept]
   756 E C0680282:toleration [Social Behavior]
   741 E C0231198:Tolerant [Functional Concept]

Phrase: "were"

Phrase: "performed in 4-,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "8-,"

Phrase: "and"

Phrase: "12-wk-old animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003062:Animals [Animal]
Processing 00000000.tx.165: Blood glucose levels obtained after fasting (160.9vs. 100.5mmol/l, P<0.01) and 2h after intraperitoneal glucose administration (180.6vs. 9.70.4mmol/l, P<0.001) were already markedly elevated at 4wk of age in Fd 2Bcl-xL mice. 

Phrase: "Blood glucose levels"
Meta Candidates (Total=19; Excluded=11; Pruned=0; Remaining=8)
  1000   C0428554:blood glucose levels [Laboratory or Test Result]
   901   C0005802:Blood Glucose [Carbohydrate]
   901   C0428548:glucose levels [Laboratory or Test Result]
   867 E C0337438:glucose level [Laboratory Procedure]
   827   C0005767:Blood [Tissue]
   827   C0005768:blood [Body Substance]
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   827   C0229664:Blood [Body Substance]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   755 E C0333275:Bloody [Qualitative Concept]
   743 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   743 E C0392895:Bloods [Population Group]
   743 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   743 E C1511228:VESSEL, BLOOD [Tissue]
   727 E C1558950:VASCULAR [Finding]
   727 E C1801960:Vascular [Qualitative Concept]

Phrase: "obtained after fasting"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0015663:Fasting [Finding]
   790   C1301820:Obtained [Functional Concept]
   790   C1550565:fasting [Intellectual Product]
   756 E C0456962:Fast [Qualitative Concept]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "(160.9vs. 100.5mmol/l,"

Phrase: "P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "and"

Phrase: "2h after intraperitoneal glucose administration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1292425:2H [Temporal Concept]

Phrase: "(180.6vs. 9.70.4mmol/l,"

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "were"

Phrase: "already markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522501:Markedly [Qualitative Concept]

Phrase: "elevated at 4wk of age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001779:Age [Organism Attribute]
   760   C0205250:Elevated [Qualitative Concept]
   760   C3163633:Elevated [Qualitative Concept]

Phrase: "in Fd 2Bcl-xL mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.166: Insulin secretory and [Ca2+]i responses to glucose and KCl in isolated perifused islets. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "secretory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secretory [Cell Function]

Phrase: "and ["

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "KCl in isolated perifused islets."
Processing 00000000.tx.167: To identify the cause of hyperglycemia in Fd 2Bcl-xL transgenic mice, insulin secretory responses to glucose and KCl were measured in perifused islets. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the cause of hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015127:cause [Functional Concept]
   770   C1524003:Cause [Conceptual Entity]

Phrase: "in Fd 2Bcl-xL transgenic mice,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0025936:Mice, Transgenic [Mammal]
   804   C0003069:Transgenic [Animal]
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "insulin secretory responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "KCl"

Phrase: "were"

Phrase: "measured in perifused islets."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0444706:Measured [Qualitative Concept]
   770   C3541902:MEASURED [Diagnostic Procedure]
   737 E C0079809:Measure [Quantitative Concept]
   737 E C0242485:Measure [Functional Concept]
Processing 00000000.tx.168: As shown in Table 1, insulin secretion in response to 16.7mM glucose was reduced by 60% in islets from the Fd 2Bcl-xL (5.50.6vs. 131.9pmol/l, P<0.001) compared with wild-type islets but was normal in Fd 1Bcl-xL islets (151.9pmol/l). 

Phrase: "As"

Phrase: "shown in Table 1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "insulin secretion in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to 16.7mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "reduced by 60%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "in islets"

Phrase: "from the Fd 2Bcl-xL"

Phrase: "(5.50.6vs. 131.9pmol/l,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   895   C2348935:.5 L [Quantitative Concept]

Phrase: "P<0.001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "compared with wild-type islets"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "but"

Phrase: "was"

Phrase: "normal in Fd 1Bcl-xL islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]

Phrase: "(151.9pmol/l)."
Processing 00000000.tx.169: KCl-stimulated insulin secretion in islets of Fd 2mice was also significantly attenuated (by 34%).  

Phrase: "KCl-stimulated insulin secretion in islets of Fd 2mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1256369:insulin secretion [Cell Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: "was"

Phrase: "also significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "("

Phrase: "by 34%"

Phrase: ")."
Processing 00000000.tx.170: View this table: [in this window] [in a new window]  Table 1.  

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.171: Insulin secretion in isolated islets from Bcl-xL transgenic and wild-type mice The intracellular signaling pathway of stimulus-secretion coupling in the pancreatic -cell involves an increase in [Ca2+]i, which triggers the exocytosis of insulin. 

Phrase: "Insulin secretion in isolated islets"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "The intracellular signaling pathway of stimulus-secretion coupling"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   800   C2755994:intracellular signaling pathway [Cell Function]
   770   C0037083:signaling pathway [Cell Function]
   770   C0086982:Signaling Pathway [Molecular Function]
   767 E C0037080:pathway signaling [Molecular Function]
   767   C1159342:Secretion Pathway [Cell Function]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]

Phrase: "in the pancreatic -cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "involves"

Phrase: "an increase in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which"

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the exocytosis of insulin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015283:Exocytosis [Cell Function]
Processing 00000000.tx.172: We therefore estimated changes in [Ca2+]i in response to secretagogues. 

Phrase: "We therefore estimated changes in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021966:I- [Inorganic Chemical]
   790   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "to secretagogues."
Processing 00000000.tx.173: [Ca2+]i responses to 12mM glucose and 30mM KCl, as measured by the area under the curve (AUC), were decreased by 627and 468%, respectively, in islets from Bcl-xL mice (Fig. 5A). 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to 12mM glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "30mM KCl,"

Phrase: "as"

Phrase: "measured by the area under the curve (AUC),"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   831   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   748   C0017446:Area [Geographic Area]
   748   C0205134:Curve [Spatial Concept]
   748   C0205146:Area [Spatial Concept]
   748   C0444706:Measured [Qualitative Concept]
   748   C3541902:MEASURED [Diagnostic Procedure]
   714 E C0079809:Measure [Quantitative Concept]
   714 E C0242485:Measure [Functional Concept]

Phrase: "were"

Phrase: "decreased by 627and 468%,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205216:Decreased [Quantitative Concept]
   770   C0392756:Decreased [Qualitative Concept]
   770   C0442797:decreased [Qualitative Concept]
   737 E C0547047:Decrease [Quantitative Concept]

Phrase: "respectively,"

Phrase: "in islets"

Phrase: "from Bcl-xL mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.174: View larger version (18K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.175: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.176: Intracellular free Ca2+ concentration ([Ca2+]i) responses to glucose, KCl, and carbachol in islets from Bcl-xL transgenic and wild-type mice. 

Phrase: "Intracellular free Ca2+ concentration"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   812   C0086045:Concentration [Mental Process]
   812   C0175996:intracellular [Cell Component]
   812   C0178719:Intracellular [Spatial Concept]
   812   C0332296:free [Functional Concept]
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1446561:Concentration [Quantitative Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "("

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i) responses to glucose,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "KCl,"

Phrase: "and"

Phrase: "carbachol in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "from Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.177: Islets from Fd 2Bcl-xL and wild-type mice were loaded with 5M fura 2-AM for 30min and then were perifused with Krebs-Ringer bicarbonate (KRB) buffer with 12mM glucose or 30mM KCl. 

Phrase: "Islets from Fd 2Bcl-xL"

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "loaded with 5M fura 2-"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   806   C0079389:Fura-2 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1708715:Loaded [Activity]
   726 E C1550025:Load [Idea or Concept]
   726 E C1704782:Load [Manufactured Object]

Phrase: "AM for 30min"

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "were"

Phrase: "perifused with Krebs-Ringer bicarbonate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   760   C0973231:Bicarbonate [Inorganic Chemical]
   760   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   760   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "(KRB) buffer with 12mM glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0973231:Bicarbonate [Inorganic Chemical]
   748   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   748   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "30mM KCl."
Processing 00000000.tx.178: Changes in [Ca2+]i, as reflected by the ratio absorbance at 340to 380nm, were monitored with a computerized digital imaging system. 

Phrase: "Changes in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "as"

Phrase: "reflected by the ratio absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0456603:Ratio [Quantitative Concept]
   760   C0558058:reflected [Mental Process]
   760   C1268822:Absorbance [Clinical Attribute]
   760   C1547037:Ratio [Intellectual Product]
   760   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 340to 380nm,"

Phrase: "were"

Phrase: "monitored with a computerized digital imaging system."
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   778   C0596446:digital imaging [Machine Activity]
   778   C2697665:Imaging System [Manufactured Object]
   757   C1139730:monitor system [Medical Device]
   748   C0011923:Imaging [Diagnostic Procedure]
   748   C0079595:Imaging [Diagnostic Procedure]
   748   C0442015:Digital [Intellectual Product]
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
   748   C1883674:Digital [Qualitative Concept]
   714   C0030695:monitor [Health Care Activity]
   714   C0150369:monitor [Health Care Activity]
   714   C0181904:Monitor [Medical Device]
   714   C0596972:Monitor [Medical Device]
   714   C1521743:Monitor [Professional or Occupational Group]
   714 E C1704254:Image [Intellectual Product]
   714   C1704646:Monitor [Manufactured Object]
   714 E C1704922:Image [Entity]
   714 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.179: Representative records of [Ca2+]i responses to glucose and KCl (A) and carbachol (CCh) before and after exposure to EGTA (B) in islets from Fd 2Bcl-xL transgenic and wild-type mice are shown. 

Phrase: "Representative records of [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "KCl"

Phrase: "(A)"

Phrase: "and"

Phrase: "carbachol (CCh) before"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "and after exposure"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0274281:Exposure, NOS [Injury or Poisoning]
   790   C0332157:Exposure [Clinical Attribute]
   790   C1515981:And [Idea or Concept]

Phrase: "to EGTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(B) in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2347469:/B [Quantitative Concept]

Phrase: "from Fd 2Bcl-xL"

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "are"

Phrase: "shown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]
Processing 00000000.tx.180: Long-term hyperglycemia per se is known to cause a wide range of disturbances of islet function, including a reduction in the [Ca2+]i response to glucose (15). 

Phrase: "Long-term hyperglycemia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0020456:Hyperglycaemia [Disease or Syndrome]
   734   C0443252:Long-term [Temporal Concept]

Phrase: "per se"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "a wide range of disturbances of islet function,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1514721:Range [Quantitative Concept]
   744   C2348147:Range [Quantitative Concept]
   744   C3542016:Range [Intellectual Product]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "a reduction in the [Ca2+"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "]i response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "(15"

Phrase: ")."
Processing 00000000.tx.181: Therefore, additional [Ca2+]i experiments were performed in islets from insulin-treated Bcl-xL mice that had been normoglycemic for 1wk. 

Phrase: "Therefore,"

Phrase: "additional"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Additional [Functional Concept]
   928 E C1883712:Addition [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "were"

Phrase: "performed in islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from insulin-treated Bcl-xL mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025914:Mice [Mammal]
   804   C0025929:mice [Mammal]
   804   C0026809:Mice [Mammal]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "normoglycemic for 1wk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0580545:Normoglycaemic [Finding]
Processing 00000000.tx.182: The responses to glucose, pyruvate methylester (PME), and KCl were reduced to a similar extent in islets from insulin-treated and untreated Bcl-xL mice. 

Phrase: "The responses to glucose,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "pyruvate methylester"

Phrase: "(PME"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "KCl"

Phrase: "were"

Phrase: "reduced to a similar extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392756:Reduced [Qualitative Concept]
   760   C0439792:Extent [Spatial Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "in islets"

Phrase: "from insulin-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "untreated Bcl-xL mice."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.183: The integrated [Ca2+]i responses also remained reduced after insulin treatment and represented only 687,612(P<0.01), and 8610% (P<0.05) of the responses in wild-type islets, respectively, indicating that defects of the [Ca2+]i response in Bcl-xL mice are not secondary to hyperglycemia. 

Phrase: "The integrated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C1158478:Integration [Genetic Function]
   928   C1705422:Integration [Machine Activity]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses also"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   827   C0871261:responses [Organism Attribute]
   793 E C1704632:Response [Finding]
   793 E C1706817:Response [Intellectual Product]
   793 E C2911692:Response [Mental Process]

Phrase: "remained"

Phrase: "reduced after insulin treatment"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   833   C0745343:insulin treatment [Therapeutic or Preventive Procedure]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0392756:Reduced [Qualitative Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1579433:Insulin [Pharmacologic Substance]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "and"

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "only 687,612"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205171:Only [Quantitative Concept]
   827   C1720467:Only [Intellectual Product]

Phrase: "(P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "8610%"

Phrase: "(P<0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: "of the responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0871261:responses [Organism Attribute]
   966 E C1704632:Response [Finding]
   966 E C1706817:Response [Intellectual Product]
   966 E C2911692:Response [Mental Process]

Phrase: "in wild-type islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "respectively,"

Phrase: "indicating"

Phrase: "that defects of the [Ca2+"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0243067:defects [Functional Concept]
   726 E C1457869:Defect [Functional Concept]
   726 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "]i response in Bcl-xL mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]

Phrase: "are"

Phrase: "not secondary to hyperglycemia."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0175668:Secondary to [Temporal Concept]
           Secondary
   770   C0027627:secondary [Neoplastic Process]
   770   C0205436:Secondary [Quantitative Concept]
Processing 00000000.tx.184: Insulin secretory and [Ca2+]i responses to carbachol. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "secretory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secretory [Cell Function]

Phrase: "and ["

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to carbachol."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]
Processing 00000000.tx.185: Carbachol, a muscarinic agonist, stimulates insulin secretion by releasing Ca2+ from intracellular stores, a process that is mediated by inositol 1,4,5-trisphosphate (IP3; see Ref. 7). 

Phrase: "Carbachol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006945:Carbachol [Organic Chemical,Pharmacologic Substance]

Phrase: "a muscarinic agonist,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0242947:Muscarinic Agonist [Pharmacologic Substance]
  1000   C3536929:Muscarinic Agonist [Pharmacologic Substance]
   861   C2987634:Agonist [Pharmacologic Substance]

Phrase: "stimulates"

Phrase: "insulin secretion by releasing Ca2+"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "from intracellular stores,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "is"

Phrase: "mediated by inositol 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0021547:Inositol [Carbohydrate,Pharmacologic Substance,Vitamin]
   770   C0086597:mediated [Social Behavior]
   770   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "4,"

Phrase: "5-trisphosphate"

Phrase: "(IP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
  1000   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: ";"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref. 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.186: Addition of EGTA (2.5mM) to the incubation medium, by preventing entry of extracellular Ca2+ into islets, isolated the effects of carbachol on release of Ca2+ from intracellular stores. 

Phrase: "Addition of EGTA"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1883712:Addition [Functional Concept]
   718 E C1524062:Additional [Functional Concept]

Phrase: "(2.5mM"

Phrase: ")"

Phrase: "to the incubation medium,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0009458:Medium [Intellectual Product]
   861   C0439536:Medium [Quantitative Concept]
   861   C1705217:Medium [Substance]
   861   C3244283:medium [Intellectual Product]

Phrase: "by preventing entry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705654:Entry [Intellectual Product]

Phrase: "of extracellular Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "into islets,"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "the effects of carbachol"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "from intracellular stores."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]
Processing 00000000.tx.187: Addition of 250M carbachol in the presence or absence of extracellular Ca2+ triggered similar [Ca2+]i responses in Bcl-xL and wild-type islets (Fig. 5B), suggesting that the intracellular Ca2+ stores and their release mechanisms are intact in Fd 2Bcl-xL islets. 

Phrase: "Addition of 250M carbachol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of extracellular Ca2+ triggered similar"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332197:absence [Quantitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses in Bcl-xL"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "wild-type islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 5B"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the intracellular Ca2+ stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1698986:Store [Functional Concept]

Phrase: "and"

Phrase: "their release mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "are"

Phrase: "intact in Fd 2Bcl-xL islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205266:Intact [Qualitative Concept]
   753   C1554187:Intact [Idea or Concept]
Processing 00000000.tx.188: Consistent with this observation, insulin responses to carbachol from perifused Fd 2Bcl-xL islets in the presence of 2mM glucose were not impaired (Table 1). 

Phrase: "Consistent with this observation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "insulin responses to carbachol"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "from perifused Fd 2Bcl-xL islets"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 2mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "impaired"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.189: Insulin secretory and [Ca2+]i responses to mitochondrial substrates and tolbutamide. 

Phrase: "Insulin"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
  1000   C1579433:Insulin [Pharmacologic Substance]
   944 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   916 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "secretory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1327616:Secretory [Cell Function]

Phrase: "and ["

Phrase: "Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to mitochondrial substrates"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "tolbutamide."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.190: To test mitochondrial function in Bcl-xL islets, two agents that are metabolized in mitochondria [PME, a cell-permeable derivative of pyruvate (44), and -ketoisocaproic acid (KIC)] were used as secretagogues as well. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "mitochondrial function in Bcl-xL islets,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0031843:function [Physiologic Function]
   753   C0542341:Function [Functional Concept]
   753   C0700205:FUNCTION [Classification]
   753   C1705273:Function [Intellectual Product]

Phrase: "two agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "are"

Phrase: "metabolized in mitochondria"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0026237:Mitochondria [Cell Component]
   790   C1524026:Metabolized [Cell Function]

Phrase: "[PME,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: "a cell-permeable derivative of pyruvate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1527240:Derivative [Functional Concept]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "and -"

Phrase: "ketoisocaproic acid (KIC)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "]"

Phrase: "were"

Phrase: "used as secretagogues"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "as well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]
Processing 00000000.tx.191: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.192: 6, insulin responses to glucose and PME in pancreata from Bcl-xL mice were reduced by 7910and 7613%, respectively (P<0.01for both, see Fig. 6B). 

Phrase: "6,"

Phrase: "insulin responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "PME in pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0536667:methyl pyruvate [Organic Chemical]
   760   C0014898:Ester [Organic Chemical]

Phrase: "from Bcl-xL mice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "were"

Phrase: "reduced by 7910and 7613%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "respectively"

Phrase: "(P<0.01for"

Phrase: "both,"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 6B"

Phrase: ")."
Processing 00000000.tx.193: [Ca2+]i responses to 24mM PME and 10mM KIC were reduced by 583and 585%, respectively (P<0.01,n=5) in Fd 2Bcl-xL islets compared with a 527% reduction in the [Ca2+]i response to glucose (comparisons were made based on AUC, data not shown). 

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses to 24mM PME"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   748   C0871261:responses [Organism Attribute]
   714 E C1704632:Response [Finding]
   714 E C1706817:Response [Intellectual Product]
   714 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "10mM KIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "were"

Phrase: "reduced by 583and 585%,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "respectively"

Phrase: "(P<0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "n=5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0129575:N 5' [Organic Chemical,Pharmacologic Substance]
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "in Fd 2Bcl-xL islets"

Phrase: "compared with a 527% reduction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
   760   C1707455:Compared [Activity]

Phrase: "in the [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "(comparisons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Comparison [Activity]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "based on AUC,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   882   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   767   C1532459:Base curve [Clinical Attribute]
   753   C0017446:Area [Geographic Area]
   753   C0205134:Curve [Spatial Concept]
   753   C0205146:Area [Spatial Concept]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.194: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.195: 6.  

Phrase: "6."
Processing 00000000.tx.196: A: insulin secretory responses to glucose, pyruvate methyl ester (PME), and tolbutamide (Tolb) in perfused pancreas. 

Phrase: "A"

Phrase: ":"

Phrase: "insulin secretory responses to glucose,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0871261:responses [Organism Attribute]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "pyruvate methyl ester"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: "(PME"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "tolbutamide (Tolb) in perfused pancreas."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   715 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.197: Isolated pancreata from Bcl-xL transgenic and wild-type mice were sequentially stimulated by 20mM glucose, 24mM PME, and 250M tolbutamide for 10min each. 

Phrase: "Isolated pancreata from Bcl-xL"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   726   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "transgenic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003069:Transgenic [Animal]

Phrase: "and"

Phrase: "wild-type mice"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]

Phrase: "were"

Phrase: "sequentially"

Phrase: "stimulated by 20mM glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "24mM PME,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014898:Ester [Organic Chemical]

Phrase: "and"

Phrase: "250M tolbutamide for 10min"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   715 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "each."
Processing 00000000.tx.198: Each agent was washed out for 15min with KRB medium containing 5mM glucose. 

Phrase: "Each agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450442:Agent [Chemical Viewed Functionally]
  1000   C1254351:Agent [Pharmacologic Substance]
  1000   C1521826:Agent [Intellectual Product]

Phrase: "was"

Phrase: "washed out for 15min"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0392674:Washed out [Sign or Symptom]
   770   C0439787:Out [Spatial Concept]
   770   C0849355:Out [Qualitative Concept]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "with KRB medium containing 5mM glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.199: B: insulin secretion from pancreata of Fd 2Bcl-xL mice as percentage of that from pancreata of wild-type mice. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "insulin secretion from pancreata of Fd 2Bcl-xL mice"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1256369:insulin secretion [Cell Function]
   742   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C0036536:secretion [Biologic Function]
   742   C0036537:Secretion [Body Substance]
   742   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   742   C1579433:Insulin [Pharmacologic Substance]

Phrase: "as percentage"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439165:Percentage [Quantitative Concept]
  1000   C1549488:Percentage [Idea or Concept]
  1000   C1561533:Percentage [Idea or Concept]

Phrase: "of that"

Phrase: "from pancreata"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   966   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "of wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.200: Data represent meansSE of 3mice in each group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "meansSE of 3mice"

Phrase: "in each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.201: * P<0.05and ** P<0.01compared with wild-type mice. 

Phrase: "* P<0.05and"

Phrase: "*"

Phrase: "* P<0.01compared with wild-type mice."
Processing 00000000.tx.202: Insulin secretion in response to tolbutamide, a sulfonylurea that closes the ATP-sensitive K+ channel directly by binding to the sulfonylurea receptor subunit of the channel (32), was also significantly reduced (by ~50%, P<0.05,Fig. 6). 

Phrase: "Insulin secretion in response"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "to tolbutamide,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040374:Tolbutamide [Organic Chemical,Pharmacologic Substance]
   944 E C0701229:Orinase [Organic Chemical,Pharmacologic Substance]

Phrase: "a sulfonylurea"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038766:Sulfonylurea [Organic Chemical,Pharmacologic Substance]
  1000   C3536898:Sulfonylurea [Pharmacologic Substance]

Phrase: "that"

Phrase: "closes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0587267:Close [Functional Concept]

Phrase: "the ATP-sensitive K+ channel directly by binding"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C1148923:ATP binding [Molecular Function]
   744   C0332324:Sensitive [Functional Concept]
   744   C0439799:Channel [Spatial Concept]
   744   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   744   C1550474:sensitive [Idea or Concept]
   744   C1706095:Channel [Conceptual Entity]
   744   C1708601:K' [Quantitative Concept]

Phrase: "to the sulfonylurea receptor subunit"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1711351:Subunit [Quantitative Concept]
   734   C0075586:sulfonylurea receptor [Amino Acid, Peptide, or Protein,Receptor]
   734   C1412082:SULFONYLUREA RECEPTOR [Gene or Genome]

Phrase: "of the channel"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439799:Channel [Spatial Concept]
  1000   C1706095:Channel [Conceptual Entity]

Phrase: "(32"

Phrase: ")"

Phrase: ","

Phrase: "was"

Phrase: "also significantly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "("

Phrase: "by ~50%,"

Phrase: "P<0.05,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.203: Glucose metabolism in islets from Bcl-xL transgenic mice. 

Phrase: "Glucose metabolism in islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0596620:glucose metabolism [Molecular Function]
   770   C0025519:Metabolism [Organism Function]
   770   C0025520:metabolism [Functional Concept]

Phrase: "from Bcl-xL transgenic mice."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0025936:Mice, Transgenic [Mammal]
   812   C0003069:Transgenic [Animal]
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]
Processing 00000000.tx.204: The rates of glycolytic flux (3H2O production from [5-3H]glucose) and glucose oxidation within mitochondria (14CO2 production from [6-14C]glucose) were measured simultaneously. 

Phrase: "The rates of glycolytic flux"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0871208:Rate [Activity]
   726   C1521828:Rate [Quantitative Concept]

Phrase: "(3H2O production from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "[5-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "and"

Phrase: "glucose oxidation within mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "(14CO2 production from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "[6-14C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "simultaneously."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521115:simultaneously [Temporal Concept]
Processing 00000000.tx.205: As illustrated in Fig. 

Phrase: "As"

Phrase: "illustrated in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.206: 7A, the basal glucose metabolic rates at 2mM glucose were not different in the two groups of islets. 

Phrase: "7A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the basal glucose metabolic rates at 2mM glucose"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   793   C0678121:Rates, Basal Metabolic [Organism Function]
   770   C0870882:metabolic rates [Physiologic Function]
   750   C1648294:Basal rate [Clinical Attribute]
   744   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   744   C0311400:Metabolic [Functional Concept]
   744   C1524026:Metabolic [Cell Function]
   744   C2707259:Metabolic [Clinical Attribute]
   711   C0871208:Rate [Activity]
   711   C1521828:Rate [Quantitative Concept]

Phrase: "were"

Phrase: "not different in the two groups of islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.207: At 24mM glucose, glycolytic flux in Bcl-xL islets was slightly higher (statistically nonsignificant) than in wild-type islets, whereas the rate of glucose oxidation in mitochondria was significantly lower in Fd 2Bcl-xL than in wild-type islets (P<0.01at 24mM glucose, Fig. 7A). 

Phrase: "At 24mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "glycolytic flux in Bcl-xL islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2348693:Flux [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "slightly higher"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205250:High [Qualitative Concept]
   827   C1299351:High [Qualitative Concept]
   827   C2700149:HIGH [Intellectual Product]
   777 E C0489786:Height [Organism Attribute]

Phrase: "(statistically nonsignificant"

Phrase: ")"

Phrase: "than"

Phrase: "in wild-type islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "whereas"

Phrase: "the rate of glucose oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "was"

Phrase: "significantly lower in Fd 2Bcl-xL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C2003888:Lower [Activity]

Phrase: "than"

Phrase: "in wild-type islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(P<0.01at 24mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.208: Hence, the ratio of glucose oxidation to utilization in Bcl-xL islets was significantly reduced at 24mM glucose (Fig. 7B). 

Phrase: "Hence,"

Phrase: "the ratio of glucose oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0456603:Ratio [Quantitative Concept]
   760   C1547037:Ratio [Intellectual Product]

Phrase: "to utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042153:utilization [Functional Concept]

Phrase: "in Bcl-xL islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced at 24mM glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "(Fig. 7B"

Phrase: ")."
Processing 00000000.tx.209: View larger version (14K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.210: 7.  

Phrase: "7."
Processing 00000000.tx.211: Glucose utilization and oxidation in islets from Fd 2Bcl-xL and wild-type mice. 

Phrase: "Glucose utilization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042153:utilization [Functional Concept]

Phrase: "and"

Phrase: "oxidation in islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "from Fd 2Bcl-xL"

Phrase: "and"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.212: 3H2O production from D-[5-3H]glucose and 14CO2 from D-[6-14C]glucose were determined simultaneously in batches of 10islets incubated in duplicate for 2h in 100l KRB medium. 

Phrase: "3H2O production from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0033268:production [Occupational Activity]

Phrase: "D-["

Phrase: "5-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "14CO2 from"

Phrase: "D-["

Phrase: "6-14C"

Phrase: "]glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "determined"

Phrase: "simultaneously in batches of 10islets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0521115:simultaneously [Temporal Concept]
   760   C1550176:Batch [Idea or Concept]
   760   C1948031:Batch [Quantitative Concept]

Phrase: "incubated in duplicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205173:Duplicate [Functional Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C3539942:Duplicate [Intellectual Product]

Phrase: "for 2h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292425:2H [Temporal Concept]

Phrase: "in 100l KRB medium."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0009458:Medium [Intellectual Product]
   804   C0439536:Medium [Quantitative Concept]
   804   C1705217:Medium [Substance]
   804   C3244283:medium [Intellectual Product]
Processing 00000000.tx.213: A: rates of glycolytic flux (D-[5-3H]glucose 3H2O) and mitochondrial glucose oxidation (D-[6-14C]glucose 14CO2) at different concentrations of glucose in Fd 2Bcl-xL and wild-type islets. 

Phrase: "A"

Phrase: ":"

Phrase: "rates of glycolytic flux"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0871208:Rate [Activity]
   737   C1521828:Rate [Quantitative Concept]

Phrase: "("

Phrase: "D-["

Phrase: "5-3H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442460:3H [Temporal Concept]

Phrase: "]glucose 3H2O"

Phrase: ")"

Phrase: "and"

Phrase: "mitochondrial glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "("

Phrase: "D-["

Phrase: "6-14C"

Phrase: "]glucose 14CO2"

Phrase: ")"

Phrase: "at different concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in Fd 2Bcl-xL"

Phrase: "and"

Phrase: "wild-type islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.214: B: ratios of glucose oxidation to utilization. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "ratios of glucose oxidation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0456603:Ratios [Quantitative Concept]
   770   C1610540:*Ratios [Quantitative Concept]
   737 E C1547037:Ratio [Intellectual Product]

Phrase: "to utilization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0042153:utilization [Functional Concept]
Processing 00000000.tx.215: Data represent meansSE of 4mice in each group. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "meansSE of 4mice"

Phrase: "in each group."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]
Processing 00000000.tx.216: ** P<0.01compared with wild-type mice. 

Phrase: "*"

Phrase: "* P<0.01compared with wild-type mice."
Processing 00000000.tx.217: Consistent with defective mitochondrial nutrient metabolism, the NAD(P)H responses to 10mM KIC or 20mM PME in Fd 2Bcl-xL islets were significantly lower than the responses in wild-type islets (Fig. 8). 

Phrase: "Consistent with defective mitochondrial nutrient metabolism,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "the NAD(P)H responses to 10mM KIC"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   773   C1327572:response to acid [Organism Function]
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "20mM PME in Fd 2Bcl-xL islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0536667:methyl pyruvate [Organic Chemical]
   742   C0014898:Ester [Organic Chemical]

Phrase: "were"

Phrase: "significantly lower than the responses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0441994:Lower [Spatial Concept]
   760   C1548802:Lower [Body Location or Region]
   760   C2003888:Lower [Activity]

Phrase: "in wild-type islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.218: However, the NAD(P)H response to glucose was not different between Fd 2Bcl-xL and wild-type islets. 

Phrase: "However,"

Phrase: "the NAD(P)H response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "was"

Phrase: "not different between Fd 2Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "wild-type islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.219: View larger version (16K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.220: 8.  

Phrase: "8."
Processing 00000000.tx.221: NAD(P)H responses to glucose, PME, and -ketoisocaproic acid (KIC). 

Phrase: "NAD(P)H responses to glucose,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "PME,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: "and -"

Phrase: "ketoisocaproic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(KIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.222: Autofluorescence of NAD(P)H in perifused islets was measured with same imaging system used for measurement of [Ca2+]i. 

Phrase: "Autofluorescence of NAD(P)H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0544711:Autofluorescence [Finding]

Phrase: "in perifused islets"

Phrase: "was"

Phrase: "measured with same imaging system"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   806   C2697665:Imaging System [Manufactured Object]
   760   C0011923:Imaging [Diagnostic Procedure]
   760   C0079595:Imaging [Diagnostic Procedure]
   760   C0444706:Measured [Qualitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]
   726 E C1704254:Image [Intellectual Product]
   726 E C1704922:Image [Entity]
   726 E C3542466:Image [Intellectual Product]

Phrase: "used for measurement of [Ca2+"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C1524063:Use of [Functional Concept]
   760   C0242485:Measurement [Functional Concept]
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "]i."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.223: Intensity of the fluorescent signal was normalized with its own basal level (at 2mM glucose) to correct for variation in intensity resulting from the differences in islet size. 

Phrase: "Intensity of the fluorescent signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0871362:signal intensity [Quantitative Concept]
   760   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "normalized with its own basal level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0205112:Basal [Spatial Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C1882115:Normalized [Research Activity]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "at 2mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: ")"

Phrase: "to correct"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349182:Correct [Qualitative Concept]

Phrase: "for variation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205419:Variation [Qualitative Concept]

Phrase: "in intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:Intensity [Qualitative Concept]

Phrase: "resulting from the differences"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737   C1705241:*Difference [Quantitative Concept]
   737   C1705242:Difference [Qualitative Concept]
   737 E C2825142:Result [Finding]

Phrase: "in islet size."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]
Processing 00000000.tx.224: A: typical NAD(P)H responses to 12mM glucose, 10mM KIC, and 20mM PME in wild-type (top) and Bcl-xL (bottom) islets. 

Phrase: "A"

Phrase: ":"

Phrase: "typical NAD(P)H responses to 12mM glucose,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   744   C0871261:responses [Organism Attribute]
   711 E C1704632:Response [Finding]
   711 E C1706817:Response [Intellectual Product]
   711 E C2911692:Response [Mental Process]

Phrase: "10mM KIC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "20mM PME in wild-type"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0536667:methyl pyruvate [Organic Chemical]
   748   C0014898:Ester [Organic Chemical]

Phrase: "(top)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704458:Top [Spatial Concept]

Phrase: "and"

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "(bottom"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511276:Bottom [Spatial Concept]
  1000   C1552825:bottom [Idea or Concept]

Phrase: ")"

Phrase: "islets."
Processing 00000000.tx.225: B: integrated NAD(P)H responses [calculated from the area under the curve (AUC)] in Bcl-xL islets expressed as %response in wild-type islets. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "integrated NAD(P)H responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   804   C0871261:responses [Organism Attribute]
   771 E C1704632:Response [Finding]
   771 E C1706817:Response [Intellectual Product]
   771 E C2911692:Response [Mental Process]

Phrase: "["

Phrase: "calculated from the area under the curve"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   831   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   748   C0017446:Area [Geographic Area]
   748   C0205134:Curve [Spatial Concept]
   748   C0205146:Area [Spatial Concept]
   748   C0444686:Calculated [Functional Concept]
   748   C1441506:Calculated [Activity]
   748   C1443182:Calculated [Laboratory Procedure]

Phrase: "(AUC"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   770   C0017446:Area [Geographic Area]
   770   C0205146:Area [Spatial Concept]

Phrase: ")"

Phrase: "]"

Phrase: "in Bcl-xL islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "expressed"

Phrase: "as %response in wild-type islets."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0871261:Response [Organism Attribute]
   753   C1704632:Response [Finding]
   753   C1706817:Response [Intellectual Product]
   753   C2911692:Response [Mental Process]
Processing 00000000.tx.226: Data represent meansSE of 6experiments performed in islets from different animals. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "meansSE of 6experiments"

Phrase: "performed in islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from different animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.227: * P<0.05compared with wild-type mice. 

Phrase: "* P<0.05compared with wild-type mice."
Processing 00000000.tx.228: Responses of m to glucose and PME. 

Phrase: "Responses of m"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   790   C0871261:responses [Organism Attribute]
   756 E C1704632:Response [Finding]
   756 E C1706817:Response [Intellectual Product]
   756 E C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "PME."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]
Processing 00000000.tx.229: Nutrient metabolism and NAD(P)H generation in -cells normally increases the rate of electron transport and proton efflux across the innermitochondrial membrane, leading to the hyperpolarization of m and ATP production. 

Phrase: "Nutrient metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "NAD(P)H generation in -cells normally"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the rate of electron transport"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0871208:Rate [Activity]
   760   C1521828:Rate [Quantitative Concept]

Phrase: "and"

Phrase: "proton efflux across the innermitochondrial membrane,"

Phrase: "leading to the hyperpolarization of m"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0332152:Leading [Temporal Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1522538:Leading [Functional Concept]
   719 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   719 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   719 E C2348269:Lead [Element, Ion, or Isotope]
   719 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "ATP production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.230: In the present study, increasing glucose concentration from 2to 12mM induced a two-phase decrease of the Rh123 signal in wild-type islets: a rapid drop within the first 120s, followed by a much slower second-phase decrease lasting for another 120s before maintaining a hyperpolarized state (Fig. 9A). 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "glucose concentration from 2to 12mM"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0427743:Glucose concentration [Laboratory Procedure]
   806   C1287281:Glucose concentration [Laboratory or Test Result]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a two-phase decrease of the Rh123 signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392756:Decrease [Qualitative Concept]
   744   C0547047:Decrease [Quantitative Concept]

Phrase: "in wild-type islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: ":"

Phrase: "a rapid drop within the first 120s,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1321095:Drop [Quantitative Concept]
   748   C1705648:Drop [Activity]
   748   C2347093:Drop [Quantitative Concept]
   748   C2348338:Drop [Quantitative Concept]

Phrase: "followed by a much slower second-phase decrease lasting"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   764   C0332283:Followed by [Temporal Concept]
           followed
   742   C0205390:Phase [Temporal Concept]
   742   C0205436:Second [Quantitative Concept]
   742   C0392756:Decrease [Qualitative Concept]
   742   C0457385:Second [Temporal Concept]
   742   C0547047:Decrease [Quantitative Concept]
   742   C0565930:/second [Quantitative Concept]
   742   C1561503:second [Idea or Concept]
   742   C1705190:Second [Qualitative Concept]
   708   C0439834:Slow [Qualitative Concept]
   708 E C1719822:Follow [Intellectual Product]

Phrase: "for another 120s"

Phrase: "before maintaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0024501:Maintain [Activity]

Phrase: "a hyperpolarized state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "(Fig. 9A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553641:9a [Body Part, Organ, or Organ Component]

Phrase: ")."
Processing 00000000.tx.231: After withdrawal of 12mM glucose, m returned almost completely to the prestimulation level. 

Phrase: "After withdrawal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2349954:Withdrawal [Activity]
  1000   C2825032:Withdrawal [Mental or Behavioral Dysfunction]

Phrase: "of 12mM glucose,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "returned"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332156:Return [Qualitative Concept]

Phrase: "almost completely to the prestimulation level."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0205197:Completely [Qualitative Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.232: Stimulation of wild-type islets with 24mM PME caused a steep drop of m that reached the nadir in <1 min. 

Phrase: "Stimulation of wild-type islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 24mM PME"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014898:Ester [Organic Chemical]

Phrase: "caused"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0015127:cause [Functional Concept]
   966   C1524003:Cause [Conceptual Entity]

Phrase: "a steep drop of m"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1321095:Drop [Quantitative Concept]
   760   C1705648:Drop [Activity]
   760   C2347093:Drop [Quantitative Concept]
   760   C2348338:Drop [Quantitative Concept]

Phrase: "that"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "the nadir in <1 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0702093:/min [Temporal Concept]
Processing 00000000.tx.233: The response of m to glucose in Fd 2Bcl-xL islets was markedly different from that of control islets. 

Phrase: "The response of m"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0871261:Response [Organism Attribute]
   770   C1704632:Response [Finding]
   770   C1706817:Response [Intellectual Product]
   770   C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "in Fd 2Bcl-xL islets"

Phrase: "was"

Phrase: "markedly different from that of control islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.234: The normal biphasic decrease in m was replaced by a single, slow decrease of the Rh123 signal in Bcl-xL islets, and no rapid drop at the beginning of stimulation was observed. 

Phrase: "The normal biphasic decrease in m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "replaced by a single, slow decrease of the Rh123 signal"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   760   C1299987:Replaced by [Functional Concept]
           replaced
   739   C0037179:Single [Population Group]
   739   C0087136:single [Finding]
   739   C0205171:Single [Quantitative Concept]
   739   C0392756:Decrease [Qualitative Concept]
   739   C0439834:Slow [Qualitative Concept]
   739   C0547047:Decrease [Quantitative Concept]
   739   C0559956:Replaced [Functional Concept]
   739   C1710082:Signal [Phenomenon or Process]
   706 E C1554078:Replace [Idea or Concept]

Phrase: "in Bcl-xL islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "and"

Phrase: "no rapid drop at the beginning of stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1321095:Drop [Quantitative Concept]
   744   C1705648:Drop [Activity]
   744   C2347093:Drop [Quantitative Concept]
   744   C2348338:Drop [Quantitative Concept]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.235: The degree of hyperpolarization of m, as measured by the maximum decrease in Rh123 signal, was decreased by 50% in Fd 2Bcl-xL islets relative to that of wild-type controls (Fig. 9B). 

Phrase: "The degree of hyperpolarization of m,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0441889:Degree [Qualitative Concept]
   753   C0449286:Degree [Quantitative Concept]
   753   C0542560:Degree [Intellectual Product]
   753   C1561545:degree [Quantitative Concept]
   753   C2348088:Degree [Quantitative Concept]

Phrase: "as"

Phrase: "measured by the maximum decrease"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0444706:Measured [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0806909:Maximum [Quantitative Concept]
   760   C1552615:maximum [Quantitative Concept]
   760   C2826546:MAXIMUM [Quantitative Concept]
   760   C3541902:MEASURED [Diagnostic Procedure]
   726 E C0079809:Measure [Quantitative Concept]
   726 E C0242485:Measure [Functional Concept]

Phrase: "in Rh123 signal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "decreased by 50%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0205216:Decreased [Quantitative Concept]
   790   C0392756:Decreased [Qualitative Concept]
   790   C0442797:decreased [Qualitative Concept]
   756 E C0547047:Decrease [Quantitative Concept]

Phrase: "in Fd 2Bcl-xL islets"

Phrase: "relative to that of wild-type controls"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]

Phrase: "(Fig. 9B"

Phrase: ")."
Processing 00000000.tx.236: View larger version (15K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(15K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.237: 9.  

Phrase: "9."
Processing 00000000.tx.238: Alteration in mitochondrial membrane potential (m) induced by glucose, PME, and carbonyl cyanide m-chlorophenylhydrazone (CCCP). 

Phrase: "Alteration in mitochondrial membrane potential"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   844   C0544929:Alteration, mitochondrial membrane [Cell or Molecular Dysfunction]
   797   C0541642:Membrane Alteration [Cell or Molecular Dysfunction]
   797   C0544926:Mitochondrial alteration [Cell or Molecular Dysfunction]
   760   C1515926:Alteration [Idea or Concept]

Phrase: "("

Phrase: "m)"

Phrase: "induced by glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "PME,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: "and"

Phrase: "carbonyl cyanide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0066028:carbonyl cyanide [Organic Chemical]
   861   C0010505:Cyanide [Inorganic Chemical]

Phrase: "m-"

Phrase: "chlorophenylhydrazone"

Phrase: "(CCCP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007043:CCCP [Organic Chemical]

Phrase: ")."
Processing 00000000.tx.239: Islets were loaded with rhodamine 123(Rh123) in KRB for 30min, and the fluorescence intensity was monitored as in Fig. 

Phrase: "Islets"

Phrase: "were"

Phrase: "loaded with rhodamine 123"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   833   C0073192:Rhodamine 123 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]

Phrase: "(Rh123"

Phrase: ")"

Phrase: "in KRB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   827   C0973231:Bicarbonate [Inorganic Chemical]
   827   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "for 30min,"

Phrase: "and"

Phrase: "the fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0522510:Intensity [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "monitored"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   966   C0030695:monitor [Health Care Activity]
   966   C0150369:monitor [Health Care Activity]
   966   C0181904:Monitor [Medical Device]
   966   C0596972:Monitor [Medical Device]
   966   C1521743:Monitor [Professional or Occupational Group]
   966   C1704646:Monitor [Manufactured Object]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.240: 8. 

Phrase: "8."
Processing 00000000.tx.241: Data were normalized for each experiment to the fluorescent intensity obtained at 2mM glucose. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "normalized for each experiment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0681814:Experiment [Research Activity]
   770   C1706386:Experiment [Conceptual Entity]
   770   C1882115:Normalized [Research Activity]

Phrase: "to the fluorescent intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0522510:Intensity [Qualitative Concept]

Phrase: "obtained at 2mM glucose."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C0860803:glucose increased [Finding]
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C1301820:Obtained [Functional Concept]
   737 E C1706701:Obtain [Activity]
Processing 00000000.tx.242: A: representative m responses to 12mM glucose, 20mM PME, and 10M CCCP in wild-type (left) and Bcl-xL (right) islets. 

Phrase: "A"

Phrase: ":"

Phrase: "representative m responses to 12mM glucose,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "20mM PME,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0014898:Ester [Organic Chemical]

Phrase: "and"

Phrase: "10M CCCP in wild-type"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0007043:CCCP [Organic Chemical]

Phrase: "(left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "(right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205090:Right [Spatial Concept]

Phrase: ")"

Phrase: "islets."
Processing 00000000.tx.243: B: summary of m changes over the basal level in Bcl-xL and wild-type islets. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "summary of m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552616:summary [Intellectual Product]
   790   C1706244:Summary [Intellectual Product]

Phrase: "changes over the basal level"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0205112:Basal [Spatial Concept]
   760   C0392747:Change [Functional Concept]
   760   C0441889:Level [Qualitative Concept]
   760   C0443172:change [Quantitative Concept]
   760   C0456079:Level [Classification]
   760   C1547707:Level [Geographic Area]
   760   C1705241:Change [Quantitative Concept]
   760   C2946261:Level [Pharmacologic Substance]

Phrase: "in Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "and"

Phrase: "wild-type islets."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]
Processing 00000000.tx.244: Data represent meansSE of 8experiments performed in islets from different animals. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "meansSE of 8experiments"

Phrase: "performed in islets"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "from different animals."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]
Processing 00000000.tx.245: * P<0.05and ** P<0.01compared with wild-type mice. 

Phrase: "* P<0.05and"

Phrase: "*"

Phrase: "* P<0.01compared with wild-type mice."
Processing 00000000.tx.246: The pattern of the m response to PME in Fd 2Bcl-xL islets was similar to that of wild-type controls but was attenuated by 605% (P<0.01). 

Phrase: "The pattern of the m response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449774:Pattern [Spatial Concept]

Phrase: "to PME"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0014898:Ester [Organic Chemical]

Phrase: "in Fd 2Bcl-xL islets"

Phrase: "was"

Phrase: "similar to that of wild-type controls"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2348205:Similar [Qualitative Concept]

Phrase: "but"

Phrase: "was"

Phrase: "attenuated by 605%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332161:Attenuated [Qualitative Concept]
   790   C0599946:Attenuated [Activity]

Phrase: "(P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.247: No such abnormality was observed in Fd 1Bcl-xL islets. 

Phrase: "No"

Phrase: "such abnormality"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1704258:Abnormality [Finding]
   928 E C0205161:Abnormal [Qualitative Concept]
   928 E C2347472:% Abnormal [Quantitative Concept]
   928 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "was"

Phrase: "observed in Fd 1Bcl-xL islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0263541:Founder [Disease or Syndrome]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.248: In an effort to compare the dynamics of m in Bcl-xL and wild-type islets, we treated the islets with 10M CCCP, an uncoupler of oxidative phosphorylation in mitochondria that disrupts m (33). 

Phrase: "In an effort to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015264:Effort [Organism Function]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the dynamics of m"

Phrase: "in Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "and"

Phrase: "wild-type islets,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "we"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "the islets with 10M CCCP,"

Phrase: "an uncoupler of oxidative phosphorylation"

Phrase: "in mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "that"

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "m ("

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.249: As expected, addition of CCCP immediately resulted in a robust increase in Rh123 signal (Fig. 9), reflecting a release of Rh123 from the mitochondrial membrane into the cytosol after the depolarization of m. 

Phrase: "As"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: ","

Phrase: "addition of CCCP immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "resulted in a robust increase"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0442805:Increase [Functional Concept]
   760   C2986815:Robust [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in Rh123 signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "a release of Rh123"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0030685:Release [Health Care Activity]
   770   C0391871:Release [Functional Concept]
   770   C0439180:% release [Quantitative Concept]
   770   C0680255:release [Health Care Activity]
   770   C1283071:Release [Functional Concept]
   770   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the mitochondrial membrane"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0596952:Mitochondrial membrane [Cell Component]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "into the cytosol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1383501:Cytosol [Cell Component]

Phrase: "after the depolarization"

Phrase: "of m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.250: The rise of the Rh123 signal induced by CCCP stimulation over the basal level in Fd 2Bcl-xL islets was significantly lower than in wild-type islets (22034vs. 30533%, P<0.01), indicating the preservation of m, even in the presence of CCCP in the transgenic islets. 

Phrase: "The rise of the Rh123 signal"

Phrase: "induced by CCCP stimulation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0007043:CCCP [Organic Chemical]
   770   C0205263:Induced [Functional Concept]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "over the basal level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "in Fd 2Bcl-xL islets"

Phrase: "was"

Phrase: "significantly lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "in wild-type islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1883559:Wild Type [Organism Attribute]

Phrase: "(22034vs. 30533%,"

Phrase: "P<0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "indicating"

Phrase: "the preservation of m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0033085:Preservation [Laboratory Procedure]
   770   C1514402:Preservation [Laboratory Procedure]

Phrase: "even in the presence of CCCP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0007043:CCCP [Organic Chemical]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in the transgenic islets."
Processing 00000000.tx.251: Intracellular ATP response to glucose and KIC. 

Phrase: "Intracellular ATP response to glucose"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C2246604:response to ATP [Cell Function]
   760   C0871261:Response [Organism Attribute]
   760   C1704632:Response [Finding]
   760   C1706817:Response [Intellectual Product]
   760   C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "KIC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.252: Changes in ATP level or the ATP-to-ADP ratio after glucose and KIC stimulation were measured indirectly by monitoring changes in the intracellular free Mg2+ level with MgGreen (16). 

Phrase: "Changes in ATP level"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "or"

Phrase: "the ATP-to-ADP ratio after glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0456603:Ratio [Quantitative Concept]
   748   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "KIC stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: "indirectly by monitoring changes"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0150369:Monitoring [Health Care Activity]
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C1516647:monitoring [Research Activity]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "in the intracellular free Mg2+ level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]

Phrase: "with MgGreen"

Phrase: "(16"

Phrase: ")."
Processing 00000000.tx.253: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.254: 10, stimulation of wild-type islets with 16mM glucose or 10mM KIC elicited a 20-25% decrease in free Mg2+, reflecting an increase in ATP levels. 

Phrase: "10,"

Phrase: "stimulation of wild-type islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   760   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "with 16mM glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "10mM KIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "elicited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449265:elicited [Qualitative Concept]

Phrase: "a 20-25% decrease in free Mg2+,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "reflecting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:Reflecting [Mental Process]

Phrase: "an increase in ATP levels."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]
Processing 00000000.tx.255: A decrease of only 8-11% was obtained in Fd 2Bcl-xL islets with the same concentration of glucose and KIC (P<0.01vs. wild-type controls), again suggesting that a defect in metabolism was primarily at the level of the Bcl-xL mitochondria. 

Phrase: "A decrease of only 8-11%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "was"

Phrase: "obtained in Fd 2Bcl-xL islets"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0263541:Founder [Disease or Syndrome]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "with the same concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "KIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(P<0.01vs. wild-type controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   766   C0243148:control [Qualitative Concept]
   766   C1550141:Control [Substance]
   766   C1882979:Control [Conceptual Entity]
   766   C2587213:Control [Functional Concept]
   766   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "again"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a defect in metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1457869:Defect [Functional Concept]
   770   C1861101:DEFECT [Disease or Syndrome]

Phrase: "was"

Phrase: "primarily at the level of the Bcl-xL mitochondria."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1332397:bcl-xL [Gene or Genome]
   742   C0026237:Mitochondria [Cell Component]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.256: View larger version (17K): [in this window] [in a new window]  Fig. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(17K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.257: 10.  

Phrase: "10."
Processing 00000000.tx.258: Response of ATP or ATP-to-ADP ratio to glucose and KIC in islets from Bcl-xL mice. 

Phrase: "Response of ATP"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "ATP-to-ADP ratio to glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0456603:Ratio [Quantitative Concept]
   753   C1547037:Ratio [Intellectual Product]

Phrase: "and"

Phrase: "KIC in islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "from Bcl-xL mice."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   734   C1332397:bcl-xL [Gene or Genome]
Processing 00000000.tx.259: After loading islets with 10M MgGreen-AM in KRB without glucose for 30min, the signal was monitored at 535nm after excitation at 495nm. 

Phrase: "After loading islets with 10M MgGreen-"

Phrase: "AM in KRB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0005367:Bicarbonate [Inorganic Chemical,Pharmacologic Substance]
   760   C0973231:Bicarbonate [Inorganic Chemical]
   760   C1875730:RINGER'S [Organic Chemical,Pharmacologic Substance]
   760   C2722820:BICARBONATE [Organic Chemical,Pharmacologic Substance]

Phrase: "without glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "for 30min,"

Phrase: "the signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "monitored at 535nm"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "after excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "at 495nm."
Processing 00000000.tx.260: A: representative changes after stimulation by glucose and KIC. 

Phrase: "A"

Phrase: ":"

Phrase: "representative changes after stimulation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "by glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "KIC."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.261: B: AUC of the responses to glucose and KIC in islets from Fd 2Bcl-xL and wild-type mice. 

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ":"

Phrase: "AUC of the responses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0376690:Area under the curve [Quantitative Concept]
           Area Under Curve
   748   C0017446:Area [Geographic Area]
   748   C0205146:Area [Spatial Concept]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "KIC in islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]

Phrase: "from Fd 2Bcl-xL"

Phrase: "and"

Phrase: "wild-type mice."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   966   C1520150:Wild Type Mouse [Mammal]
   901   C1883559:Wild Type [Organism Attribute]
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]
   827   C0332307:Type [Qualitative Concept]
   827   C0445392:Wild [Intellectual Product]
   827   C1547052:*Type [Quantitative Concept]
Processing 00000000.tx.262: * P<0.01compared with wild-type mice.  

Phrase: "* P<0.01compared with wild-type mice."
Processing 00000000.tx.263: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES In view of the mounting evidence that apoptosis mediates destruction of -cells in type 1and possibly type 2diabetes, interventions that reduce the rate of -cell apoptosis could potentially offer therapeutic benefit in the prevention and treatment of these conditions. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES In view of the mounting evidence"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C0449911:View [Spatial Concept]
   748   C1514811:Reference [Idea or Concept]
   748   C1706462:Reference [Conceptual Entity]
   714   C0181909:Mount [Medical Device]
   714   C0449878:mount [Finding]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "destruction of -cells in type 1and possibly type 2diabetes,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   773   C0449475:Type of cell [Intellectual Product]
           cells type
   745 E C0007634:Cell Type [Cell]
           Cells
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: "interventions"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0886296:interventions [Health Care Activity]
  1000   C1273869:Interventions [Health Care Activity]
  1000   C2979881:Interventions [Clinical Attribute]
  1000   C3542921:Interventions [Classification]
   966 E C1948041:Intervention [Therapeutic or Preventive Procedure]
   916 E C3274035:INTERVENTIONAL [Research Activity]

Phrase: "that"

Phrase: "reduce"

Phrase: "the rate of -cell apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "could"

Phrase: "potentially"

Phrase: "offer"

Phrase: "therapeutic benefit in the prevention"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0814225:Benefit [Quantitative Concept]

Phrase: "and"

Phrase: "treatment of these conditions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.264: The present study was undertaken as a prelude to the development of such a therapeutic approach. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "undertaken as a prelude"

Phrase: "to the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of such"

Phrase: "a therapeutic approach."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449445:Approach [Spatial Concept]
Processing 00000000.tx.265: Transgenic mice were produced in which the anti-apoptotic protein Bcl-xL was expressed in the pancreatic -cells. 

Phrase: "Transgenic mice"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0025936:Mice, Transgenic [Mammal]
   861   C0003069:Transgenic [Animal]
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "were"

Phrase: "produced in which"

Phrase: "the anti-apoptotic protein Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   840   C1332397:bcl-xL [Gene or Genome]

Phrase: "was"

Phrase: "expressed in the pancreatic -cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.266: Tissue-specific expression of Bcl-xL was obtained by using rat insulin II promoter constructs, and the level of Bcl-xL expression was determined by the length of the promoters. 

Phrase: "Tissue-specific expression of Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "obtained by"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
   833   C1301820:Obtained [Functional Concept]
   799 E C1706701:Obtain [Activity]
   761 E C1517378:Gain [Quantitative Concept]
   740 E C0205217:Increased [Quantitative Concept]
   740 E C0439661:Acquired [Temporal Concept]
   740 E C0442805:Increase [Functional Concept]
   740 E C0442808:Increasing [Functional Concept]
   740 E C3245488:acquired [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "rat insulin II promoter constructs,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C2827421:Construct [Classification]

Phrase: "and"

Phrase: "the level of Bcl-xL expression"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C3244092:expression level [Idea or Concept]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "determined by the length of the promoters."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0086860:promoters [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C1444754:Length [Quantitative Concept]
   748   C1706316:LENGTH [Research Activity]
Processing 00000000.tx.267: The longer promoter construct, RIP7, resulted in levels of Bcl-xL that were ~10-fold those seen in wild-type islets, whereas a shorter promoter, RIP1 led to an ~2- to 3-fold increase in the level of expression. 

Phrase: "The longer promoter construct,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2827421:Construct [Classification]

Phrase: "RIP7,"

Phrase: "resulted in levels of Bcl-xL"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   790   C1332397:bcl-xL [Gene or Genome]
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719 E C1547707:Level [Geographic Area]
   719   C2825142:Result [Finding]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "that"

Phrase: "were"

Phrase: "~10-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332462:Fold [Spatial Concept]
   861   C1880834:FOLD [Phenomenon or Process]

Phrase: "those"

Phrase: "seen in wild-type islets,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0205397:Seen [Qualitative Concept]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "whereas"

Phrase: "a shorter promoter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "RIP1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539807:RIP1 [Gene or Genome]

Phrase: "led to an ~2-"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   802   C2346661:Lead 2+ [Element, Ion, or Isotope]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to 3-fold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0442805:Increase [Functional Concept]

Phrase: "in the level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "of expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.268: This experimental design allowed us to study the effects of two levels of overexpression of Bcl-xL on the function of pancreatic islets as well as the ability of islets to resist apoptosis induced by thapsigargin. 

Phrase: "This experimental design"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0015320:Experimental Design [Research Activity]
  1000   C0035171:Experimental Design [Research Activity]
   861   C1517586:Experimental [Qualitative Concept]
   861   C1707689:Design [Activity]
   861   C2983265:DESIGN [Intellectual Product]

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the effects of two levels of overexpression of Bcl-xL"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   739   C1280500:effects [Qualitative Concept]
   706 E C2348382:Effect [Qualitative Concept]

Phrase: "on the function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
  1000   C0031843:function [Physiologic Function]
  1000   C0542341:Function [Functional Concept]
  1000   C0700205:FUNCTION [Classification]
  1000   C1705273:Function [Intellectual Product]
   928 E C0205245:Functional [Functional Concept]
   928 E C2700217:Functional [Conceptual Entity]

Phrase: "of pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: "as well as"

Phrase: "the ability of islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0085732:Ability [Organism Attribute]

Phrase: "to"

Phrase: "resist"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by thapsigargin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]
   790   C0205263:Induced [Functional Concept]
Processing 00000000.tx.269: Bcl-xL overexpression in pancreatic -cells did not alter islet development or morphology in either founder line of transgenic mice, as evidenced by the normal islet architecture and insulin staining. 

Phrase: "Bcl-xL overexpression in pancreatic -cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "islet development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "or"

Phrase: "morphology in either founder line of transgenic mice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0332437:Morphology [Qualitative Concept]
   744   C0543482:morphology [Spatial Concept]
   744   C0700329:Morphology, NOS [Finding]
   744   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "as"

Phrase: "evidenced by the normal islet architecture"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003737:Architecture [Occupation or Discipline]
   753   C0205307:Normal [Qualitative Concept]
   753   C0439166:% normal [Quantitative Concept]
   753   C2347086:% Normal [Quantitative Concept]
   719   C0332120:Evidence [Functional Concept]

Phrase: "and"

Phrase: "insulin staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.270: Normal pancreatic insulin content, in conjunction with normal pancreas weight, excludes the possibility of major changes in -cell mass in the transgenic animals. 

Phrase: "Normal pancreatic insulin content,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C0858301:normal insulin [Finding]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   812   C0423896:Content [Mental Process]
   812   C0456205:Content [Conceptual Entity]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "in conjunction with normal pancreas weight,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2712185:Normal weight [Finding]
   827   C0005910:weight [Organism Attribute]
   827   C0043100:Weight [Quantitative Concept]
   827   C1305866:weight [Diagnostic Procedure]
   827   C1705104:Weight [Idea or Concept]
   734   C0940731:Normal pancreas [Finding]

Phrase: "excludes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "the possibility of major changes in -cell mass"

Phrase: "in the transgenic animals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003069:Animals, Transgenic [Animal]
   861   C0003062:Animals [Animal]
Processing 00000000.tx.271: Additionally, increased expression of Bcl-xL protein in transgenic islets afforded protection against thapsigargin-induced cell death when compared with wild-type islets, and the level of protection appeared to correlate with the quantity of Bcl-xL expressed in islets. 

Phrase: "Additionally,"

Phrase: "increased expression of Bcl-xL protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1171362:expression protein [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in transgenic islets"

Phrase: "afforded"

Phrase: "protection against thapsigargin-induced cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0524828:Cell Protection [Physiologic Function]
   753   C1545588:Protection [Finding]

Phrase: "when"

Phrase: "compared with wild-type islets,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "the level of protection"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "correlate with the quantity of Bcl-xL"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C1332397:bcl-xL [Gene or Genome]
   748   C1265611:Quantity [Quantitative Concept]
   748   C1554108:Quantity [Intellectual Product]
   748   C1561573:Quantity [Intellectual Product]

Phrase: "expressed in islets."
Processing 00000000.tx.272: These results are consistent with previous findings in other cell types and insulinoma cell lines transfected with Bcl-2 (10, 17). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with previous findings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
   767   C0332529:Consistency finding [Qualitative Concept]

Phrase: "in other cell types"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C0449475:Cell types [Intellectual Product]
   966 E C0007634:Cell Type [Cell]
           Cell
   861   C0332307:Types [Qualitative Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "insulinoma cell lines"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: "transfected with Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0376515:Bcl-2 [Gene or Genome]

Phrase: "(10,"

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.273: This is the first demonstration that Bcl-xL promotes the survival of primary -cells. 

Phrase: "This"

Phrase: "is"

Phrase: "the first demonstration"

Phrase: "that Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the survival of primary -cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   781   C0007620:Cell Survival [Cell Function]
   760   C0038952:Survival [Activity]
   760   C0220921:survival [Functional Concept]
Processing 00000000.tx.274: Thapsigargin is known to induce apoptosis in many cell types, including insulin-secreting -cells, by depleting intracellular Ca2+ stores (46). 

Phrase: "Thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in many cell types,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "insulin-secreting -cells,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0030281:Insulin-Secreting Cells [Cell]
           Insulin Cell
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "by depleting intracellular Ca2+ stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   779   C1698986:Store [Functional Concept]

Phrase: "(46"

Phrase: ")."
Processing 00000000.tx.275: Cytokines such as interleukin-1, interferon-, and tumor necrosis factor- have been widely implicated in autoimmune destruction of -cells associated with type 1diabetes. 

Phrase: "Cytokines such as interleukin-1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "interferon-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021747:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
  1000   C0733470:Interferon [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "tumor necrosis factor-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0041368:tumor necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C1323304:tumor necrosis factor [Molecular Function]
  1000   C1456820:Tumour necrosis factor [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C0333516:Tumor necrosis [Neoplastic Process]
   827   C0027540:Necrosis [Organ or Tissue Function]
   827   C0027651:Tumor [Neoplastic Process]
   827   C1334928:Necrosis [Finding]
   827   C1521761:Factor [Functional Concept]
   827   C1578706:Tumor [Intellectual Product]
   827   C2827422:Factor [Conceptual Entity]
   827   C3273930:Tumor [Finding]

Phrase: "have"

Phrase: "been"

Phrase: "widely"

Phrase: "implicated in autoimmune destruction of -cells"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   753   C0007634:Cells [Cell]
   753   C0443146:Autoimmune [Pathologic Function]
   753   C1261381:Destruction [Therapeutic or Preventive Procedure]
   753   C1948029:Destruction [Activity]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "associated with type 1diabetes."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0332307:Type [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.276: However, the potency of the cytokines to induce cell death in intact islets was much lower than thapsigargin in our hands, and others have shown that cytokines also induce necrosis in pancreatic -cells. 

Phrase: "However,"

Phrase: "the potency of the cytokines to"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell death in intact islets"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   806   C0007587:Cell Death [Cell Function]
   797   C0022131:cell islets [Body Part, Organ, or Organ Component]
   797   C0682538:intact cell [Cell]
   781 E C1522529:Islet Cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "much lower than thapsigargin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "in our hands,"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0018563:Hands [Body Part, Organ, or Organ Component]
   966 E C1281583:Hand [Body Part, Organ, or Organ Component]
   966 E C1552914:hand [Quantitative Concept]
   928 E C0024763:Manual [Intellectual Product,Manufactured Object]
   928 E C0175674:Manual [Functional Concept]

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that cytokines also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079189:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C1524094:Cytokines [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "necrosis in pancreatic -cells."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0267953:Pancreatic necrosis [Disease or Syndrome]
   770   C0027540:Necrosis [Organ or Tissue Function]
   770   C1334928:Necrosis [Finding]
Processing 00000000.tx.277: Because thapsigargin is a more potent inducer of -cell death, we would expect that islets overexpressing Bcl-xL are protected against cytokine-induced cell death. 

Phrase: "Because"

Phrase: "thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "is"

Phrase: "a more potent inducer of -cell death,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   839   C0018894:Inducer cell [Cell]
   827   C0007587:Cell Death [Cell Function]
   799   C0007634:Cell [Cell]
   799   C0011065:Death [Organism Function]
   799   C1269647:Cell [Cell]
   799   C1306577:Death, NOS [Finding]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]

Phrase: "we"

Phrase: "would"

Phrase: "expect"

Phrase: "that islets"

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "are"

Phrase: "protected against cytokine-induced cell death."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0007587:Cell Death [Cell Function]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C0079189:cytokine [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0205263:Induced [Functional Concept]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.278: The high level of Bcl-xL expression achieved in the Fd 2animals was associated with significant impairment of glucose tolerance manifested by increases in the blood glucose concentration both in the fasting state and 2h after the intraperitoneal administration of glucose. 

Phrase: "The high level of Bcl-xL expression"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C3244092:expression level [Idea or Concept]
   748   C0205250:High [Qualitative Concept]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1299351:High [Qualitative Concept]
   748   C1547707:Level [Geographic Area]
   748   C2700149:HIGH [Intellectual Product]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "achieved in the Fd 2animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0263541:Founder [Disease or Syndrome]

Phrase: "was"

Phrase: "associated with significant impairment of glucose tolerance"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   778   C0178665:Glucose tolerance [Physiologic Function]
   778   C0332281:Associated with [Qualitative Concept]
           Associated
   748   C0013220:Tolerance [Finding]
   748   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   748   C0020963:Tolerance [Pathologic Function]
   748   C0220929:tolerance [Mental Process]
   748   C0231197:Tolerance [Physiologic Function]
   748   C0237881:significant [Quantitative Concept]
   748   C0684336:Impairment [Pathologic Function]
   748   C0750502:Significant [Idea or Concept]
   748   C1546944:Significant [Qualitative Concept]
   748   C1704410:Tolerance [Qualitative Concept]
   714 E C0750490:Associate [Idea or Concept]
   714 E C1706221:Associate [Professional or Occupational Group]

Phrase: "manifested by increases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1280444:Manifested by [Qualitative Concept]
           manifested
   790   C0205319:manifested [Functional Concept]
   790   C0442805:increases [Functional Concept]

Phrase: "in the blood glucose concentration"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
  1000   C2585282:Blood glucose concentration [Finding]
   913   C0427728:Blood concentration [Laboratory or Test Result]
   913   C0699870:blood concentration [Quantitative Concept]
   913   C1313904:Blood concentration [Laboratory Procedure]
   901   C0427743:Glucose concentration [Laboratory Procedure]
   901   C1287281:Glucose concentration [Laboratory or Test Result]
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0005802:Blood Glucose [Carbohydrate]

Phrase: "both in the fasting state"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0015663:Fasting state [Finding]
           Fasting
   760   C0238767:Both [Spatial Concept]
   760   C1301808:State [Geographic Area]
   760   C1442792:State [Functional Concept]
   760   C1550565:fasting [Intellectual Product]
   760   C1706086:Both [Qualitative Concept]
   760   C3148680:State [Geographic Area]
   726 E C0456962:Fast [Qualitative Concept]

Phrase: "and"

Phrase: "2h after the intraperitoneal administration of glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1292425:2H [Temporal Concept]
Processing 00000000.tx.279: The elevation in blood glucose was present at an early age (at least 4wk) in both male and female animals and was associated with defective insulin secretion in response to glucose and other secretagogues in the isolated perfused pancreas and isolated perifused islets. 

Phrase: "The elevation in blood glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439775:Elevation [Therapeutic or Preventive Procedure]
   760   C0702240:Elevation [Spatial Concept]

Phrase: "was"

Phrase: "present at an early age ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "at least 4wk"

Phrase: ")"

Phrase: "in both male"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0024554:Male [Finding]
  1000   C0086582:male [Population Group]
  1000   C1706180:Male [Qualitative Concept]
  1000   C1706428:Male [Qualitative Concept]
  1000   C1706429:Male [Organism Attribute]

Phrase: "and"

Phrase: "female animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003062:Animals [Animal]

Phrase: "and"

Phrase: "was"

Phrase: "associated with defective insulin secretion"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1256369:insulin secretion [Cell Function]
   760   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C0036536:secretion [Biologic Function]
   760   C0036537:Secretion [Body Substance]
   760   C0332452:Defective [Functional Concept]
   760   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   760   C1579433:Insulin [Pharmacologic Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "other secretagogues in the isolated perfused pancreas"

Phrase: "and"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "perifused islets."
Processing 00000000.tx.280: The reduction in insulin secretion was paralleled by a similar reduction in [Ca2+]i responses to glucose and KCl. 

Phrase: "The reduction in insulin secretion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "paralleled by a similar reduction in [Ca2+"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0301630:Reduction [Natural Phenomenon or Process]
   748   C0392756:Reduction [Qualitative Concept]
   748   C0441610:Reduction [Therapeutic or Preventive Procedure]
   748   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C2348205:Similar [Qualitative Concept]
   714   C2348042:Parallel [Qualitative Concept]
   714   C2826345:PARALLEL [Research Activity]

Phrase: "]i responses to glucose"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0871261:responses [Organism Attribute]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "KCl."
Processing 00000000.tx.281: However, the pathways that stimulate insulin secretion after release of Ca2+ from intracellular stores appear to be intact, since the insulin secretory responses to carbachol, an agent that activates phospholipase C and generates IP3 (7), were normal. 

Phrase: "However,"

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "that"

Phrase: "stimulate"

Phrase: "insulin secretion after release of Ca2+"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1256369:insulin secretion [Cell Function]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]

Phrase: "from intracellular stores"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1698986:Store [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "intact,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205266:Intact [Qualitative Concept]
  1000   C1554187:Intact [Idea or Concept]

Phrase: "since"

Phrase: "the insulin secretory responses to carbachol,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "an agent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0450442:Agent [Chemical Viewed Functionally]
  1000   C1254351:Agent [Pharmacologic Substance]
  1000   C1521826:Agent [Intellectual Product]

Phrase: "that"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "phospholipase C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031669:Phospholipase C [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031671:Phospholipase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "generates"

Phrase: "IP3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021549:IP3 [Biologically Active Substance,Carbohydrate]
  1000   C3542924:IP3 [Body Part, Organ, or Organ Component]

Phrase: "(7"

Phrase: ")"

Phrase: ","

Phrase: "were"

Phrase: "normal."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]
Processing 00000000.tx.282: Normal insulin secretory responses to carbachol indicate that the exocytosis process distal to the rise in [Ca2+]i is intact in Bcl-xL transgenic islets. 

Phrase: "Normal insulin secretory responses to carbachol"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0871261:responses [Organism Attribute]
   719 E C1704632:Response [Finding]
   719 E C1706817:Response [Intellectual Product]
   719 E C2911692:Response [Mental Process]

Phrase: "indicate"

Phrase: "that"

Phrase: "the exocytosis process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1184743:Process [Body Part, Organ, or Organ Component]
   861   C1522240:Process [Phenomenon or Process]

Phrase: "distal to the rise in [Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205108:Distal [Spatial Concept]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "is"

Phrase: "intact in Bcl-xL transgenic islets."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205266:Intact [Qualitative Concept]
   753   C1554187:Intact [Idea or Concept]
Processing 00000000.tx.283: Taken together with the normal islet morphology and insulin content, these results indicate that the high level of Bcl-xL protein expression in the Fd 2transgenic mice interferes with the -cell signaling pathways activated by glucose. 

Phrase: "Taken together with the normal islet morphology"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   748   C0205307:Normal [Qualitative Concept]
   748   C0332437:Morphology [Qualitative Concept]
   748   C0439166:% normal [Quantitative Concept]
   748   C0543482:morphology [Spatial Concept]
   748   C0700329:Morphology, NOS [Finding]
   748   C0700619:Morphology [Biomedical Occupation or Discipline]
   748   C1883357:Together [Qualitative Concept]
   748   C1883727:Taken [Conceptual Entity]
   748   C2347086:% Normal [Quantitative Concept]
   714 E C1515187:Take [Health Care Activity]

Phrase: "and"

Phrase: "insulin content,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0423896:Content [Mental Process]
   861   C0456205:Content [Conceptual Entity]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "these results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that"

Phrase: "the high level of Bcl-xL protein expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0428479:Protein level [Laboratory or Test Result]
   767   C3244092:expression level [Idea or Concept]
   744   C0205250:High [Qualitative Concept]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1299351:High [Qualitative Concept]
   744   C1547707:Level [Geographic Area]
   744   C2700149:HIGH [Intellectual Product]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in the Fd 2transgenic mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "interferes with the -cell signaling pathways"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   790   C0037083:Cell Signaling [Cell Function]
       E   signaling pathway
           Signaling
   790   C0521102:Interferes with [Qualitative Concept]
           Interfere
   783   C0037080:pathways signaling [Molecular Function]
   773 E C0086982:Signaling Pathway [Molecular Function]
   753   C0007634:Cell [Cell]
   753   C1269647:Cell [Cell]
   753   C1704259:Pathways [Molecular Function]
   753   C1704653:Cell [Medical Device]
   753   C1705987:Pathways [Conceptual Entity]
   753   C1948049:Cell [Spatial Concept]
   753   C3537152:signaling [Biologic Function]
   719 E C1710082:Signal [Phenomenon or Process]

Phrase: "activated by glucose."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C1879547:Activated [Activity]
   756 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.284: The precise mechanisms responsible for the anti-apoptotic effects of Bcl-xL have not been fully defined. 

Phrase: "The precise mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0441712:Mechanisms [Functional Concept]
   827 E C1706376:Mechanism [Manufactured Object]

Phrase: "responsible for the anti-apoptotic effects of Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1273518:Responsible [Finding]

Phrase: "have"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "fully"

Phrase: "defined."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]
Processing 00000000.tx.285: Its subcellular localization to the mitochondrial membrane (12) and the recent demonstration of the effects of Bcl-xL on mitochondrial function (11, 22, 29, 40, 41) raised the possibility that the impairment of -cell function associated with Bcl-xL overexpression may be related to disturbances in mitochondrial signaling mediating glucose-induced insulin secretion. 

Phrase: "Its subcellular localization to the mitochondrial membrane"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1658979:localization to membrane [Cell Function]
   774   C1657244:mitochondrial localization [Biologic Function]
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "(12"

Phrase: ")"

Phrase: "and"

Phrase: "the recent demonstration of the effects of Bcl-xL"

Phrase: "on mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "(11,"

Phrase: "22,"

Phrase: "29,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "41"

Phrase: ")"

Phrase: "raised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442818:Raised [Quantitative Concept]

Phrase: "the possibility"

Phrase: "that"

Phrase: "the impairment of -cell function"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   861   C0007613:Cell Function [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0031843:function [Physiologic Function]
   812   C0542341:Function [Functional Concept]
   812   C0700205:FUNCTION [Classification]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1705273:Function [Intellectual Product]
   812   C1948049:Cell [Spatial Concept]
   741 E C0205245:Functional [Functional Concept]
   741 E C2700217:Functional [Conceptual Entity]

Phrase: "associated with Bcl-xL overexpression"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   806   C1332397:bcl-xL [Gene or Genome]
   760   C1514559:Overexpression [Genetic Function]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "may"

Phrase: "be"

Phrase: "related to disturbances"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0439849:Related [Qualitative Concept]
   790   C0445223:Related [Finding]
   756 E C0163712:Relate [Organic Chemical]
   756   C2699787:Disturbance [Qualitative Concept]

Phrase: "in mitochondrial signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "glucose-induced insulin secretion."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.286: We therefore tested the hypothesis that -cell dysfunction in Fd 2Bcl-xL transgenic mice may be related to important mitochondrial effects of Bcl-xL overexpression. 

Phrase: "We therefore"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that -cell dysfunction in Fd 2Bcl-xL transgenic mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0031847:dysfunction [Functional Concept]
   742   C0277785:Dysfunction, NOS [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "related to important mitochondrial effects of Bcl-xL overexpression."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   764   C1332397:bcl-xL [Gene or Genome]
   742   C0026237:Mitochondrial [Cell Component]
   742   C0439849:Related [Qualitative Concept]
   742   C0445223:Related [Finding]
   742   C0521451:Mitochondrial [Functional Concept]
   742   C1280500:effects [Qualitative Concept]
   742   C1514559:Overexpression [Genetic Function]
   708 E C0163712:Relate [Organic Chemical]
   708 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.287: These studies uncovered considerable evidence for mitochondrial dysfunction. 

Phrase: "These studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "uncovered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439845:Uncovered [Functional Concept]

Phrase: "considerable evidence for mitochondrial dysfunction."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.288: In Fd 2Bcl-xL pancreas or islets, the insulin secretory responses to the mitochondrial nutrients PME (Fig. 1) and KIC (data not shown) were reduced to a similar extent as the response to glucose. 

Phrase: "In Fd 2Bcl-xL pancreas"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   812   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "islets,"

Phrase: "the insulin secretory responses to the mitochondrial nutrients PME"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   761   C1160632:response to nutrients [Cell Function]
   738   C0871261:responses [Organism Attribute]
   704 E C1704632:Response [Finding]
   704 E C1706817:Response [Intellectual Product]
   704 E C2911692:Response [Mental Process]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "KIC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "reduced to a similar extent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0392756:Reduced [Qualitative Concept]
   760   C0439792:Extent [Spatial Concept]
   760   C2348205:Similar [Qualitative Concept]

Phrase: "as the response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to glucose."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
Processing 00000000.tx.289: In addition, glucose oxidation was significantly reduced at 24mM glucose in the face of a normal glycolytic flux. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "significantly"

Phrase: "reduced at 24mM glucose"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0392756:Reduced [Qualitative Concept]

Phrase: "in the face"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015450:Face [Body Location or Region]
  1000   C1281591:Face [Body Part, Organ, or Organ Component]

Phrase: "of a normal glycolytic flux."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348693:Flux [Natural Phenomenon or Process]
Processing 00000000.tx.290: Reduced NAD(P)H responses to PME or KIC stimulation in Fd 2Bcl-xL islets provided further evidence for reduced metabolism of these two nutrients within the mitochondria. 

Phrase: "Reduced NAD(P)H responses to PME"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]

Phrase: "or"

Phrase: "KIC stimulation in Fd 2Bcl-xL islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   744   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "further evidence for reduced metabolism of these two nutrients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "within the mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.291: Bcl-xL islets also demonstrated altered regulation of m, as evidenced by reduced hyperpolarization responses after nutrient stimulation. 

Phrase: "Bcl-xL islets also"

Phrase: "demonstrated"

Phrase: "altered regulation of m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]

Phrase: "as"

Phrase: "evidenced by reduced hyperpolarization responses"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0392756:Reduced [Qualitative Concept]
   760   C0871261:responses [Organism Attribute]
   726   C0332120:Evidence [Functional Concept]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]

Phrase: "after nutrient stimulation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]
Processing 00000000.tx.292: The maintenance of a normal m is crucial to a number of mitochondrial functions, such as ATP production and homeostasis of intramitochondrial Ca2+ levels, which are important for the regulation of metabolism (30). 

Phrase: "The maintenance of a normal m"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0024501:Maintenance [Activity]

Phrase: "is"

Phrase: "crucial to a number of mitochondrial functions,"

Phrase: "such as ATP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "homeostasis of intramitochondrial Ca2+ levels,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0019868:Homeostasis [Biologic Function]

Phrase: "which"

Phrase: "are"

Phrase: "important for the regulation of metabolism"

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.293: In the present study, we found that the ATP production in response to glucose and KIC stimulation was indeed reduced in Bcl-xL islets compared with wild-type islets. 

Phrase: "In the present study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the ATP production in response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "to glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "KIC stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   827   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "was"

Phrase: "indeed"

Phrase: "reduced in Bcl-xL islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C1332397:bcl-xL [Gene or Genome]
   760   C0392756:Reduced [Qualitative Concept]

Phrase: "compared with wild-type islets."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1883559:Wild Type [Organism Attribute]
   760   C0332307:Type [Qualitative Concept]
   760   C0445392:Wild [Intellectual Product]
   760   C1547052:*Type [Quantitative Concept]
   760   C1707455:Compared [Activity]
Processing 00000000.tx.294: The normal NAD(P)H response to glucose in Fd 2Bcl-xL islets is surprising in light of the alteration in glucose oxidation. 

Phrase: "The normal NAD(P)H response to glucose"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0871261:Response [Organism Attribute]
   744   C1704632:Response [Finding]
   744   C1706817:Response [Intellectual Product]
   744   C2911692:Response [Mental Process]

Phrase: "in Fd 2Bcl-xL islets"

Phrase: "is"

Phrase: "surprising in light of the alteration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C1306462:Light [Functional Concept]
   753   C1515926:Alteration [Idea or Concept]
   753   C1881376:Light [Qualitative Concept]

Phrase: "in glucose oxidation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.295: The reason for this apparent discrepancy is not known. 

Phrase: "The reason for this apparent discrepancy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392360:Reason [Idea or Concept]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "known."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]
Processing 00000000.tx.296: It may be explained by the difference in the length of time for each experiment. 

Phrase: "It"

Phrase: "may"

Phrase: "be"

Phrase: "explained by the difference"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "in the length"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1444754:Length [Quantitative Concept]
  1000   C1706316:LENGTH [Research Activity]
   928 E C0205166:Long [Qualitative Concept]
   928 E C1522425:Longest [Qualitative Concept]
   928 E C1706317:Long [Qualitative Concept]

Phrase: "of time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "for each experiment."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.297: The glucose oxidation is the total amount of oxidation over 120min, whereas the change in NAD(P)H is the maximal amplitude over 10min. 

Phrase: "The glucose oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "the total amount of oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1265611:Amount [Quantitative Concept]

Phrase: "over 120min,"

Phrase: "whereas"

Phrase: "the change in NAD(P)H"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0025320:The change [Physiologic Function]
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "the maximal amplitude over 10min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346753:Amplitude [Spatial Concept]
Processing 00000000.tx.298: Over the 120-min period, glucose would continue to be oxidized, and this would occur in all of the cells of the wild-type islets but may not happen in cells overexpressing Bcl-xL. 

Phrase: "Over the 120-min period,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0439531:/period [Temporal Concept]
   827   C1948053:Period [Temporal Concept]
   755 E C0332182:Periodic [Temporal Concept]
   755 E C1706381:PERIODIC [Intellectual Product]
   727 E C0031084:Periodicities [Temporal Concept]

Phrase: "glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]

Phrase: "would"

Phrase: "continue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549178:Continue [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: ","

Phrase: "and"

Phrase: "this"

Phrase: "would"

Phrase: "occur in all of the cells of the wild-type islets"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   759   C0449475:Type of cell [Intellectual Product]
           cells type
   756   C1883559:Wild Type [Organism Attribute]
   754   C0022131:cells islets [Body Part, Organ, or Organ Component]
   738   C0007634:Cells [Cell]
       E   Cell Type
   738   C0332307:Type [Qualitative Concept]
   738   C0445392:Wild [Intellectual Product]
   738   C1547052:*Type [Quantitative Concept]
   738   C1709305:Occur [Activity]
   738   C2745955:OCCUR [Temporal Concept]
   738   C3282337:Cells [Cell]
   721 E C1522529:Islet Cell [Cell]
   704 E C1269647:Cell [Cell]
   704 E C1704653:Cell [Medical Device]
   704 E C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "may"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "happen in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1709305:Happen [Activity]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "Bcl-xL."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]
Processing 00000000.tx.299: Also, because the change in fluorescence is a relative value, it is difficult to quantitatively compare the two experiments. 

Phrase: "Also,"

Phrase: "because"

Phrase: "the change in fluorescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0025320:The change [Physiologic Function]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "a relative value,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205345:Relative Value [Qualitative Concept]
   861   C1522609:Value [Quantitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "difficult to quantitatively"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0332218:Difficult [Qualitative Concept]
   755 E C1299586:Difficulty [Finding]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the two experiments."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]
Processing 00000000.tx.300: ATP plays an important role in the regulation of exocytosis of insulin (24, 32), and depletion of ATP impairs tolbutamide-induced insulin secretion (21). 

Phrase: "ATP"

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "an important role in the regulation of exocytosis of insulin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0035820:Role [Social Behavior]
   739   C1705810:Role [Conceptual Entity]

Phrase: "(24,"

Phrase: "32"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "depletion of ATP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333668:Depletion [Functional Concept]

Phrase: "impairs"

Phrase: "tolbutamide-induced insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(21"

Phrase: ")."
Processing 00000000.tx.301: The reduction in KCl and tolbutamide-induced [Ca2+]i and insulin responses seen in islets of Fd 2Bcl-xL mice are likely due to mitochondrial dysfunction in the -cell, since similar results have recently been observed in a pancreatic -cell line lacking mitochondrial DNA (39). 

Phrase: "The reduction in KCl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "tolbutamide-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "insulin responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "seen in islets of Fd 2Bcl-xL mice"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   750   C1522528:Mouse Islets [Tissue]
   744   C0025914:Mice [Mammal]
   744   C0025929:mice [Mammal]
   744   C0026809:Mice [Mammal]
   744   C0205397:Seen [Qualitative Concept]
   744   C0263541:Founder [Disease or Syndrome]
   711 E C0042789:see [Organism Function]
   711 E C1947903:See [Activity]

Phrase: "are"

Phrase: "likely due to mitochondrial dysfunction"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0026237:Mitochondrial [Cell Component]
   760   C0031847:dysfunction [Functional Concept]
   760   C0277785:Dysfunction, NOS [Qualitative Concept]
   760   C0332148:Likely [Qualitative Concept]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0750492:Likely [Idea or Concept]
   760   C3146286:Due [Idea or Concept]
   704 E C0231174:Malfunction [Functional Concept]
   704 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "in the -cell,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "since"

Phrase: "similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "have"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "been"

Phrase: "observed in a pancreatic -cell line"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   814   C0030280:Pancreatic A-cell [Cell]
   790   C0007600:Cell Line [Cell]
   753   C0007634:Cell [Cell]
   753   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   753   C0205132:Line [Spatial Concept]
   753   C1269647:Cell [Cell]
   753   C1441672:Observed [Functional Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "(39"

Phrase: ")."
Processing 00000000.tx.302: Because mitochondrial DNA encodes proteins responsible for ATP production through oxidative phosphorylation, depletion of mitochondrial DNA is expected to abolish mitochondrial ATP generation. 

Phrase: "Because"

Phrase: "mitochondrial DNA"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0012929:DNA, Mitochondrial [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C1819717:mitochondrial DNA [Cell Component]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0026237:Mitochondrial [Cell Component]
   861   C0521451:Mitochondrial [Functional Concept]

Phrase: "encodes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2700640:Encode [Activity]

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "responsible for ATP production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "through oxidative phosphorylation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0030013:Oxidative Phosphorylation [Molecular Function]
   861   C0031715:Phosphorylation [Molecular Function]
   861   C0311404:Oxidative [Functional Concept]
   861   C1158886:Phosphorylation [Molecular Function]

Phrase: "depletion of mitochondrial DNA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0342782:Depletion of mitochondrial DNA [Disease or Syndrome]
           Mitochondrial DNA depletion
   770   C0333668:Depletion [Functional Concept]

Phrase: "is"

Phrase: "expected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517001:Expected [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "abolish"

Phrase: "mitochondrial ATP generation."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.303: In Fd 2Bcl-xL islets, there is indeed a dramatic reduction in nutrient metabolism and ATP production. 

Phrase: "In Fd 2Bcl-xL islets,"

Phrase: "there"

Phrase: "is"

Phrase: "indeed"

Phrase: "a dramatic reduction in nutrient metabolism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "ATP production."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033268:production [Occupational Activity]
Processing 00000000.tx.304: These observations indicate that ATP or other factors generated from mitochondrial nutrient metabolism play an important role in KCl- and tolbutamide-induced [Ca2+]i responses and insulin secretion and in glucose-induced insulin secretion. 

Phrase: "These observations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "indicate"

Phrase: "that ATP"

Phrase: "or"

Phrase: "other factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1521761:Factor [Functional Concept]
   966   C2827422:Factor [Conceptual Entity]

Phrase: "generated from mitochondrial nutrient metabolism"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0678695:Nutrient [Food]
   760   C2347375:Nutrient [Conceptual Entity]
   760   C3146294:Generated [Activity]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an important role in KCl-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "and"

Phrase: "tolbutamide-induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205263:Induced [Functional Concept]

Phrase: "[Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "and"

Phrase: "insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and in glucose-induced insulin secretion."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C1256369:insulin secretion [Cell Function]
   783   C1719133:Glucose/Insulin [Quantitative Concept]
   753   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   753   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C0036536:secretion [Biologic Function]
   753   C0036537:Secretion [Body Substance]
   753   C0205263:Induced [Functional Concept]
   753   C1515981:And [Idea or Concept]
   753   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   753   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.305: Increased expression of Bcl-xL seen in islets from Fd 1and Fd 2mice was associated with protection from thapsigargin-induced apoptosis. 

Phrase: "Increased expression of Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "seen in islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "from Fd 1and Fd 2mice"

Phrase: "was"

Phrase: "associated with protection"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1545588:Protection [Finding]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "from thapsigargin-induced apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.306: These results are consistent with those of Biroccio et al. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with those of Biroccio et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.307: (2) and others, who have suggested that a decrease in mitochondrial nutrient metabolism may help to restrain the release of cytochrome c and other death-promoting molecules from the space between the inner and outer mitochondrial membranes to the cytosol. 

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "others,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "who"

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "a decrease in mitochondrial nutrient metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "may"

Phrase: "help"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018896:Help [Social Behavior]
  1000   C1552861:help [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "restrain"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   944   C0311403:Inhibited [Qualitative Concept]
   944   C3463820:Inhibiting [Activity]
   916 E C0018790:arrested [Disease or Syndrome]
   916 E C0237477:Arrest [Temporal Concept]
   916 E C0392351:arrest [Governmental or Regulatory Activity]
   916 E C0521111:Retarded [Qualitative Concept]

Phrase: "the release of cytochrome c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "other death-promoting molecules from the space"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0567416:molecules [Substance]

Phrase: "between the inner"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205102:Inner [Spatial Concept]

Phrase: "and"

Phrase: "outer mitochondrial membranes to the cytosol."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0230839:Outer Mitochondrial Membranes [Cell Component]
   790   C0596952:Mitochondrial Membranes [Cell Component]
   767   C1167331:outer membrane [Cell Component]
   753   C0025255:Membranes [Tissue]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0205101:Outer [Spatial Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   719 E C0596901:Membrane [Cell Component]
   719 E C1706182:Membrane [Manufactured Object]
Processing 00000000.tx.308: However, although even a modest overexpression of Bcl-xL, as seen in the Fd 1islets, was sufficient to protect the islets from thapsigargin-induced cell death, only marked overexpression of the protein, as seen in the islets from the Fd 2animals, resulted in sufficient disturbance of mitochondrial distribution and metabolism to reduce glucose-induced insulin secretion. 

Phrase: "However,"

Phrase: "although"

Phrase: "even"

Phrase: "a modest overexpression of Bcl-xL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1514559:Overexpression [Genetic Function]

Phrase: "as"

Phrase: "seen in the Fd 1islets,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0205397:Seen [Qualitative Concept]
   760   C0263541:Founder [Disease or Syndrome]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "protect"

Phrase: "the islets from thapsigargin-induced cell death,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   774   C0022131:cell islets [Body Part, Organ, or Organ Component]
   757 E C1522529:Islet Cell [Cell]

Phrase: "only marked overexpression of the protein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1514559:Protein Overexpression [Genetic Function]
           Overexpression

Phrase: "as"

Phrase: "seen in the islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "from the Fd 2animals,"

Phrase: "resulted in sufficient disturbance of mitochondrial distribution"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C1522855:mitochondrial distribution [Cell Function]
   748   C0026237:Mitochondrial [Cell Component]
   748   C0205410:Sufficient [Qualitative Concept]
   748   C0520511:distribution [Idea or Concept]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C1704711:Distribution [Functional Concept]
   748   C2699787:Disturbance [Qualitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "metabolism to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "reduce"

Phrase: "glucose-induced insulin secretion."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   875   C1719133:Glucose/Insulin [Quantitative Concept]
   861   C1256369:insulin secretion [Cell Function]
   812   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C0036536:secretion [Biologic Function]
   812   C0036537:Secretion [Body Substance]
   812   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   812   C1579433:Insulin [Pharmacologic Substance]
   756 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   729 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.309: Although it is possible that the diabetic phenotype in the Fd 2line could also be linked to a very rare insertional disruption of the host gene, we believe that the chance of this mechanism being responsible for the observed changes is very small. 

Phrase: "Although"

Phrase: "it"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the diabetic phenotype in the Fd 2line"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0031437:Phenotype [Organism Attribute]
   748   C1285572:Phenotype [Laboratory Procedure]

Phrase: "could"

Phrase: "also"

Phrase: "be"

Phrase: "linked to a very rare insertional disruption of the host gene,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   756   C1855575:Very rare [Finding]
   754   C0314613:Linked gene [Genetic Function]
   738   C0017337:Gene [Gene or Genome]
   738   C0332453:Disruption [Functional Concept]
   738   C0442824:Very [Qualitative Concept]
   738   C0521114:Rare [Temporal Concept]
   738   C0522498:Rare [Qualitative Concept]
   738   C1167395:Host [Organism]
   738   C1514917:RARE [Gene or Genome]
   718   C1955829:Gene Insertion [Cell or Molecular Dysfunction]
   704   C1517892:Link [Intellectual Product]
   704   C1704666:Link [Intellectual Product]

Phrase: "we"

Phrase: "believe"

Phrase: "that"

Phrase: "the chance of this mechanism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0237506:Chance [Qualitative Concept]

Phrase: "being"

Phrase: "responsible for the observed changes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "is"

Phrase: "very small."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0700321:Small [Quantitative Concept]
Processing 00000000.tx.310: First, we always performed wild-typetransgenic breeding to avoid the disruption of both alleles of a particular gene. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "we always"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003902:Always [Temporal Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "wild-typetransgenic breeding to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006159:Breeding [Organism Function]

Phrase: "avoid"

Phrase: "the disruption of both alleles of a particular gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332453:Disruption [Functional Concept]
Processing 00000000.tx.311: Second, the phenotype of the Fd 2Bcl-xL mice is unique; 

Phrase: "Second,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0205436:Second [Quantitative Concept]
  1000   C0457385:Second [Temporal Concept]
  1000   C0565930:/second [Quantitative Concept]
  1000   C1561503:second [Idea or Concept]
  1000   C1705190:Second [Qualitative Concept]
   928 E C0027627:secondary [Neoplastic Process]
   928 E C0175668:Secondary [Temporal Concept]

Phrase: "the phenotype of the Fd 2Bcl-xL mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0031437:Phenotype [Organism Attribute]
   744   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "unique"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710548:Unique [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.312: the animals were viable, reproductively competent, and had a glucose-signaling defect consistent with possible effects of Bcl-xL. 

Phrase: "the animals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003062:Animals [Animal]

Phrase: "were"

Phrase: "viable, reproductively competent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0086035:Competent [Qualitative Concept]

Phrase: "and"

Phrase: "had"

Phrase: "a glucose-signaling defect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1457869:Defect [Functional Concept]
   827   C1861101:DEFECT [Disease or Syndrome]

Phrase: "consistent with possible effects of Bcl-xL."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.313: It is also unlikely that we introduced a gene disruption to a position that happened to be more important for -cell function then elsewhere. 

Phrase: "It"

Phrase: "is"

Phrase: "also unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0750558:Unlikely [Conceptual Entity]
   861   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "we"

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "a gene disruption to a position"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332453:Disruption [Functional Concept]

Phrase: "that"

Phrase: "happened"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709305:Happened [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "more important for -cell function then elsewhere."
Processing 00000000.tx.314: However, because we did not get the chance to study more positive founders generated with the RIP7 construct, we can not totally rule out insertional disruption of a host gene as a mechanism for the phenotype of the Fd 2animals. 

Phrase: "However,"

Phrase: "because"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "get"

Phrase: "the chance to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0237506:Chance [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "more positive founders"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0263541:founders [Disease or Syndrome]

Phrase: "generated with the RIP7 construct,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C2827421:Construct [Classification]
   760   C3146294:Generated [Activity]

Phrase: "we"

Phrase: "can"

Phrase: "not totally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out insertional disruption of a host gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:Disruption [Functional Concept]

Phrase: "as a mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441712:Mechanism [Functional Concept]
  1000   C1706376:Mechanism [Manufactured Object]

Phrase: "for the phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "of the Fd 2animals."
Processing 00000000.tx.315: In summary, the two- to threefold increase in Bcl-xL expression seen in islets from the Fd 1animals afforded protection against thapsigargin-induced apoptosis and did not interfere with insulin secretion. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "the two-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "to threefold increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in Bcl-xL expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C1332397:bcl-xL [Gene or Genome]

Phrase: "seen in islets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]

Phrase: "from the Fd 1animals"

Phrase: "afforded"

Phrase: "protection against thapsigargin-induced apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "interfere with insulin secretion."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1256369:insulin secretion [Cell Function]
   770   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C0036536:secretion [Biologic Function]
   770   C0036537:Secretion [Body Substance]
   770   C0521102:Interfere [Qualitative Concept]
   770   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   770   C1579433:Insulin [Pharmacologic Substance]
   715 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
Processing 00000000.tx.316: The ~10-fold increase in expression of Bcl-xL found in the Fd 2animals afforded greater protection against thapsigargin-induced apoptosis but was associated with a severe defect in insulin secretion that caused diabetes. 

Phrase: "The ~10-fold increase in expression of Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "found in the Fd 2animals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0150312:Found [Quantitative Concept]
   760   C0263541:Founder [Disease or Syndrome]
   726 E C0243095:Find [Finding]

Phrase: "afforded"

Phrase: "greater protection against thapsigargin-induced apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1545588:Protection [Finding]

Phrase: "but"

Phrase: "was"

Phrase: "associated with a severe defect"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0205082:Severe [Qualitative Concept]
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "that caused diabetes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.317: This defect in insulin secretion is due to a novel mitochondrial defect resulting in reduced responses to mitochondrial substrates, decreased mitochondrial glucose oxidation, and abnormal control of /m. 

Phrase: "This defect in insulin secretion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1457869:Defect [Functional Concept]
   760   C1861101:DEFECT [Disease or Syndrome]

Phrase: "is due to a novel mitochondrial defect"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0678226:Due to [Functional Concept]
           due
   748   C0026237:Mitochondrial [Cell Component]
   748   C0205314:Novel [Temporal Concept]
   748   C0521451:Mitochondrial [Functional Concept]
   748   C0679622:novel [Intellectual Product]
   748   C1457869:Defect [Functional Concept]
   748   C1861101:DEFECT [Disease or Syndrome]
   748   C3146286:Due [Idea or Concept]

Phrase: "resulting in reduced responses"
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   833   C0332294:Resulting in [Functional Concept]
   770   C0392756:Reduced [Qualitative Concept]
   770   C0678226:resulting [Functional Concept]
   770   C0871261:responses [Organism Attribute]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C1704632:Response [Finding]
   737 E C1706817:Response [Intellectual Product]
   737 E C2825142:Result [Finding]
   737 E C2911692:Response [Mental Process]

Phrase: "to mitochondrial substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710236:Substrate [Manufactured Object]

Phrase: "decreased"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0205216:Decreased [Quantitative Concept]
  1000   C0392756:Decreased [Qualitative Concept]
  1000   C0442797:decreased [Qualitative Concept]
   966 E C0547047:Decrease [Quantitative Concept]

Phrase: "mitochondrial glucose oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "abnormal control of /m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.318: These results underscore the complexity of developing therapeutic approaches by transferring novel proteins into -cells to modify their underlying function or to enhance their ability to survive. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "underscore"

Phrase: "the complexity of developing therapeutic approaches"

Phrase: "by transferring novel proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "into -cells to"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "modify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:MODIFY [Functional Concept]

Phrase: "their underlying function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "or"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "survive."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0310255:SURVIVE [Pharmacologic Substance]
Processing 00000000.tx.319: In designing such therapeutic strategies, not only must the desired therapeutic effect of the protein under study be considered but unexpected adverse influences of the particular protein on islet function need to be considered also. 

Phrase: "In designing"

Phrase: "such therapeutic strategies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0679199:strategies [Mental Process]

Phrase: "not only"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205171:Only [Quantitative Concept]
   861   C1518422:Not [Functional Concept]
   861   C1720467:Only [Intellectual Product]

Phrase: "must"

Phrase: "the desired therapeutic effect of the protein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1527144:Therapeutic Effect [Health Care Activity]
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "under study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "but"

Phrase: "unexpected adverse influences of the particular protein"

Phrase: "on islet function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "also."
Processing 00000000.tx.320: On the other hand, the Fd 2Bcl-xL mice represent a unique model of -cell-specific mitochondrial impairment that underscores the critical role of mitochondrial metabolism in insulin secretion (5, 6).  

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "the Fd 2Bcl-xL mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025914:Mice [Mammal]
   812   C0025929:mice [Mammal]
   812   C0026809:Mice [Mammal]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a unique model of -cell-specific mitochondrial impairment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0684336:Impairment [Pathologic Function]

Phrase: "that"

Phrase: "underscores"

Phrase: "the critical role of mitochondrial metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.321: ACKNOWLEDGEMENTS We thank Kimberly Fox for technical assistance.  

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Kimberly Fox for technical assistance."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0016633:Fox [Mammal]
Processing 00000000.tx.322: FOOTNOTES This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK-31842, DK-44840, DK-20595, and DK-49799, the Blum-Kovler Foundation, and the Jack and Dollie Galter Center of Excellence of the Juvenile Diabetes Foundation International. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by National Institute of Diabetes"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0011847:Diabetes [Disease or Syndrome]
   753   C0011849:Diabetes [Disease or Syndrome]
   753   C0021622:institute [Organization]
   753   C1272753:Institute [Idea or Concept]
   753   C1521721:Supported [Conceptual Entity]
   753   C3245503:national [Intellectual Product]
   719 E C0183683:Support [Medical Device]

Phrase: "and"

Phrase: "Digestive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012238:Digestive [Organism Function]
  1000   C0012240:Digestive [Body System]

Phrase: "and"

Phrase: "Kidney Diseases Grants DK-31842,"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   840   C0022658:Kidney Diseases [Disease or Syndrome]
   804   C0011318:DK [Geographic Area]
   804   C0012634:Diseases [Disease or Syndrome]
   804   C0018173:Grants [Quantitative Concept]
   804   C0022646:Kidney [Body Part, Organ, or Organ Component]
   804   C0227665:kidney [Body Part, Organ, or Organ Component]
   804   C1278978:Kidney [Body Part, Organ, or Organ Component]
   804   C1514845:KIDNEY [Tissue]
   771 E C1548284:Grant [Idea or Concept]
   733 E C1836721:MALS [Finding]
   733 E C3538764:MALS [Gene or Genome]
   733 E C3540595:MAL [Gene or Genome]
   711 E C0027697:Nephritides [Disease or Syndrome]

Phrase: "DK-44840,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "DK-20595,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "and"

Phrase: "DK-49799,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0011318:DK [Geographic Area]

Phrase: "the Blum-Kovler Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Jack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1708586:Jack [Manufactured Object]

Phrase: "and"

Phrase: "Dollie Galter Center of Excellence of the Juvenile Diabetes Foundation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0205099:Center [Spatial Concept]

Phrase: "International."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]
Processing 00000000.tx.323: M.

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.324: Levisetti was supported by a mentor-based postdoctoral fellowship award of American Diabetes Association. 

Phrase: "Levisetti"

Phrase: "was"

Phrase: "supported by a mentor-based postdoctoral fellowship award of American Diabetes Association."
Meta Candidates (Total=18; Excluded=4; Pruned=0; Remaining=14)
   770   C1705019:American Diabetes Association [Professional Society]
   736   C0004083:Association [Mental Process]
   736   C0004446:Award [Manufactured Object]
   736   C0011847:Diabetes [Disease or Syndrome]
   736   C0011849:Diabetes [Disease or Syndrome]
   736   C0015770:Fellowship [Educational Activity]
   736   C0025369:Mentor [Population Group]
   736   C0439849:Association [Qualitative Concept]
   736   C0596070:American [Population Group]
   736   C0596306:Association [Phenomenon or Process]
   736   C0699792:association [Social Behavior]
   736   C1521721:Supported [Conceptual Entity]
   736   C1527178:Based [Functional Concept]
   736   C1705938:Based [Idea or Concept]
   703 E C0002055:base [Inorganic Chemical]
   703 E C0178499:Base [Chemical Viewed Functionally]
   703 E C0183683:Support [Medical Device]
   703 E C1880279:Base [Biomedical or Dental Material]
Processing 00000000.tx.325: The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.326: The article must therefore be hereby marked "advertisement" in accordance with 18U.S.C. 

Phrase: "The article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18U.S.C."
Processing 00000000.tx.327: 1734 solely to indicate this fact. 

Phrase: "1734 solely to"

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.328: Address for reprint requests and other correspondence: K.S.

Phrase: "Address for reprint requests"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0376649:Address [Intellectual Product]
   770   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "other correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "K.S."
Processing 00000000.tx.329: Polonsky, Section of Endocrinology, Univ. of Chicago, MC 1027,5841S.

Phrase: "Polonsky,"

Phrase: "Section of Endocrinology,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0205155:Section [Spatial Concept]
   790   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   790   C1522472:Section [Substance]
   790   C1552923:Section [Quantitative Concept]
   790   C1705191:Section [Physical Object]

Phrase: "Univ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041740:UNIV [Manufactured Object,Organization]

Phrase: "of Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "MC 1027,"

Phrase: "5841S."
Processing 00000000.tx.330: Maryland Ave., Chicago, IL 60637(E-mail: polonsky{at}medicine.bsd.uchicago.edu ). 

Phrase: "Maryland Ave.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0108844:AVE [Therapeutic or Preventive Procedure]

Phrase: "Chicago,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0008044:Chicago [Geographic Area]

Phrase: "IL 60637"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0020898:IL [Geographic Area]
   861   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0022271:IL [Geographic Area]

Phrase: "(E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "polonsky{at}medicine.bsd.uchicago.edu"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.331: Received 10 May 1999; 

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "10 May 1999"

Phrase: ";"
Processing 00000000.tx.332: accepted in final form 12 October 1999.  

Phrase: "accepted in final form 12 October 1999."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   748   C0205088:Final [Temporal Concept]
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1272684:Accepted [Qualitative Concept]
   748   C1522492:Form [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   748   C1548435:Accepted [Idea or Concept]
   714 E C1548601:Accept [Idea or Concept]
Processing 00000000.tx.333: REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES 1.  

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.334: Bar-On, H., R. 

Phrase: "Bar-On,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0687760:bar [Manufactured Object]
   833   C1551065:bar [Quantitative Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.335: Ben-Sasson, E. 

Phrase: "Ben-Sasson,"

Phrase: "E."
Processing 00000000.tx.336: Zivv, N. 

Phrase: "Zivv,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.337: Arar, and E. 

Phrase: "Arar,"

Phrase: "and"

Phrase: "E."
Processing 00000000.tx.338: Shafrir. 

Phrase: "Shafrir."
Processing 00000000.tx.339: Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to beta-cell apoptosis. 

Phrase: "Irreversibility of nutritionally induced NIDDM"

Phrase: "in Psammomys obesus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1013768:Psammomys obesus [Mammal]
   861   C0033783:Psammomys [Mammal]

Phrase: "is"

Phrase: "related to beta-cell apoptosis."
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   806   C0030281:Beta cell [Cell]
   760   C0007634:Cell [Cell]
   760   C0162638:Apoptosis [Cell Function]
   760   C0330390:Beta [Plant]
   760   C0439096:Beta [Intellectual Product]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2004068:Beta [Qualitative Concept]
   726 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.340: Pancreas 18: 259-265, 1999[ISI][Medline]. 

Phrase: "Pancreas 18"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "259-265,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.341: 2.  

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.342: Biroccio, A, D. 

Phrase: "Biroccio,"

Phrase: "A,"

Phrase: "D."
Processing 00000000.tx.343: Del Bufalo, M. 

Phrase: "Del Bufalo,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.344: Fanciulli, T. 

Phrase: "Fanciulli,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.345: Bruno, G. 

Phrase: "Bruno,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.346: Zupi, and A. 

Phrase: "Zupi,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.347: Floridi. 

Phrase: "Floridi."
Processing 00000000.tx.348: Bcl-2 inhibits mitochondrial metabolism and lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells. 

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "mitochondrial metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "lonidamine-induced apoptosis in adriamycin-resistant MCF7 cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.349: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.350: J.

Phrase: "J."
Processing 00000000.tx.351: Cancer 82: 125-130, 1999[ISI][Medline]. 

Phrase: "Cancer 82"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: ":"

Phrase: "125-130,"

Phrase: "1999"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.352: 3.  

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.353: Boise, L. 

Phrase: "Boise,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.354: H., M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.355: Gonzalez-Garcia, C. 

Phrase: "Gonzalez-Garcia,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0442999:Garcia [Intellectual Product]
   861   C1621797:Garcia [Plant]

Phrase: "C."
Processing 00000000.tx.356: E. 

Phrase: "E."
Processing 00000000.tx.357: Postema, L. 

Phrase: "Postema,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.358: Ding, T. 

Phrase: "Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.359: Lindsten, L. 

Phrase: "Lindsten,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.360: A. 

Phrase: "A."
Processing 00000000.tx.361: Turka, X. 

Phrase: "Turka,"

Phrase: "X."
Processing 00000000.tx.362: Mao, G. 

Phrase: "Mao,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.363: Nunez, and C. 

Phrase: "Nunez,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.364: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.365: Thompson. 

Phrase: "Thompson."
Processing 00000000.tx.366: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. 

Phrase: "Bcl-x,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0219472:BCL-X [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332397:BCLX [Gene or Genome]
  1000   C1704960:BCLX [Gene or Genome]

Phrase: "a bcl-2-related gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0376515:bcl-2 Gene [Gene or Genome]
   923   C1704467:BCL-2 Gene [Gene or Genome]
   812   C0017337:Gene [Gene or Genome]

Phrase: "that functions as a dominant regulator of apoptotic cell death."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C0007613:cell functions [Cell Function]
   739   C0542341:Functions [Functional Concept]
   706 E C0031843:function [Physiologic Function]
   706 E C0700205:FUNCTION [Classification]
   706 E C1705273:Function [Intellectual Product]
Processing 00000000.tx.367: Cell 74: 597-608, 1993[ISI][Medline]. 

Phrase: "Cell 74"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "597-608,"

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.368: 4.  

Phrase: "4."
Processing 00000000.tx.369: Duchen, M. 

Phrase: "Duchen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.370: R., P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.371: A. 

Phrase: "A."
Processing 00000000.tx.372: Smith, and F. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.373: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.374: Ashcroft. 

Phrase: "Ashcroft."
Processing 00000000.tx.375: Substrate-dependent changes in mitochondrial function, intracellular free calcium concentration and membrane channels in pancreatic -cells. 

Phrase: "Substrate-dependent changes in mitochondrial function,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0392747:changes [Functional Concept]
   753   C0443172:changes [Quantitative Concept]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "intracellular free calcium concentration"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   861   C0596235:Free Calcium [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   812   C0006726:Calcium [Inorganic Chemical]
   812   C0086045:Concentration [Mental Process]
   812   C0175996:intracellular [Cell Component]
   812   C0178719:Intracellular [Spatial Concept]
   812   C0332296:free [Functional Concept]
   812   C1446561:Concentration [Quantitative Concept]
   812   C1880497:Free [Qualitative Concept]
   812   C1996904:Free [Qualitative Concept]
   812   C2936886:Calcium [Pharmacologic Substance]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "and"

Phrase: "membrane"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025255:Membrane [Tissue]
  1000   C0596901:Membrane [Cell Component]
  1000   C1706182:Membrane [Manufactured Object]
   928 E C0205287:Membranous [Qualitative Concept]

Phrase: "channels in pancreatic -cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   770   C0439799:Channel [Spatial Concept]
   770   C1706095:Channel [Conceptual Entity]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.376: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.377: J. 

Phrase: "J."
Processing 00000000.tx.378: 294: 35-42, 1993[ISI][Medline]. 

Phrase: "294"

Phrase: ":"

Phrase: "35-42,"

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.379: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.380: Dukes, I. 

Phrase: "Dukes,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1512090:Dukes [Classification]
   966 E C1446468:Duke [Laboratory Procedure]

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.381: D., M. 

Phrase: "D."

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.382: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.383: McIntyre, R. 

Phrase: "McIntyre,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.384: J. 

Phrase: "J."
Processing 00000000.tx.385: Mertz, L. 

Phrase: "Mertz,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.386: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.387: Philipson, M. 

Phrase: "Philipson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.388: W. 

Phrase: "W."
Processing 00000000.tx.389: Roe, B. 

Phrase: "Roe,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.390: Spencer, and J. 

Phrase: "Spencer,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.391: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.392: Worley, III. 

Phrase: "Worley,"

Phrase: "III."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]
Processing 00000000.tx.393: Dependence on NADH produced during glycolysis for beta-cell glucose signaling. 

Phrase: "Dependence on NADH"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0011546:Dependence [Mental Process]
   790   C0439857:Dependence [Mental or Behavioral Dysfunction]
   790   C2698668:DEPENDENCE [Regulation or Law]
   718 E C0851827:Dependent [Qualitative Concept]
   718 E C1701901:Dependent [Qualitative Concept]
   718 E C3244310:dependent [Functional Concept]

Phrase: "produced during glycolysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0017952:Glycolysis [Molecular Function]

Phrase: "for beta-cell glucose signaling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0037083:Cell Signaling [Cell Function]
           Signaling
   812   C3537152:signaling [Biologic Function]
Processing 00000000.tx.394: J. 

Phrase: "J."
Processing 00000000.tx.395: Biol. 

Phrase: "Biol."
Processing 00000000.tx.396: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.397: 269: 10979-10982, 1994[Abstract/Free FullText]. 

Phrase: "269"

Phrase: ":"

Phrase: "10979-10982,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.398: 6.  

Phrase: "6."
Processing 00000000.tx.399: Eto, K., Y. 

Phrase: "Eto,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Y."
Processing 00000000.tx.400: Tsubamoto, Y. 

Phrase: "Tsubamoto,"

Phrase: "Y."
Processing 00000000.tx.401: Terauchi, T. 

Phrase: "Terauchi,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.402: Sugiyama, T. 

Phrase: "Sugiyama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.403: Kishimoto, N. 

Phrase: "Kishimoto,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.404: Takahashi, N. 

Phrase: "Takahashi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.405: Yamauchi, N. 

Phrase: "Yamauchi,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.406: Kubota, S. 

Phrase: "Kubota,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.407: Murayama, T. 

Phrase: "Murayama,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.408: Aizawa, Y. 

Phrase: "Aizawa,"

Phrase: "Y."
Processing 00000000.tx.409: Akanuma, S. 

Phrase: "Akanuma,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.410: Aizawa, H. 

Phrase: "Aizawa,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.411: Kasai, Y. 

Phrase: "Kasai,"

Phrase: "Y."
Processing 00000000.tx.412: Yazaki, and T. 

Phrase: "Yazaki,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.413: Kadowaki. 

Phrase: "Kadowaki."
Processing 00000000.tx.414: Role of NADH shuttle system in glucose-induced activation of mitochondrial metabolism and insulin secretion. 

Phrase: "Role of NADH shuttle system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in glucose-induced activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "of mitochondrial metabolism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0025519:Metabolism [Organism Function]
   861   C0025520:metabolism [Functional Concept]

Phrase: "and"

Phrase: "insulin secretion."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
  1000   C1256369:insulin secretion [Cell Function]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0036536:secretion [Biologic Function]
   861   C0036537:Secretion [Body Substance]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   777 E C3537244:Insulins [Pharmacologic Substance]
Processing 00000000.tx.415: Science 283: 981-985, 1999[Abstract/Free FullText]. 

Phrase: "Science 283"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "981-985,"

Phrase: "1999"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.416: 7.  

Phrase: "7."
Processing 00000000.tx.417: Gilon, P., M. 

Phrase: "Gilon,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.418: Nenquin, and J.-C. 

Phrase: "Nenquin,"

Phrase: "and"

Phrase: "J.-C."
Processing 00000000.tx.419: Henquin. 

Phrase: "Henquin."
Processing 00000000.tx.420: Muscarinic stimulation exerts both stimulatory and inhibitory effects on the concentration of cytoplasmic Ca2+ in the electrically excitable pancreatic -cell. 

Phrase: "Muscarinic stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "exerts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015264:exert [Organism Function]

Phrase: "both stimulatory"

Phrase: "and"

Phrase: "inhibitory effects on the concentration of cytoplasmic Ca2+"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C1280500:effects [Qualitative Concept]
   711 E C2348382:Effect [Qualitative Concept]

Phrase: "in the electrically excitable pancreatic -cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.421: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.422: J. 

Phrase: "J."
Processing 00000000.tx.423: 311: 259-267, 1995[ISI][Medline]. 

Phrase: "311"

Phrase: ":"

Phrase: "259-267,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.424: 8.  

Phrase: "8."
Processing 00000000.tx.425: Grill, V., M. 

Phrase: "Grill,"

Phrase: "V.,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.426: Rundfeld, and S. 

Phrase: "Rundfeld,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.427: Efendic. 

Phrase: "Efendic."
Processing 00000000.tx.428: Previous exposure to glucose enhances somatostatin secretion from the isolated perfused rat pancreas. 

Phrase: "Previous exposure to glucose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "somatostatin secretion from the isolated perfused rat pancreas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C2610946:somatostatin secretion [Cell Function]
   744   C0036536:secretion [Biologic Function]
   744   C0036537:Secretion [Body Substance]
Processing 00000000.tx.429: Diabetologia 30: 495-500, 1981. 

Phrase: "Diabetologia 30"

Phrase: ":"

Phrase: "495-500,"

Phrase: "1981."
Processing 00000000.tx.430: 9.  

Phrase: "9."
Processing 00000000.tx.431: Harlan, D. 

Phrase: "Harlan,"

Phrase: "D."
Processing 00000000.tx.432: M., M. 

Phrase: "M."

Phrase: ","

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.433: A. 

Phrase: "A."
Processing 00000000.tx.434: Barnett, R. 

Phrase: "Barnett,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.435: Abe, K. 

Phrase: "Abe,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0155685:abe [Disease or Syndrome]

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.436: Pechhold, N. 

Phrase: "Pechhold,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.437: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.438: Patterson, G. 

Phrase: "Patterson,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.439: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.440: Gray, and C. 

Phrase: "Gray,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0556636:gray [Quantitative Concept]
  1000   C1269776:Gray [Qualitative Concept]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.441: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.442: June. 

Phrase: "June."
Processing 00000000.tx.443: Very-low-dose streptozotocin induces diabetes in insulin promoter-mB7-1 transgenic mice. 

Phrase: "Very-low-dose streptozotocin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0038432:Streptozotocin [Antibiotic,Carbohydrate]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "diabetes in insulin promoter-mB7-1 transgenic mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011847:Diabetes [Disease or Syndrome]
   744   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.444: Diabetes 44: 816-823, 1995[Abstract]. 

Phrase: "Diabetes 44"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "816-823,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.445: 10.  

Phrase: "10."
Processing 00000000.tx.446: Iwahashi, H., T. 

Phrase: "Iwahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.447: Hanafusa, Y. 

Phrase: "Hanafusa,"

Phrase: "Y."
Processing 00000000.tx.448: Eguchi, H. 

Phrase: "Eguchi,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.449: Nakajima, J. 

Phrase: "Nakajima,"

Phrase: "J."
Processing 00000000.tx.450: Miyagawa, N. 

Phrase: "Miyagawa,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.451: Itoh, K. 

Phrase: "Itoh,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.452: Tomita, M. 

Phrase: "Tomita,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.453: Namba, M. 

Phrase: "Namba,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.454: Kuwajima, T. 

Phrase: "Kuwajima,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.455: Noguchi, Y. 

Phrase: "Noguchi,"

Phrase: "Y."
Processing 00000000.tx.456: Tsujimoto, and Y. 

Phrase: "Tsujimoto,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.457: Matsuzawa. 

Phrase: "Matsuzawa."
Processing 00000000.tx.458: Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: inhibition by Bcl-2. 

Phrase: "Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0162638:apoptotic cell death [Cell Function]
   766   C0030280:Pancreatic A-cell [Cell]
   766   C1513528:Mouse Cell Line [Cell]
   753   C0007587:Cell Death [Cell Function]
   751   C0007600:Cell Line [Cell]
   736   C0007634:Cell [Cell]
   736   C0011065:Death [Organism Function]
   736   C1269647:Cell [Cell]
   736   C1306577:Death, NOS [Finding]
   736   C1704653:Cell [Medical Device]
   736   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "inhibition by Bcl-2."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]
Processing 00000000.tx.459: Diabetologia 39: 530-536, 1996[ISI][Medline]. 

Phrase: "Diabetologia 39"

Phrase: ":"

Phrase: "530-536,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.460: 11.  

Phrase: "11."
Processing 00000000.tx.461: Kluck, R. 

Phrase: "Kluck,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.462: M., E. 

Phrase: "M."

Phrase: ","

Phrase: "E."
Processing 00000000.tx.463: Bossy-Wetzel, D. 

Phrase: "Bossy-Wetzel,"

Phrase: "D."
Processing 00000000.tx.464: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.465: Green, and D. 

Phrase: "Green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.466: D. 

Phrase: "D."
Processing 00000000.tx.467: Newmeyer. 

Phrase: "Newmeyer."
Processing 00000000.tx.468: The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. 

Phrase: "The release of cytochrome c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: ":"

Phrase: "a primary site for Bcl-2 regulation of apoptosis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0449695:Primary site [Spatial Concept]
   762   C2945843:Site of [Qualitative Concept]
   742   C0205145:Site [Spatial Concept]
   742   C1515974:Site [Body Location or Region]
   742   C2825164:Site [Spatial Concept]
Processing 00000000.tx.469: Science 275: 1132-1136, 1997[Abstract/Free FullText]. 

Phrase: "Science 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1132-1136,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.470: 12.  

Phrase: "12."
Processing 00000000.tx.471: Kroemer, G. 

Phrase: "Kroemer,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.472: The proto-oncogen bcl-2 and its role in regulating apoptosis. 

Phrase: "The proto-oncogen bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "its role in"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "regulating"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.473: Nat. 

Phrase: "Nat."
Processing 00000000.tx.474: Med. 

Phrase: "Med."
Processing 00000000.tx.475: 3: 614-620, 1997[ISI][Medline]. 

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ":"

Phrase: "614-620,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.476: 13.  

Phrase: "13."
Processing 00000000.tx.477: Kurrer, M. 

Phrase: "Kurrer,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.478: O., H. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.479: Pakala, L. 

Phrase: "Pakala,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.480: Hanson, and J. 

Phrase: "Hanson,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.481: D. 

Phrase: "D."
Processing 00000000.tx.482: Katz. 

Phrase: "Katz."
Processing 00000000.tx.483: -cell apoptosis in T-cell mediated autoimmune diabetes. 

Phrase: "-cell apoptosis in T-cell"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C2610891:T cell apoptosis [Cell Function]
   760   C0162638:Apoptosis [Cell Function]

Phrase: "mediated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0086597:mediated [Social Behavior]
  1000   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "autoimmune diabetes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205734:Diabetes, Autoimmune [Disease or Syndrome]
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]
Processing 00000000.tx.484: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.485: Natl. 

Phrase: "Natl."
Processing 00000000.tx.486: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.487: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.488: USA 94: 213-218, 1997[Abstract/Free FullText]. 

Phrase: "USA 94"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "213-218,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.489: 14.  

Phrase: "14."
Processing 00000000.tx.490: Lacy, P. 

Phrase: "Lacy, P."
Processing 00000000.tx.491: E, and M. 

Phrase: "E,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.492: Kostianovsky. 

Phrase: "Kostianovsky."
Processing 00000000.tx.493: Method for the isolation of intact islet of Langerhans from the rat pancreas. 

Phrase: "Method for the isolation of intact islet of Langerhans"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "from the rat pancreas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   861   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   861   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.494: Diabetes 16: 35-39, 1967[ISI][Medline]. 

Phrase: "Diabetes 16"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "35-39,"

Phrase: "1967"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.495: 15.  

Phrase: "15."
Processing 00000000.tx.496: Leahy, J. 

Phrase: "Leahy,"

Phrase: "J."
Processing 00000000.tx.497: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.498: Impaired -cell function with chronic hyperglycemia: overworked -cell hypothesis. 

Phrase: "Impaired -"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0221099:Impaired [Functional Concept]
  1000   C0684336:Impaired [Pathologic Function]

Phrase: "cell function with chronic hyperglycemia"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0007613:Cell Function [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1269647:Cell [Cell]
   760   C1704653:Cell [Medical Device]
   760   C1705273:Function [Intellectual Product]
   760   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "overworked -cell hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.499: Diabetes Res. 

Phrase: "Diabetes Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.500: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.501: Pract. 

Phrase: "Pract."
Processing 00000000.tx.502: 4: 298-319, 1996. 

Phrase: "4"

Phrase: ":"

Phrase: "298-319,"

Phrase: "1996."
Processing 00000000.tx.503: 16.  

Phrase: "16."
Processing 00000000.tx.504: Leyssens, A., A. 

Phrase: "Leyssens,"

Phrase: "A.,"

Phrase: "A."
Processing 00000000.tx.505: V. 

Phrase: "V."
Processing 00000000.tx.506: Nowicky, L. 

Phrase: "Nowicky,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.507: Patterson, M. 

Phrase: "Patterson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.508: Crompton, and M. 

Phrase: "Crompton,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.509: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.510: Duchen. 

Phrase: "Duchen."
Processing 00000000.tx.511: The relationship beween mitochondrial state, ATP hydrolysis, [Mg2+]i studied in isolated rat cardiomyocytes. 

Phrase: "The relationship beween mitochondrial state,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1301808:State [Geographic Area]
   812   C1442792:State [Functional Concept]
   812   C3148680:State [Geographic Area]

Phrase: "ATP hydrolysis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510699:ATP Hydrolysis [Molecular Function]
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "[Mg2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1417500:MG2 [Gene or Genome]
  1000   C2346927:Mg2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "]i"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "studied in isolated rat cardiomyocytes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0034693:Rat, NOS [Mammal]
   760   C0034721:Rat [Mammal]
   760   C0205409:Isolated [Functional Concept]
   760   C0225828:Cardiomyocytes [Cell]
   760   C1548221:Isolated [Idea or Concept]
   726   C0557651:Study [Manufactured Object]
   726   C2603343:Study [Research Activity]
Processing 00000000.tx.512: J. 

Phrase: "J."
Processing 00000000.tx.513: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.514: (Lond.) 

Phrase: "(Lond."

Phrase: ")"
Processing 00000000.tx.515: 496: 111-128, 1996[Abstract]. 

Phrase: "496"

Phrase: ":"

Phrase: "111-128,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.516: 17.  

Phrase: "17."
Processing 00000000.tx.517: Liu, Y., A. 

Phrase: "Liu,"

Phrase: "Y.,"

Phrase: "A."
Processing 00000000.tx.518: Rabinovitch, W. 

Phrase: "Rabinovitch,"

Phrase: "W."
Processing 00000000.tx.519: Suarez-Pinzon, B. 

Phrase: "Suarez-Pinzon,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.520: Muhkerjee, M. 

Phrase: "Muhkerjee,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.521: Brownlee, D. 

Phrase: "Brownlee,"

Phrase: "D."
Processing 00000000.tx.522: Edelstein, and H. 

Phrase: "Edelstein,"

Phrase: "and"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.523: J. 

Phrase: "J."
Processing 00000000.tx.524: Federoff. 

Phrase: "Federoff."
Processing 00000000.tx.525: Expression of the bcl-2 gene from a defective HSV-1 amplicon vector protects pancreatic -cells from apoptosis. 

Phrase: "Expression of the bcl-2 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "from a defective HSV-1 amplicon vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0442335:Vector [Spatial Concept]
   804   C1705099:Vector [Idea or Concept]

Phrase: "protects"

Phrase: "pancreatic -cells from apoptosis."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0007634:Cells [Cell]
   770   C3282337:Cells [Cell]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.526: Hum. 

Phrase: "Hum."
Processing 00000000.tx.527: Gene Ther. 

Phrase: "Gene Ther."
Processing 00000000.tx.528: 7: 1719-1726, 1996[ISI][Medline]. 

Phrase: "7"

Phrase: ":"

Phrase: "1719-1726,"

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.529: 18.  

Phrase: "18."
Processing 00000000.tx.530: Ma, A., J. 

Phrase: "Ma,"

Phrase: "A.,"

Phrase: "J."
Processing 00000000.tx.531: C. 

Phrase: "C."
Processing 00000000.tx.532: Pena, B. 

Phrase: "Pena,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.533: Change, E. 

Phrase: "Change,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "E."
Processing 00000000.tx.534: Margosian, L. 

Phrase: "Margosian,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.535: Davidson, and C. 

Phrase: "Davidson,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.536: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.537: Thompson. 

Phrase: "Thompson."
Processing 00000000.tx.538: Bcl-x regulates the survival of double-positive thymocytes. 

Phrase: "Bcl-x"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0219472:BCL-X [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332397:BCLX [Gene or Genome]
  1000   C1704960:BCLX [Gene or Genome]

Phrase: "regulates"

Phrase: "the survival of double-positive thymocytes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0038952:Survival [Activity]
   753   C0220921:survival [Functional Concept]
Processing 00000000.tx.539: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.540: Natl. 

Phrase: "Natl."
Processing 00000000.tx.541: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.542: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.543: USA 92: 4763-4767, 1995[Abstract]. 

Phrase: "USA 92"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "4763-4767,"

Phrase: "1995"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.544: 19.  

Phrase: "19."
Processing 00000000.tx.545: Maechler, P., E. 

Phrase: "Maechler,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "E."
Processing 00000000.tx.546: D. 

Phrase: "D."
Processing 00000000.tx.547: Kennedy, T. 

Phrase: "Kennedy,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.548: Pozzan, and C. 

Phrase: "Pozzan,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.549: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.550: Wollheim. 

Phrase: "Wollheim."
Processing 00000000.tx.551: Mitochondrial activation directly triggers the exocytosis of insulin in permeabilized pancreatic -cells. 

Phrase: "Mitochondrial activation directly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "triggers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032930:Trigger [Clinical Attribute]
  1000   C1444748:Trigger [Qualitative Concept]

Phrase: "the exocytosis of insulin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015283:Exocytosis [Cell Function]

Phrase: "in permeabilized pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.552: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.553: 16: 3833-3841, 1997[Abstract/Free FullText]. 

Phrase: "16"

Phrase: ":"

Phrase: "3833-3841,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.554: 20.  

Phrase: "20."
Processing 00000000.tx.555: Mosemann, T. 

Phrase: "Mosemann,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.556: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. 

Phrase: "Rapid colorimetric assay for cellular growth"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1516365:Cellular Assay [Research Activity]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "survival"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038952:Survival [Activity]
  1000   C0220921:survival [Functional Concept]

Phrase: ":"

Phrase: "application to proliferation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0185125:Application [Health Care Activity]
   790   C1947919:Application [Intellectual Product]
   790   C2347934:Application [Intellectual Product]
   790   C3539080:APPLICATION [Quantitative Concept]

Phrase: "and"

Phrase: "cytotoxicity assay."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0201622:Cytotoxicity assay [Laboratory Procedure]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   861   C1510438:Assay [Laboratory Procedure]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]
Processing 00000000.tx.557: J. 

Phrase: "J."
Processing 00000000.tx.558: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.559: Methods 65: 55-63, 1983[ISI][Medline]. 

Phrase: "Methods 65"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   861   C0450385:65 [Intellectual Product]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "55-63,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450382:55 [Intellectual Product]

Phrase: "1983"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.560: 21.  

Phrase: "21."
Processing 00000000.tx.561: Mukai, E., H. 

Phrase: "Mukai,"

Phrase: "E.,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.562: Ishida, S. 

Phrase: "Ishida,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.563: Kato, Y. 

Phrase: "Kato,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0721226:Kato [Inorganic Chemical,Pharmacologic Substance]
  1000   C1551914:Kato [Language]

Phrase: "Y."
Processing 00000000.tx.564: Tsuura, S. 

Phrase: "Tsuura,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.565: Fujimoto, A. 

Phrase: "Fujimoto,"

Phrase: "A."
Processing 00000000.tx.566: Ishida-Takahashi, M. 

Phrase: "Ishida-Takahashi,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.567: Horie, K. 

Phrase: "Horie,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.568: Tsuda, and Y. 

Phrase: "Tsuda,"

Phrase: "and"

Phrase: "Y."
Processing 00000000.tx.569: Seino. 

Phrase: "Seino."
Processing 00000000.tx.570: Metabolic inhibition impairs ATP-sensitive K+ channel block by sulfonylurea in pancreatic -cells. 

Phrase: "Metabolic inhibition"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0021469:Metabolic Inhibition [Molecular Function]
           Inhibition
   861   C0021467:Inhibition [Mental Process]
   861   C1628982:% inhibition [Quantitative Concept]
   861   C3463820:Inhibition [Activity]
   789 E C0311403:Inhibited [Qualitative Concept]

Phrase: "impairs"

Phrase: "ATP-sensitive K+ channel block by sulfonylurea"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0028778:Block [Pathologic Function]
   748   C0332206:Block [Functional Concept]
   748   C1533157:Block [Substance]
   748   C1706084:Block [Geographic Area]
   748   C2828370:Block [Quantitative Concept]

Phrase: "in pancreatic -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.571: Am. 

Phrase: "Am."
Processing 00000000.tx.572: J.

Phrase: "J."
Processing 00000000.tx.573: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.574: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.575: Metab. 

Phrase: "Metab."
Processing 00000000.tx.576: 274: E38-E44, 1998[Abstract/Free FullText]. 

Phrase: "274"

Phrase: ":"

Phrase: "E38-E44,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.577: 22.  

Phrase: "22."
Processing 00000000.tx.578: Murphy, A. 

Phrase: "Murphy,"

Phrase: "A."
Processing 00000000.tx.579: N., D. 

Phrase: "N., D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1513911:N.D. [Intellectual Product]
Processing 00000000.tx.580: E. 

Phrase: "E."
Processing 00000000.tx.581: Bredesen, G. 

Phrase: "Bredesen,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.582: Cortopassi, E. 

Phrase: "Cortopassi,"

Phrase: "E."
Processing 00000000.tx.583: Wang, and G. 

Phrase: "Wang,"

Phrase: "and"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.584: Fiskum. 

Phrase: "Fiskum."
Processing 00000000.tx.585: Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. 

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "potentiates"

Phrase: "the maximal calcium uptake capacity of neural cell mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1516240:Capacity [Quantitative Concept]
Processing 00000000.tx.586: Proc. 

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.587: Natl. 

Phrase: "Natl."
Processing 00000000.tx.588: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.589: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.590: USA 94: 9893-9898, 1996[Abstract/Free FullText]. 

Phrase: "USA 94"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041703:USA [Geographic Area]

Phrase: ":"

Phrase: "9893-9898,"

Phrase: "1996"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.591: 23.  

Phrase: "23."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]
Processing 00000000.tx.592: Naik, P., J. 

Phrase: "Naik,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "J."
Processing 00000000.tx.593: Karrim, and D. 

Phrase: "Karrim,"

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.594: Hanahan. 

Phrase: "Hanahan."
Processing 00000000.tx.595: The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors. 

Phrase: "The rise"

Phrase: "and"

Phrase: "fall of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085639:Fall [Finding]
   790   C0238715:Fall [Temporal Concept]

Phrase: "during multistage tumorigenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0007621:Tumorigenesis [Neoplastic Process]
   861   C0596263:Tumorigenesis [Neoplastic Process]

Phrase: ":"

Phrase: "down-modulation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0205104:Down [Spatial Concept]
   861   C0443264:Modulation [Spatial Concept]
   805 E C0423866:Lanugo [Body Part, Organ, or Organ Component]
   805 E C2626739:Lanugo [Eukaryote]

Phrase: "contributes to tumor progression"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0178874:Tumor Progression [Neoplastic Process]
   770   C0027651:Tumor [Neoplastic Process]
   770   C0242656:progression [Pathologic Function]
   770   C0449258:Progression [Functional Concept]
   770   C1578706:Tumor [Intellectual Product]
   770   C1880177:Contribute [Activity]
   770   C3273930:Tumor [Finding]

Phrase: "from angiogenic progenitors."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0870134:Progenitor [Family Group]
Processing 00000000.tx.596: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.597: 10: 2105-2116, 1996[Abstract]. 

Phrase: "10"

Phrase: ":"

Phrase: "2105-2116,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.598: 24.  

Phrase: "24."
Processing 00000000.tx.599: Newgard, C. 

Phrase: "Newgard,"

Phrase: "C."
Processing 00000000.tx.600: B., and J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.601: D. 

Phrase: "D."
Processing 00000000.tx.602: McGarry. 

Phrase: "McGarry."
Processing 00000000.tx.603: Metabolic coupling factors in pancreatic -cell signal transduction. 

Phrase: "Metabolic coupling factors in pancreatic -cell signal transduction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1521761:Factor [Functional Concept]
   711   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.604: Annu. 

Phrase: "Annu."
Processing 00000000.tx.605: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.606: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.607: 64: 689-719, 1995[ISI][Medline]. 

Phrase: "64"

Phrase: ":"

Phrase: "689-719,"

Phrase: "1995"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.608: 25.  

Phrase: "25."
Processing 00000000.tx.609: Pena, J. 

Phrase: "Pena,"

Phrase: "J."
Processing 00000000.tx.610: C., E. 

Phrase: "C., E."
Processing 00000000.tx.611: Fuchs, and C. 

Phrase: "Fuchs,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.612: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.613: Thompson. 

Phrase: "Thompson."
Processing 00000000.tx.614: Bcl-x expression influences keratinocyte cell survival but not terminal differentiation. 

Phrase: "Bcl-x expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]
   734   C0219472:BCL-X [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332397:BCLX [Gene or Genome]
   734   C1704960:BCLX [Gene or Genome]

Phrase: "influences"

Phrase: "keratinocyte cell survival"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0007620:Cell Survival [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0038952:Survival [Activity]
   827   C0220921:survival [Functional Concept]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "but"

Phrase: "not terminal differentiation."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C2752630:terminal differentiation [Cell Function]
   827   C0007589:Differentiation [Cell Function]
   827   C1511938:Differentiation [Clinical Attribute]
   827   C2945687:Differentiation [Functional Concept]
   755 E C0205615:Differentiated [Qualitative Concept]
Processing 00000000.tx.615: Cell Growth Differ. 

Phrase: "Cell Growth"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0007595:Cell Growth [Cell Function]
   861   C0018270:'growth' NOS [Organism Function]
   861   C0220844:growth [Physiologic Function]
   861   C1621966:Growth [Organ or Tissue Function]
   861   C2911660:Growth [Activity]

Phrase: "Differ."
Processing 00000000.tx.616: 8: 619-629, 1997[Abstract]. 

Phrase: "8"

Phrase: ":"

Phrase: "619-629,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.617: 26.  

Phrase: "26."
Processing 00000000.tx.618: Pick, A., J. 

Phrase: "Pick,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1707391:Pick [Activity]
  1000   C1826583:PICK [Gene or Genome]

Phrase: "A.,"

Phrase: "J."
Processing 00000000.tx.619: Clark, C. 

Phrase: "Clark,"

Phrase: "C."
Processing 00000000.tx.620: Kubstrup, M. 

Phrase: "Kubstrup,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.621: Levisetti, W. 

Phrase: "Levisetti,"

Phrase: "W."
Processing 00000000.tx.622: Pugh, S Bonner-Weir, and K. 

Phrase: "Pugh,"

Phrase: "S Bonner-Weir,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.623: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.624: Polonsky. 

Phrase: "Polonsky."
Processing 00000000.tx.625: Role of apoptosis in failure of -cell mass compensation for insulin resistance and -cell defects in the male Zucker diabetic fatty rats. 

Phrase: "Role of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035820:Role [Social Behavior]
   790   C1705810:Role [Conceptual Entity]

Phrase: "in failure of -cell mass compensation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0152057:Compensation [Mental Process]
   804   C0152058:Compensation [Physiologic Function]
   804   C0220808:Compensation [Quantitative Concept]

Phrase: "for insulin resistance"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0021655:Insulin Resistance [Pathologic Function]
  1000   C2700570:INSULIN RESISTANCE [Gene or Genome]
   861   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C0237834:Resistance [Mental Process]
   861   C1514892:Resistance [Physiologic Function]
   861   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   861   C1579433:Insulin [Pharmacologic Substance]
   805 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   789 E C0332325:Resistant [Functional Concept]
   789 E C1550464:resistent [Idea or Concept]
   789 E C2827757:RESISTANT [Laboratory or Test Result]
   777 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "and -"

Phrase: "cell defects in the male Zucker diabetic fatty rats."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   742   C0243067:defects [Functional Concept]
   708 E C1457869:Defect [Functional Concept]
   708 E C1861101:DEFECT [Disease or Syndrome]
Processing 00000000.tx.626: Diabetes 47: 358-364, 1998[Abstract]. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "358-364,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.627: 27.  

Phrase: "27."
Processing 00000000.tx.628: Pontoglio, M., S. 

Phrase: "Pontoglio,"

Phrase: "M."

Phrase: ","

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.629: Sreenan, M. 

Phrase: "Sreenan,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.630: Roe, W. 

Phrase: "Roe,"

Phrase: "W."
Processing 00000000.tx.631: Pugh, D. 

Phrase: "Pugh,"

Phrase: "D."
Processing 00000000.tx.632: Ostrega, A. 

Phrase: "Ostrega,"

Phrase: "A."
Processing 00000000.tx.633: Doyen, A. 

Phrase: "Doyen,"

Phrase: "A."
Processing 00000000.tx.634: J. 

Phrase: "J."
Processing 00000000.tx.635: Pick, A. 

Phrase: "Pick,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1707391:Pick [Activity]
  1000   C1826583:PICK [Gene or Genome]

Phrase: "A."
Processing 00000000.tx.636: Baldwin, G. 

Phrase: "Baldwin,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.637: Velho, P. 

Phrase: "Velho,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.638: Froguel, M. 

Phrase: "Froguel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.639: Levisetti, S. 

Phrase: "Levisetti,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.640: Bonner-Weir, G. 

Phrase: "Bonner-Weir,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.641: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.642: Bell, M. 

Phrase: "Bell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706917:Bell [Manufactured Object]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.643: Yaniv, and K. 

Phrase: "Yaniv,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.644: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.645: Polonsky. 

Phrase: "Polonsky."
Processing 00000000.tx.646: Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. 

Phrase: "Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C1256369:insulin secretion [Cell Function]
   739   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C0036536:secretion [Biologic Function]
   739   C0036537:Secretion [Body Substance]
   739   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   739   C1579433:Insulin [Pharmacologic Substance]
Processing 00000000.tx.647: J. 

Phrase: "J."
Processing 00000000.tx.648: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.649: Invest. 

Phrase: "Invest."
Processing 00000000.tx.650: 101: 2215-2222, 1998[Abstract/Free FullText]. 

Phrase: "101"

Phrase: ":"

Phrase: "2215-2222,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.651: 28.  

Phrase: "28."
Processing 00000000.tx.652: Pralong, W-F., C. 

Phrase: "Pralong,"

Phrase: "W-F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "C."
Processing 00000000.tx.653: Bartley, and C. 

Phrase: "Bartley,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.654: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.655: Wollheim. 

Phrase: "Wollheim."
Processing 00000000.tx.656: Single islet -cell stimulation by nutrients: relationship between pyridine nucleotides, cytosolic Ca2+ and secretion. 

Phrase: "Single islet -cell stimulation by nutrients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   753   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: ":"

Phrase: "relationship between pyridine nucleotides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "cytosolic Ca2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "secretion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0036536:secretion [Biologic Function]
  1000   C0036537:Secretion [Body Substance]
Processing 00000000.tx.657: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.658: 9: 53-60, 1990[Abstract]. 

Phrase: "9"

Phrase: ":"

Phrase: "53-60,"

Phrase: "1990"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.659: 29.  

Phrase: "29."
Processing 00000000.tx.660: Reed, J. 

Phrase: "Reed,"

Phrase: "J."
Processing 00000000.tx.661: C., J. 

Phrase: "C., J."
Processing 00000000.tx.662: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.663: Jurgensmeier, and S. 

Phrase: "Jurgensmeier,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.664: Matsuyama. 

Phrase: "Matsuyama."
Processing 00000000.tx.665: Bcl-2 family proteins and mitochondria. 

Phrase: "Bcl-2 family proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   912   C0597712:BCL-2 Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]
Processing 00000000.tx.666: Biochim. 

Phrase: "Biochim."
Processing 00000000.tx.667: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.668: Acta 1366: 127-137, 1998[ISI][Medline]. 

Phrase: "Acta 1366"

Phrase: ":"

Phrase: "127-137,"

Phrase: "1998"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.669: 30.  

Phrase: "30."
Processing 00000000.tx.670: Robb-Gaspers, L. 

Phrase: "Robb-Gaspers,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.671: D., P. 

Phrase: "D."

Phrase: ","

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.672: Burnett, G. 

Phrase: "Burnett,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.673: A. 

Phrase: "A."
Processing 00000000.tx.674: Rutter, R. 

Phrase: "Rutter,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.675: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.676: Denton, R. 

Phrase: "Denton,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.677: Rizzuto, and A. 

Phrase: "Rizzuto,"

Phrase: "and"

Phrase: "A."
Processing 00000000.tx.678: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.679: Thomas. 

Phrase: "Thomas."
Processing 00000000.tx.680: Integrating cytosolic calcium signals into mitochondrial metabolism responses. 

Phrase: "Integrating"

Phrase: "cytosolic calcium"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0006726:Calcium [Inorganic Chemical]
   861   C2936886:Calcium [Pharmacologic Substance]

Phrase: "signals into mitochondrial metabolism responses."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   760   C0025519:Metabolism [Organism Function]
   760   C0025520:metabolism [Functional Concept]
   760   C0026237:Mitochondrial [Cell Component]
   760   C0521451:Mitochondrial [Functional Concept]
   760   C0871261:responses [Organism Attribute]
   760   C1710082:Signal [Phenomenon or Process]
   726 E C1704632:Response [Finding]
   726 E C1706817:Response [Intellectual Product]
   726 E C2911692:Response [Mental Process]
Processing 00000000.tx.681: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.682: 17: 4987-5000, 1998[Abstract/Free FullText]. 

Phrase: "17"

Phrase: ":"

Phrase: "4987-5000,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.683: 31.  

Phrase: "31."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]
Processing 00000000.tx.684: Roe, M. 

Phrase: "Roe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.685: W., R. 

Phrase: "W., R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.686: J. 

Phrase: "J."
Processing 00000000.tx.687: Mertz, M. 

Phrase: "Mertz,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.688: E. 

Phrase: "E."
Processing 00000000.tx.689: Lancaster, J. 

Phrase: "Lancaster,"

Phrase: "J."
Processing 00000000.tx.690: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.691: Worley III, and I. 

Phrase: "Worley III,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: "and"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.692: D. 

Phrase: "D."
Processing 00000000.tx.693: Dukes. 

Phrase: "Dukes."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1512090:Dukes [Classification]
   966 E C1446468:Duke [Laboratory Procedure]
Processing 00000000.tx.694: Thapsigargin inhibits the glucose-induced decrease of intracellular Ca2+ in mouse islets of Langerhans. 

Phrase: "Thapsigargin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076374:Thapsigargin [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the glucose-induced decrease of intracellular Ca2+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0392756:Decrease [Qualitative Concept]
   748   C0547047:Decrease [Quantitative Concept]

Phrase: "in mouse islets"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522528:Mouse Islets [Tissue]

Phrase: "of Langerhans."
Processing 00000000.tx.695: Am. 

Phrase: "Am."
Processing 00000000.tx.696: J.

Phrase: "J."
Processing 00000000.tx.697: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.698: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.699: Metab. 

Phrase: "Metab."
Processing 00000000.tx.700: 266: E852-E862, 1994[Abstract/Free FullText]. 

Phrase: "266"

Phrase: ":"

Phrase: "E852-E862,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.701: 32.  

Phrase: "32."
Processing 00000000.tx.702: Rorsman, P. 

Phrase: "Rorsman,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.703: The pancreatic beta-cell as a fuel sensor: an electrophysiologist's view point. 

Phrase: "The pancreatic beta-cell as a fuel sensor"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0030281:Pancreatic beta cell [Cell]
           Beta cell
   789   C0030280:Pancreatic A-cell [Cell]
   767   C0007634:THE CELL [Cell]
           Cell
   744   C0030274:Pancreatic [Body Part, Organ, or Organ Component]
   744   C0330390:Beta [Plant]
   744   C0439096:Beta [Intellectual Product]
   744   C1269647:Cell [Cell]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]
   744   C2004068:Beta [Qualitative Concept]

Phrase: ":"

Phrase: "an electrophysiologist's view point."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0449911:View [Spatial Concept]
   827   C1552961:Point [Quantitative Concept]
   827   C2347617:point [Quantitative Concept]
Processing 00000000.tx.704: Diabetologia 40: 487-495, 1997[ISI][Medline]. 

Phrase: "Diabetologia 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "487-495,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.705: 33.  

Phrase: "33."
Processing 00000000.tx.706: Rustenbeck, I., C. 

Phrase: "Rustenbeck,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "C."
Processing 00000000.tx.707: Herrmann, and T. 

Phrase: "Herrmann,"

Phrase: "and"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.708: Grimmsmann. 

Phrase: "Grimmsmann."
Processing 00000000.tx.709: Energetic requirement of insulin secretion distal to calcium influx. 

Phrase: "Energetic requirement of insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1514873:Requirement [Functional Concept]

Phrase: "distal to calcium influx."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205108:Distal [Spatial Concept]
Processing 00000000.tx.710: Diabetes 46: 1305-1311, 1997[Abstract]. 

Phrase: "Diabetes 46"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "1305-1311,"

Phrase: "1997"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.711: 34.  

Phrase: "34."
Processing 00000000.tx.712: Scaglia, L., F. 

Phrase: "Scaglia,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.713: E. 

Phrase: "E."
Processing 00000000.tx.714: Smith, and S. 

Phrase: "Smith,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.715: BonnerWeir. 

Phrase: "BonnerWeir."
Processing 00000000.tx.716: Apoptosis contributes to the involution of -cell mass in the postpartum rat pancreas. 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "contributes to the involution of -cell mass"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0007634:Cell [Cell]
   748   C0333953:Involution [Organism Function]
   748   C0577559:Mass [Finding]
   748   C1269647:Cell [Cell]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1704653:Cell [Medical Device]
   748   C1880177:Contribute [Activity]
   748   C1948049:Cell [Spatial Concept]
   748   C3152252:Mass [Quantitative Concept]

Phrase: "in the postpartum rat pancreas."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C1882810:Rat Pancreas [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreas [Body Part, Organ, or Organ Component]
   827   C1278931:Pancreas [Body Part, Organ, or Organ Component]
Processing 00000000.tx.717: Endocrinology 136: 5461-5468, 1996[Abstract]. 

Phrase: "Endocrinology 136"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0014137:Endocrinology [Biomedical Occupation or Discipline]
   789 E C0694557:endocrinologic [Functional Concept]

Phrase: ":"

Phrase: "5461-5468,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.718: 35.  

Phrase: "35."
Processing 00000000.tx.719: Schuit, F., A. 

Phrase: "Schuit,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.720: De Vos, S. 

Phrase: "De Vos,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.721: Farfari, K. 

Phrase: "Farfari,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.722: Moens, D. 

Phrase: "Moens,"

Phrase: "D."
Processing 00000000.tx.723: Pipeleers, T. 

Phrase: "Pipeleers,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.724: Brun, and M. 

Phrase: "Brun,"

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.725: Prentki. 

Phrase: "Prentki."
Processing 00000000.tx.726: Metabolic fate of glucose in purified islet cells, glucose-regulated anaplerosis in -cells. 

Phrase: "Metabolic fate of glucose"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1539479:FATE [Gene or Genome]

Phrase: "in purified islet cells,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   901   C0022131:Islet Cells [Body Part, Organ, or Organ Component]
   867 E C1522529:Islet Cell [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "glucose-regulated anaplerosis in -cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.727: J. 

Phrase: "J."
Processing 00000000.tx.728: Biol. 

Phrase: "Biol."
Processing 00000000.tx.729: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.730: 272: 18572-18579, 1997[Abstract/Free FullText]. 

Phrase: "272"

Phrase: ":"

Phrase: "18572-18579,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.731: 36.  

Phrase: "36."
Processing 00000000.tx.732: Schwartzman, R. 

Phrase: "Schwartzman,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.733: A., and J. 

Phrase: "A.,"

Phrase: "and"

Phrase: "J."
Processing 00000000.tx.734: A. 

Phrase: "A."
Processing 00000000.tx.735: Cidlowski. 

Phrase: "Cidlowski."
Processing 00000000.tx.736: Apoptosis: the biolochemistry and molecular biology of programmed cell death. 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ":"

Phrase: "the biolochemistry"

Phrase: "and"

Phrase: "molecular biology of programmed cell death."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0026376:Molecular Biology [Biomedical Occupation or Discipline]
   783   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   753   C0005532:Biology [Biomedical Occupation or Discipline]
   753   C1521991:Molecular [Qualitative Concept]
   748   C0011065:biological death [Organism Function]
Processing 00000000.tx.737: Endocr. 

Phrase: "Endocr."
Processing 00000000.tx.738: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.739: 14: 133-151, 1993[ISI][Medline]. 

Phrase: "14"

Phrase: ":"

Phrase: "133-151,"

Phrase: "1993"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.740: 37.  

Phrase: "37."
Processing 00000000.tx.741: Sturis, J., W. 

Phrase: "Sturis,"

Phrase: "J.,"

Phrase: "W."
Processing 00000000.tx.742: Pugh, J. 

Phrase: "Pugh,"

Phrase: "J."
Processing 00000000.tx.743: Tang, D. 

Phrase: "Tang,"

Phrase: "D."
Processing 00000000.tx.744: Ostrga, J. 

Phrase: "Ostrga,"

Phrase: "J."
Processing 00000000.tx.745: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.746: Polonsky, and K. 

Phrase: "Polonsky,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.747: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.748: Polonsky. 

Phrase: "Polonsky."
Processing 00000000.tx.749: Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat. 

Phrase: "Alterations in pulsatile insulin secretion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "in the Zucker diabetic fatty rat."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   902   C0034719:Zucker rat [Mammal]
   812   C0034693:Rat, NOS [Mammal]
   812   C0034721:Rat [Mammal]
Processing 00000000.tx.750: Am. 

Phrase: "Am."
Processing 00000000.tx.751: J.

Phrase: "J."
Processing 00000000.tx.752: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.753: Endocrinol. 

Phrase: "Endocrinol."
Processing 00000000.tx.754: Metab. 

Phrase: "Metab."
Processing 00000000.tx.755: 267: E250-E259, 1994[Abstract/Free FullText]. 

Phrase: "267"

Phrase: ":"

Phrase: "E250-E259,"

Phrase: "1994"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.756: 38.  

Phrase: "38."
Processing 00000000.tx.757: Thompson, C. 

Phrase: "Thompson,"

Phrase: "C."
Processing 00000000.tx.758: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.759: Apoptosis in the pathogenesis and treatment of disease. 

Phrase: "Apoptosis in the pathogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "treatment of disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.760: Science 267: 1465-1562, 1995. 

Phrase: "Science 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "1465-1562,"

Phrase: "1995."
Processing 00000000.tx.761: 39.  

Phrase: "39."
Processing 00000000.tx.762: Tsuruzoe, K., E. 

Phrase: "Tsuruzoe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "E."
Processing 00000000.tx.763: Araki, N. 

Phrase: "Araki,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.764: Furukawa, T. 

Phrase: "Furukawa,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.765: Shirotani, K. 

Phrase: "Shirotani,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.766: Matsumoto, K. 

Phrase: "Matsumoto,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.767: Kaneko, H. 

Phrase: "Kaneko,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.768: Motoshima, K. 

Phrase: "Motoshima,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.769: Yoshizato, A. 

Phrase: "Yoshizato,"

Phrase: "A."
Processing 00000000.tx.770: Shirakami, H. 

Phrase: "Shirakami,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.771: Kishikawa, J. 

Phrase: "Kishikawa,"

Phrase: "J."
Processing 00000000.tx.772: Miyazaki, and M. 

Phrase: "Miyazaki,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0315755:Miyazaki [Bacterium]

Phrase: "and"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.773: Shichiri. 

Phrase: "Shichiri."
Processing 00000000.tx.774: Creation and characterization of a mitochondrial DNA-depleted pancreatic -cell line, impaired insulin secretion induced by glucose, leucine, and sulfonylureas. 

Phrase: "Creation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441513:Creation [Therapeutic or Preventive Procedure]
  1000   C1706214:Creation [Activity]

Phrase: "and"

Phrase: "characterization of a mitochondrial DNA-depleted pancreatic -cell line,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1880022:Characterization [Activity]

Phrase: "impaired insulin secretion"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   901   C1256369:insulin secretion [Cell Function]
   827   C0021641:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C0036536:secretion [Biologic Function]
   827   C0036537:Secretion [Body Substance]
   827   C1533581:Insulin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   827   C1579433:Insulin [Pharmacologic Substance]
   771 E C0020884:Iletin [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]
   743 E C3537244:Insulins [Pharmacologic Substance]

Phrase: "induced by glucose,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0017725:Glucose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   790   C0205263:Induced [Functional Concept]

Phrase: "leucine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023401:Leucine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "sulfonylureas."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0038766:SULFONYLUREAS [Organic Chemical,Pharmacologic Substance]
   966 E C3536898:Sulfonylurea [Pharmacologic Substance]
Processing 00000000.tx.775: Diabetes 47: 621-631, 1998[Abstract]. 

Phrase: "Diabetes 47"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "621-631,"

Phrase: "1998"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.776: 40.  

Phrase: "40."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]
Processing 00000000.tx.777: Vander Heiden, M. 

Phrase: "Vander Heiden,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.778: G., N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.779: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.780: Chandel, P. 

Phrase: "Chandel,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.781: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.782: Schumacker, and C. 

Phrase: "Schumacker,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.783: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.784: Thompson. 

Phrase: "Thompson."
Processing 00000000.tx.785: Bcl-xL prevents cell death following growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange. 

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "growth factor withdrawal by facilitating mitochondrial ATP/ADP exchange."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C2349954:Withdrawal [Activity]
   742   C2825032:Withdrawal [Mental or Behavioral Dysfunction]
Processing 00000000.tx.786: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.787: Cells 3: 159-167, 1999. 

Phrase: "Cells 3"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "159-167,"

Phrase: "1999."
Processing 00000000.tx.788: 41.  

Phrase: "41."
Processing 00000000.tx.789: Vander Heiden, M. 

Phrase: "Vander Heiden,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.790: G., N. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.791: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.792: Chandel, E. 

Phrase: "Chandel,"

Phrase: "E."
Processing 00000000.tx.793: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.794: Williamson, P. 

Phrase: "Williamson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.795: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.796: Schumacker, and C. 

Phrase: "Schumacker,"

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.797: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.798: Thompson. 

Phrase: "Thompson."
Processing 00000000.tx.799: Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. 

Phrase: "Bcl-xL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1332397:bcl-xL [Gene or Genome]

Phrase: "regulates"

Phrase: "the membrane potential"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0025251:Membrane Potential [Cell Function]
   861   C0025255:Membrane [Tissue]
   861   C0596901:Membrane [Cell Component]
   861   C1706182:Membrane [Manufactured Object]
   861   C3245505:Potential [Qualitative Concept]
   789 E C0205287:Membranous [Qualitative Concept]

Phrase: "and"

Phrase: "volume homeostasis of mitochondria."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019868:Homeostasis [Biologic Function]
Processing 00000000.tx.800: Cell 91: 627-637, 1997[ISI][Medline]. 

Phrase: "Cell 91"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "627-637,"

Phrase: "1997"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.801: 42.  

Phrase: "42."
Processing 00000000.tx.802: White, E. 

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "E."
Processing 00000000.tx.803: Life, death, and the pursuit of apoptosis. 

Phrase: "Life,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0376558:Life [Idea or Concept]
   916 E C0595998:lives [Finding]

Phrase: "death,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011065:Death [Organism Function]
  1000   C1306577:Death, NOS [Finding]

Phrase: "and"

Phrase: "the pursuit of apoptosis."
Processing 00000000.tx.804: Genes Dev. 

Phrase: "Genes Dev."
Processing 00000000.tx.805: 10: 1-15, 1996[ISI][Medline]. 

Phrase: "10"

Phrase: ":"

Phrase: "1-15,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "1996"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]."
Processing 00000000.tx.806: 43.  

Phrase: "43."
Processing 00000000.tx.807: Yang, E., and S. 

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "E.,"

Phrase: "and"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.808: J. 

Phrase: "J."
Processing 00000000.tx.809: Kershly. 

Phrase: "Kershly."
Processing 00000000.tx.810: Molecular thanatopsis: a discourse on the BCL2 family and cell death. 

Phrase: "Molecular thanatopsis"

Phrase: ":"

Phrase: "a discourse on the BCL2 family"

Phrase: "and"

Phrase: "cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.811: Blood 88: 386-401, 1996[Free FullText]. 

Phrase: "Blood 88"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: ":"

Phrase: "386-401,"

Phrase: "1996"

Phrase: "[Free FullText"

Phrase: "]."
Processing 00000000.tx.812: 44.  

Phrase: "44."
Processing 00000000.tx.813: Zawalich, W. 

Phrase: "Zawalich,"

Phrase: "W."
Processing 00000000.tx.814: S., and K. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.815: C. 

Phrase: "C."
Processing 00000000.tx.816: Zawalich. 

Phrase: "Zawalich."
Processing 00000000.tx.817: Influence of pyruvic acid methyl ester on rat pancreatic islets: effects on insulin secretion, phosphoinositide hydrolysis, and sensitization of the beta cell. 

Phrase: "Influence of pyruvic acid methyl ester"

Phrase: "on rat pancreatic islets"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0022131:Pancreatic Islets [Body Part, Organ, or Organ Component]
   827   C0030274:Pancreatic [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "effects on insulin secretion,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "phosphoinositide hydrolysis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "sensitization of the beta cell."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1325847:Sensitisation [Mental Process]
Processing 00000000.tx.818: J. 

Phrase: "J."
Processing 00000000.tx.819: Biol. 

Phrase: "Biol."
Processing 00000000.tx.820: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.821: 272: 3527-3531, 1997[Abstract/Free FullText]. 

Phrase: "272"

Phrase: ":"

Phrase: "3527-3531,"

Phrase: "1997"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.822: 45.  

Phrase: "45."
Processing 00000000.tx.823: Zhou, Y. 

Phrase: "Zhou,"

Phrase: "Y."
Processing 00000000.tx.824: P., P-O. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "P-O."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.825: Berggren, and V. 

Phrase: "Berggren,"

Phrase: "and"

Phrase: "V."
Processing 00000000.tx.826: Grill. 

Phrase: "Grill."
Processing 00000000.tx.827: A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of -cell dysfunction in the obese diabetic db/db mouse. 

Phrase: "A fatty acid-induced decrease in pyruvate dehydrogenase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0392756:Decrease [Qualitative Concept]
   742   C0547047:Decrease [Quantitative Concept]

Phrase: "is"

Phrase: "an important determinant of -cell dysfunction"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0031847:dysfunction [Functional Concept]
   804   C0277785:Dysfunction, NOS [Qualitative Concept]
   748 E C0231174:Malfunction [Functional Concept]
   748 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "in the obese diabetic db/db mouse."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   897   C0025933:Mouse, Obese [Mammal]
   804   C0025914:Mouse [Mammal]
   804   C0025929:mouse [Mammal]
   804   C0026809:Mouse [Mammal]
Processing 00000000.tx.828: Diabetes 45: 580-586, 1996[Abstract]. 

Phrase: "Diabetes 45"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0011847:Diabetes [Disease or Syndrome]
   861   C0011849:Diabetes [Disease or Syndrome]

Phrase: ":"

Phrase: "580-586,"

Phrase: "1996"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "]."
Processing 00000000.tx.829: 46.  

Phrase: "46."
Processing 00000000.tx.830: Zhou, Y. 

Phrase: "Zhou,"

Phrase: "Y."
Processing 00000000.tx.831: P., D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "D."
Processing 00000000.tx.832: Teng, F. 

Phrase: "Teng,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.833: Dralyuk, D. 

Phrase: "Dralyuk,"

Phrase: "D."
Processing 00000000.tx.834: Ostrega, M. 

Phrase: "Ostrega,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.835: W. 

Phrase: "W."
Processing 00000000.tx.836: Roe, L. 

Phrase: "Roe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.837: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.838: Philipson, and K. 

Phrase: "Philipson,"

Phrase: "and"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.839: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.840: Polonsky. 

Phrase: "Polonsky."
Processing 00000000.tx.841: Apoptosis in insulin-secreting cells: evidence for the role of intracellular Ca2+ stores and arachidonic acid metabolism. 

Phrase: "Apoptosis in insulin-secreting cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162638:Apoptosis [Cell Function]

Phrase: ":"

Phrase: "evidence for the role of intracellular Ca2+ stores"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "and"

Phrase: "arachidonic acid metabolism."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1158360:arachidonic acid metabolism [Molecular Function]
  1000   C1879725:Arachidonic Acid Metabolism [Molecular Function]
   913   C0596480:arachidonic metabolism [Molecular Function]
   827   C0025519:Metabolism [Organism Function]
   827   C0025520:metabolism [Functional Concept]
   734   C0003695:Arachidonic Acid [Eicosanoid]
   734   C2316832:Arachidonic Acid [Laboratory Procedure]
Processing 00000000.tx.842: J. 

Phrase: "J."
Processing 00000000.tx.843: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.844: Invest. 

Phrase: "Invest."
Processing 00000000.tx.845: 101: 1623-1632, 1998[Abstract/Free FullText]. 

Phrase: "101"

Phrase: ":"

Phrase: "1623-1632,"

Phrase: "1998"

Phrase: "[Abstract/Free FullText"

Phrase: "]."
Processing 00000000.tx.846: Am J Physiol Endocrinol Metab 278(2):E340-E351 0193-1849/00 $5.00 Copyright  2000 the American Physiological Society

Phrase: "Am"

Phrase: "J Physiol Endocrinol Metab 278"

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ":"

Phrase: "E340-E351 0193-1849/00 $5.00 Copyright  2000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0009993:Copyright [Intellectual Product]
   791   C1552856:copyright [Idea or Concept]

Phrase: "the American Physiological Society"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0037455:society [Organization]
   827   C0205463:Physiological [Functional Concept]
   827   C0596070:American [Population Group]
   755 E C0031842:Physiology [Biomedical Occupation or Discipline]
   755 E C0031843:physiology [Physiologic Function]

